
<html lang="en"     class="pb-page"  data-request-id="4c517f48-ea1c-4039-b1ef-88e8ddfdde40"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm201333e;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-1;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Anaplastic Lymphoma Kinase (ALK) Inhibitory Activity for a Novel Series of 2,4,8,22-Tetraazatetracyclo[14.3.1.13,7.19,13]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Macrocycles" /></meta><meta name="dc.Creator" content="Henry J.  Breslin" /></meta><meta name="dc.Creator" content="Brandon M.  Lane" /></meta><meta name="dc.Creator" content="Gregory R.  Ott" /></meta><meta name="dc.Creator" content="Arup K.  Ghose" /></meta><meta name="dc.Creator" content="Thelma S.  Angeles" /></meta><meta name="dc.Creator" content="Mark S.  Albom" /></meta><meta name="dc.Creator" content="Mangeng  Cheng" /></meta><meta name="dc.Creator" content="Weihua  Wan" /></meta><meta name="dc.Creator" content="R. Curtis  Haltiwanger" /></meta><meta name="dc.Creator" content="Kevin J.  Wells-Knecht" /></meta><meta name="dc.Creator" content="Bruce D.  Dorsey" /></meta><meta name="dc.Description" content="A novel set of 2,4,8,22-tetraazatetracyclo[14.3.1.13,7.19,13]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene macrocycles were prepared as potential anaplastic lymphoma kinase (ALK) inhibitors, des..." /></meta><meta name="Description" content="A novel set of 2,4,8,22-tetraazatetracyclo[14.3.1.13,7.19,13]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene macrocycles were prepared as potential anaplastic lymphoma kinase (ALK) inhibitors, des..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 15, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201333e" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2011 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201333e" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201333e" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201333e" /></link>
        
    
    

<title>Design, Synthesis, and Anaplastic Lymphoma Kinase (ALK) Inhibitory Activity for a Novel Series of 2,4,8,22-Tetraazatetracyclo[14.3.1.13,7.19,13]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Macrocycles | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201333e" /></meta><meta property="og:title" content="Design, Synthesis, and Anaplastic Lymphoma Kinase (ALK) Inhibitory Activity for a Novel Series of 2,4,8,22-Tetraazatetracyclo[14.3.1.13,7.19,13]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Macrocycles" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0008.jpeg" /></meta><meta property="og:description" content="A novel set of 2,4,8,22-tetraazatetracyclo[14.3.1.13,7.19,13]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene macrocycles were prepared as potential anaplastic lymphoma kinase (ALK) inhibitors, designed to rigidly lock an energy-minimized bioactive conformation of the diaminopyrimidine (DAP) scaffold, a well-documented kinase platform. From 13 analogues prepared, macrocycle 2m showed the most promising in vitro ALK enzymatic (IC50 = 0.5 nM) and cellular (IC50 = 10 nM) activities. In addition, macrocycle 2m exhibited a favorable kinase selectivity preference for inhibition of ALK relative to the highly homologous insulin receptor (IR) kinase (IR/ALK ratio of 173). The inclusive in vitro biological results for this set of macrocycles validate this scaffold as a viable kinase template and further corroborate recent DAP/ALK solid state studies indicating that the inverted “U” shaped conformation of the acyclic DAPs is a preferred bioactive conformation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201333e"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201333e">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201333e&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201333e&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201333e&amp;href=/doi/10.1021/jm201333e" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 449-464</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm2013198" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201364d" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Anaplastic Lymphoma Kinase (ALK) Inhibitory Activity for a Novel Series of 2,4,8,22-Tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Macrocycles</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henry+J.++Breslin">Henry J. Breslin</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brandon+M.++Lane">Brandon M. Lane</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+R.++Ott">Gregory R. Ott</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arup+K.++Ghose">Arup K. Ghose</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thelma+S.++Angeles">Thelma S. Angeles</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+S.++Albom">Mark S. Albom</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mangeng++Cheng">Mangeng Cheng</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Weihua++Wan">Weihua Wan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=R.+Curtis++Haltiwanger">R. Curtis Haltiwanger</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+J.++Wells-Knecht">Kevin J. Wells-Knecht</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bruce+D.++Dorsey">Bruce D. Dorsey</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Cephalon, Inc., 145 Brandywine Parkway, West Chester, Pennsylvania 19380-4245, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 610-738-6695. E-mail: <a href="/cdn-cgi/l/email-protection#773f350512041b1e19414737101a161e1b5914181a"><span class="__cf_email__" data-cfemail="69212b1b0c1a0500075f59290e04080005470a0604">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201333e&amp;href=/doi/10.1021%2Fjm201333e" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 449–464</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 15, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>6 October 2011</li><li><span class="item_label"><b>Published</b> online</span>15 December 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 January 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201333e" title="DOI URL">https://doi.org/10.1021/jm201333e</a></div><div class="article_header-article-copyright"><strong>Copyright © 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D449%26pageCount%3D16%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHenry%2BJ.%2BBreslin%252C%2BBrandon%2BM.%2BLane%252C%2BGregory%2BR.%2BOtt%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D1%26contentID%3Djm201333e%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BAnaplastic%2BLymphoma%2BKinase%2B%2528ALK%2529%2BInhibitory%2BActivity%2Bfor%2Ba%2BNovel%2BSeries%2Bof%2B2%252C4%252C8%252C22-Tetraazatetracyclo%255B14.3.1.13%252C7.19%252C13%255Ddocosa-1%252820%2529%252C3%252822%2529%252C4%252C6%252C9%252821%2529%252C10%252C12%252C16%252C18-nonaene%2BMacrocycles%26numPages%3D16%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D464%26publicationDate%3DJanuary%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201333e"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3325</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">28</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201333e" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Anaplastic Lymphoma Kinase (ALK) Inhibitory Activity for a Novel Series of 2,4,8,22-Tetraazatetracyclo[14.3.1.13,7.19,13]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Macrocycles&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Henry&quot;,&quot;last_name&quot;:&quot;J. Breslin&quot;},{&quot;first_name&quot;:&quot;Brandon&quot;,&quot;last_name&quot;:&quot;M. Lane&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;R. Ott&quot;},{&quot;first_name&quot;:&quot;Arup&quot;,&quot;last_name&quot;:&quot;K. Ghose&quot;},{&quot;first_name&quot;:&quot;Thelma&quot;,&quot;last_name&quot;:&quot;S. Angeles&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;S. Albom&quot;},{&quot;first_name&quot;:&quot;Mangeng&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Weihua&quot;,&quot;last_name&quot;:&quot;Wan&quot;},{&quot;first_name&quot;:&quot;R.&quot;,&quot;last_name&quot;:&quot;Curtis Haltiwanger&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;J. Wells-Knecht&quot;},{&quot;first_name&quot;:&quot;Bruce&quot;,&quot;last_name&quot;:&quot;D. Dorsey&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;449-464&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201333e&quot;},&quot;abstract&quot;:&quot;A novel set of 2,4,8,22-tetraazatetracyclo[14.3.1.13,7.19,13]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene macrocycles were prepared as potential anaplastic lymphoma kinase (ALK) inhibitors, designed to rigidly lock an energy-minimized bioactive conformation of the diaminopyrimidine (DAP) scaffold, a well-documented kinase platform. From 13 analogues prepared, macrocycle 2m showed the most promising in vitro ALK enzymatic (IC50 = 0.5 nM) and cellular (IC50 = 10 nM) activities. In addition, macrocycle 2m exhibited a favorable kinase selectivity preference for inhibition of ALK relative to the highly homologous insulin receptor (IR) kinase (IR/ALK ratio of 173). The inclusive in vitro biological results for this set of macrocycles validate this scaffold as a viable kinase template and further corroborate recent DAP/ALK solid state studies indicating that the inverted “U” shaped conformation of the acyclic DAPs is a preferred bioactive conformation.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201333e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201333e" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201333e&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201333e" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201333e&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201333e" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201333e&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201333e&amp;href=/doi/10.1021/jm201333e" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201333e" /></input><a href="/doi/pdf/10.1021/jm201333e" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201333e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201333e%26sid%3Dliteratum%253Aachs%26pmid%3D22172029%26genre%3Darticle%26aulast%3DBreslin%26date%3D2012%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BAnaplastic%2BLymphoma%2BKinase%2B%2528ALK%2529%2BInhibitory%2BActivity%2Bfor%2Ba%2BNovel%2BSeries%2Bof%2B2%252C4%252C8%252C22-Tetraazatetracyclo%255B14.3.1.13%252C7.19%252C13%255Ddocosa-1%252820%2529%252C3%252822%2529%252C4%252C6%252C9%252821%2529%252C10%252C12%252C16%252C18-nonaene%2BMacrocycles%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D1%26spage%3D449%26epage%3D464%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291026" title="Conformation">Conformation</a>,</li><li><a href="/action/doSearch?ConceptID=291163" title="Macrocycles">Macrocycles</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jmcmar.2012.55.issue-1/production/jmcmar.2012.55.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel set of 2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene macrocycles were prepared as potential anaplastic lymphoma kinase (ALK) inhibitors, designed to rigidly lock an energy-minimized bioactive conformation of the diaminopyrimidine (DAP) scaffold, a well-documented kinase platform. From 13 analogues prepared, macrocycle <b>2m</b> showed the most promising in vitro ALK enzymatic (IC<sub>50</sub> = 0.5 nM) and cellular (IC<sub>50</sub> = 10 nM) activities. In addition, macrocycle <b>2m</b> exhibited a favorable kinase selectivity preference for inhibition of ALK relative to the highly homologous insulin receptor (IR) kinase (IR/ALK ratio of 173). The inclusive in vitro biological results for this set of macrocycles validate this scaffold as a viable kinase template and further corroborate recent DAP/ALK solid state studies indicating that the inverted “U” shaped conformation of the acyclic DAPs is a preferred bioactive conformation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76222" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76222" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer, a group of diseases characterized by uncontrolled growth and spread of abnormal cells, was the second leading cause of deaths in the U.S. in 2010, accounting for one of every four mortalities, as reported by the American Cancer Society.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In recent years progress has been made in understanding the biomolecular etiologies contributing to certain cancers, resulting in successful targeted treatments for some of these better characterized cancers.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> One such vein of targeted cancer treatment is inhibition of various aberrant up-regulated and unregulated kinases, which have been shown to be intimately tied to certain cancers.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Kinases are a group of over 500 different proteins that are typically responsible for strategic internal regulation of normal cellular signaling pathways, via phosphorylation of key cellular substrates.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Kinases are subgrouped, dependent on which amino acid of the key cellular substrate is phosphorylated, via catalytic transfer of a phosphate group from adenosine triphosphate (ATP). One major subgroup of the kinase family is the receptor tyrosine kinases. One particular tyrosine kinase that has gained increasing attention as a therapeutic target is analplastic lymphoma kinase (ALK), a member of the insulin receptor (IR) superfamily.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The chimeric protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) has been identified in about 60–70% of cases of anaplastic large cell lymphoma (ALCL), a non-Hodgkin’s lymphoma cancer arising most often in children and young adults, with constitutively active ALK kinase activity directly associated with the pathogenesis of disease.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Other cancers that have been linked with translocated ALK proteins that have led to oncogenic signaling include non-small-cell lung cancer (NSCLC) (echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase, EML4-ALK)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and inflammatory myofibroblastic tumors (tropomyosin 3-anaplastic lymphoma kinase, TPM3-ALK).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Promisingly, a number of ATP-competitive ALK inhibitors have demonstrated oncolytic activity against ALK-positive cancer cells in vitro and in vivo. This has led to several ALK inhibitors advancing to the level of clinical studies, including crizotinib<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which recently gained FDA approval for ALK-positive cancers.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0010.jpeg" id="gr1" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">2,4-Diaminopyrimidines (DAPs) have exhibited potent enzymatic inhibition of ALK and have also shown significant antiproliferative activity for overexpressed ALK-positive cancer cells both in vitro and in vivo.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Compound <b>1a</b>, a representative DAP ALK inhibitor, was evaluated via small-molecule X-ray crystallography and found to possess an inverted “U” shaped conformation for the three core aryl groups, as depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. We questioned if locking appropriately substituted DAPs in this particular conformation (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) would yield macrocycles with enhanced ALK inhibitory activities and/or kinase selectivity profiles. A few recent overviews of varied macrocyclic efforts directed at a panorama of biomolecular targets share some other potential advantages, as well as hurdles, that have been established for this type of strategic endeavor.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Prior to initiating our efforts, a literature search revealed that a Janssen group had reported preparing DAP macrocycles.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, their macrocycles had extended linkers presenting flexible conformations that were not necessarily focused specifically toward ALK. Following are our experimental results appraising rigidly constrained, suitably functionalized DAP macrocycles that were designed purposely as ALK inhibitors.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0011.jpeg" id="gr2" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0012.jpeg" id="gr3" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12161" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12161" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To initially assess that locking the conformation of the DAPs proposed in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> might prove biologically favorable, we evaluated the potential overlap of an energy minimized macrocyclic motif relative to its respective energy minimized acyclic parent DAP via molecular modeling. Analogue <b>1c</b> was chosen as a preferable acyclic DAP for the modeling study because it was a minimally substituted DAP that possessed favorable ALK activity, as identified through routine screening. Consistent with the X-ray conformation for the aryl groups of DAP <b>1a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), the computational evaluation of the energy minimized structure of DAP <b>1c</b> displayed the three aryl groups aligned in a similar inverted “U” shaped conformation (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Tying the pendent phenyl groups of <b>1c</b> with an ethylene linker yielded macrocycle <b>2g</b>, whose energy minimized conformation overlapped nicely with DAP <b>1c</b>, with the root-mean-square deviation of all the common non-hydrogen atoms in their minimum energy conformations at 1.29 Å (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). These encouraging modeling results added confidence that the proposed macrocycles <b>2</b> would show promise as ALK inhibitors. Subsequent to these modeling experiments, solid state crystal structures of apo and ligand bound structures (including DAP bound) of ALK were reported in the literature and showed similar conformational arrangement of the DAP’s three aryl groups.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Calculated minimum energy conformation of <b>1c</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Stereoview of superimposed, minimum-energy calculated conformations of <b>1c</b> and <b>2g</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> comprehensively outlines the routes used to prepare macrocycles <b>2a</b>–<b>m</b>. A minimally substituted macrocycle (<b>2a</b>) was prepared to validate the synthetic sequence. 3-Bromoaniline (<b>3a</b>) was reacted with 2,4,5-trichloropyrimidine (<b>4</b>) to yield intermediate <b>5a</b>, which was coupled with 3-vinylaniline (<b>6a</b>) to give acyclic DAP <b>7a</b>. This set the stage for macrocyclization by employing the Heck reaction between the vinyl (W) and bromo (Y) coupling partners, which yielded <b>8a</b> in 65% yield using microwave heating (120 °C for 30 min). Pt-catalyzed hydrogenation of <b>8a</b> gave the desired macrocycle <b>2a</b>. In tandem with the reduction of the olefin, some dechlorination of the substituted pyrimidine was observed, but this side product was readily separated via chromatography. Noteworthy, during the course of our work, an alternative synthesis of the minimally substituted macrocycle <b>8a</b> was reported in the patent literature, via a ring closing olefin metathesis reaction, albeit in a modest 9% yield.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0015.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Method A</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Encouraged by our preparation of core structure <b>2a</b>, we embarked on synthesizing macrocycles <b>2b</b>–<b>m</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), decorating the core macrocycle <b>2a</b> with key appendages that have been shown to enhance ALK activity. These synthetic efforts were initially focused on introducing varied R groups on <b>2a</b>. Prior to the synthesis of R group substituted macrocycles <b>2b</b>–<b>d</b>, substituted anilines <b>6c</b> and <b>6d</b> were prepared as outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Intermediate <b>5b</b> was generated in a similar manner as <b>5a</b>. Then anilines <b>6b</b>–<b>d</b> were reacted with <b>5b</b> to form <b>7b</b>–<b>d</b> under identical reaction conditions used to construct DAP <b>7a</b>. Comparing the cyclization step for macrocycles <b>8b</b>–<b>d</b> relative to macrocycle <b>8a</b> demonstrated that the Heck macrocyclization reaction proceeded equally well regardless of whether the vinyl and bromide coupling partners were interchanged as W or Y (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Final saturated targets <b>2b</b>–<b>d</b> were generated cleanly by the selective diimide olefin reductions of <b>8b</b>–<b>d</b>. The diimide reduction circumvented potential dechlorination issues, as had been observed in the Pt catalyzed reduction of <b>2a</b>. As the related chloro moiety in acyclic DAPs has proven biologically favorable, we preferred to maintain the 6-Cl substituent as a constant on key analogues <b>2</b>; therefore, the diimide reduction was employed for all subsequent analogues.</div><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0016.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Method B</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Initial R″ substituted analogue <b>2e</b> was prepared following the general conditions used to generate <b>2a</b>. It was envisioned that the R,R″ disubstituted analogues <b>2f</b> and <b>2g</b> would be synthesized following the general procedures of analogues <b>2b</b>–<b>d</b>. Following this plan required the preparation of precursor 2-methoxy-5-vinylphenylamine (<b>3d</b>, method A), which was converted to intermediate <b>5d</b> as expected (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). However, initial attempts to  prepare DAP <b>7f</b> using the conditions to synthesize <b>7b</b>–<b>d</b> were unsuccessful. With 2-methoxyethanol as the solvent for <b>7f</b>, acid catalyzed attack by the solvent’s hydroxyl moiety at the benzylic position of the olefin yielded its respective ether (<b>7n</b>) as a major side product (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Changing the protic solvent to the more encumbered <i>t</i>-BuOH thwarted this undesirable reaction and led to clean conversions for both <b>7f</b> and <b>7g</b>, which were carried on to give <b>2f</b> and <b>2g</b>.</div><figure id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0001.jpeg" id="gr9" class="inline-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Toward the preparation of target <b>2h</b>, it was found that the initial intermediate <b>5e</b> was prepared most efficiently by running the reaction neat using <b>4</b> as both reactant and solvent. Subsequent chemistries from <b>5e</b> en route to <b>8h</b> proceeded smoothly following Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Amide <b>2h</b> was prepared over three steps from ester <b>8h</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Intermediate <b>8n</b>, generated by acid hydrolysis, was subjected to an amine coupling reaction, and the resulting amide <b>8o</b> was reduced to give <b>2h</b>.</div><figure id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0002.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Method C<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) LiOH, H<sub>2</sub>O, MeOH; (b) EDAC, HOBt, H<sub>2</sub>NMe; (c) diimide.</p></p></figure><div class="NLM_p">Target <b>2k</b> was also prepared following the general protocol of Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The syntheses of the last targeted group of macrocycles (<b>2i</b>, <b>2j</b>, <b>2l</b>, <b>2m</b>) were initiated with the preparations of anilines <b>3f</b>–<b>i</b> (Schemes <a class="ref internalNav" href="#sch5" aria-label="5">5</a> and <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). Anilines <b>3f</b>–<b>i</b> were treated with <b>4</b> under basic conditions to yield respective pyrimidines <b>5f</b>–<b>i</b>, all in reasonable yields. Subsequently, <b>5f</b>–<b>i</b> provided <b>2i</b>, <b>2j</b>, <b>2l</b>, and <b>2m</b> following Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>.</div><figure id="sch5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0003.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Method D<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 2-Propanethiol, EtOH, 50 °C, 72 h; (b) mCPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h; (c) vinylboronic acid dibutyl ester, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, glyme, H<sub>2</sub>O, 80 °C; (d) Fe, AcOH, THF, 35 °C, 16 h.</p></p></figure><figure id="sch6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0004.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Method E<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (CF<sub>3</sub>CO)<sub>2</sub>O, KNO<sub>3</sub>, CH<sub>3</sub>CN; (b) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF; (c) vinylboronic acid dibutyl ester, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, glyme, H<sub>2</sub>O, 90 °C, 16 h; (d) Fe, AcOH, THF, 35 °C, 16 h.</p></p></figure><div class="NLM_p">The acyclic DAP analogues <b>1b</b> and <b>1c</b> were prepared as outlined in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>, following similar synthetic methods used for intermediates of the macrocycles illustrated in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Stepwise addition of the required anilines to <b>4</b> proceeded smoothly over two steps to provide the regiocontrolled products.</div><figure id="sch7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0005.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Method F</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The general protocol to evaluate biological promise for the newly prepared compounds was to initially screen each for ALK enzyme inhibitory activity and subsequently select only the more potent enzyme inhibitors (ALK IC<sub>50</sub> < 50 nM) for testing in the secondary ALK cellular assay, measuring inhibition of NPM-ALK phosphorylation. The compiled biological results for all target structures are outlined in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_p">With ALK being a member of the IR tyrosine kinase superfamily and recognizing that the IR has a vital role with a normal physiological function, a preferred ALK inhibitor would be devoid of IR kinase inhibition. This reasoning is supported by preclinical in vivo studies where it has been shown that inhibition of the IR resulted in variability of glucose homeostasis.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Therefore, an IR kinase enzyme assay was chosen as a primary kinase selectivity counterscreen within the testing paradigm for the targeted macrocycles. For simplicity of viewing the relative IR/ALK kinase selectivity profile, the related IR results listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> are shown as a relative ratio to the reported ALK activity.</div><div class="NLM_table-wrap" id="tbl1">Table 1<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0006.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R′</th><th class="colsep0 rowsep0" align="center">R″</th><th class="colsep0 rowsep0" align="center">ALK enzyme IC<sub>50</sub> <a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> (nM)</th><th class="colsep0 rowsep0" align="center">NPM-ALK cell IC<sub>50</sub> <a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (nM)</th><th class="colsep0 rowsep0" align="center">IR/ALK <a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">synthesis method</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4-Me-piperazinyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">67 ± 13</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">F</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1c</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4-Me-piperazinyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">-OMe</td><td class="colsep0 rowsep0" align="left">22 ± 7</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">3.6</td><td class="colsep0 rowsep0" align="left">F</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">1-morpholinyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2c</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">-OCH<sub>2</sub>CH<sub>2</sub>-N-pyrrolodine</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">283 ± 121</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">B, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2d</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4-Me-piperazinyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">92 ± 10</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">B, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2e</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">-OMe</td><td class="colsep0 rowsep0" align="left">360 ± 80</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">>27</td><td class="colsep0 rowsep0" align="left">A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2f</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">1-morpholinyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">-OMe</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2g</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4-Me-piperazinyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">-OMe</td><td class="colsep0 rowsep0" align="left">3.1 ± 0.7</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">B, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2h</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4-Me-piperazinyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">-CONHMe</td><td class="colsep0 rowsep0" align="left">35 ± 16</td><td class="colsep0 rowsep0" align="left">1200</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">B, A, C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2i</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4-Me-piperazinyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">-SO<sub>2</sub>-<i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">3.7 ± 0.5</td><td class="colsep0 rowsep0" align="left">70</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">D, B, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2j</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4-Me-piperazinyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">-N(Me)SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="left">3.4 ± 0.8</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">E, B, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2k</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4-Me-piperazinyl</td><td class="colsep0 rowsep0" align="left">-OMe</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5 ± 2</td><td class="colsep0 rowsep0" align="left">800</td><td class="colsep0 rowsep0" align="left">58</td><td class="colsep0 rowsep0" align="left">B, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2l</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4-Me-piperazinyl</td><td class="colsep0 rowsep0" align="left">-OMe</td><td class="colsep0 rowsep0" align="left">-SO<sub>2</sub>-<i>i</i>-Pr</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">D, B, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2m</b></td><td class="colsep0 rowsep0" align="left">-CH<sub>2</sub>CH<sub>2</sub>-</td><td class="colsep0 rowsep0" align="left">4-Me-piperazinyl</td><td class="colsep0 rowsep0" align="left">-OMe</td><td class="colsep0 rowsep0" align="left">-N(Me)SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="left">0.51 ± 0.02</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">173</td><td class="colsep0 rowsep0" align="left">E, B, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="left">-CH═CH-</td><td class="colsep0 rowsep0" align="left">4-Me-piperazinyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">392 ± 149</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">B, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8g</b></td><td class="colsep0 rowsep0" align="left">-CH═CH-</td><td class="colsep0 rowsep0" align="left">4-Me-piperazinyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">-OMe</td><td class="colsep0 rowsep0" align="left">259 ± 74</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">>11</td><td class="colsep0 rowsep0" align="left">B, A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8m</b></td><td class="colsep0 rowsep0" align="left">-CH═CH-</td><td class="colsep0 rowsep0" align="left">4-Me-piperazinyl</td><td class="colsep0 rowsep0" align="left">-OMe</td><td class="colsep0 rowsep0" align="left">-N(Me)SO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="left">7.0 ± 0.8</td><td class="colsep0 rowsep0" align="left">120</td><td class="colsep0 rowsep0" align="left">>140</td><td class="colsep0 rowsep0" align="left">E, B, A</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Reported as the average ± the standard deviation of three or more determinations.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Reported as the average of two determinations. NT = not tested.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">(IR enzyme IC<sub>50</sub>)/(ALK enzyme IC<sub>50</sub>). ND = not determined.</p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68551" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68551" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The initial synthetic efforts were focused on confirming the feasibility of the planned synthetic route to generate macrocycles <b>2</b>, which was validated by the successful preparation of initial analogue <b>2a</b>. Not surprisingly, the simplified macrocycle <b>2a</b> did not demonstrate ALK inhibition at the highest testing concentration (ALK IC<sub>50</sub> > 10 μM). However, from subsequent analogues prepared with singly R appended substitution on <b>2</b>, favorable ALK enzyme activity was observed; <b>2d</b> (R = 4-Me-piperazinyl; ALK IC<sub>50</sub> = 92 nM) was more potent than <b>2c</b> (R = -OCH<sub>2</sub>CH<sub>2</sub>-N-pyrrolidine; ALK IC<sub>50</sub> = 283 nM), with <b>2b</b> (R = 1-morpholinyl; ALK IC<sub>50</sub> > 10 μM) proving inactive. Noteworthy, the activity of macrocycle <b>2d</b> (ALK IC<sub>50</sub> = 92 ± 10 nM) was comparable to the activity of its parent DAP <b>1b</b> (ALK IC<sub>50</sub> = 67 ± 13 nM). This was the first supportive experimental evidence that macrocycles <b>2</b> were constrained in a biologically desired conformation.</div><div class="NLM_p">SAR evaluation of the R″ appended groups on <b>2</b> began with replacing hydrogen (<b>2a</b>) (ALK IC<sub>50</sub> > 10 μM) with -OMe (<b>2e</b>) (ALK IC<sub>50</sub> = 360 nM). The significant increase in ALK potency of <b>2e</b> was further enhanced ∼100-fold when the R = H of <b>2e</b> was replaced with R = 4-Me-piperazinyl (<b>2g</b>) (ALK IC<sub>50</sub> = 3.1 nM). Analogue <b>2g</b> was the macrocycle that overlapped nicely with its DAP acyclic parent <b>1c</b> via molecular modeling (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), so it was interesting to find that <b>2g</b> proved greater than 5-fold more potent than <b>1c</b> in the ALK enzymatic assay. Along with improved target potency, <b>2g</b> showed an improved IR/ALK selectivity relative to <b>1c</b> (67× and 3.6×, respectively), suggesting that the conformationally constrained macrocycle avoids a preferred binding to IR. Unfortunately, the boost in enzymatic inhibition of macrocycle <b>2g</b> relative to DAP parent <b>1c</b> did not translate in the cellular assay, with both compounds displaying comparable activity (<b>2g</b>, cell IC<sub>50</sub> = 150 nM; <b>1c</b>, cell IC<sub>50</sub> = 100 nM). However, the fact that <b>2g</b> exhibited cellular activity was encouraging, as it was the first macrocycle screened in the cellular secondary assay and further validated the macrocycles. The lack of any observed ALK activity for macrocycle <b>2f</b> was surprising (ALK IC<sub>50</sub> > 1000 nM), based on the positive results for analogues <b>2e</b> and <b>2g</b>, suggesting that the morpholine interacts with ALK differently from the piperazine moiety.</div><div class="NLM_p">Having found that the most potent macrocycles shared the commonality of R as a 4-Me-piperazinyl moiety, additional SAR studies on R′ and R″ were pursued holding R constant. Three additional R″ substituted macrocycles prepared for comparison to the methoxy-substituted analogue <b>2g</b> (ALK IC<sub>50</sub> = 3.1 nM; cell IC<sub>50</sub> = 150 nM) resulted in two comparably potent ALK inhibitors, sulfone <b>2i</b> (R″ = -SO<sub>2</sub>-<i>i</i>-Pr; ALK IC<sub>50</sub> = 3.7 nM; cell IC<sub>50</sub> = 70 nM) and sulfonamide <b>2j</b> (R″ = -N(Me)SO<sub>2</sub>Me; ALK IC<sub>50</sub> = 3.4 nM; cell IC<sub>50</sub> = 120 nM), with amide <b>2h</b> (R″= -CONHMe; ALK IC<sub>50</sub> = 35 nM; cell IC<sub>50</sub> = 1200 nM) proving about 10-fold less active. Also encouraging for sulfonamide <b>2j</b> was its favorable 75-fold IR/ALK selectivity ratio, while sulfone <b>2i</b> proved less selective with only a 10-fold IR/ALK ratio.</div><div class="NLM_p">Having identified R,R″ substituted macrocycles exhibiting fairly robust ALK inhibition, we next turned our attention to the R′ substituent. The R′ substituent as a methoxy moiety has been recognized as a key ALK selectivity and potency determinant for DAPs.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> This extrapolation to macrocycles <b>2</b> proved fruitful, as exemplified by comparing the activities of <b>2k</b> (ALK IC<sub>50</sub> = 5 nM) to <b>2d</b> (ALK IC<sub>50</sub> = 92 nM). The most promising compound from this exercise, and for the series as a whole, was sulfonamide <b>2m</b>, with subnanomolar ALK enzyme inhibition (IC<sub>50</sub> = 0.51 nM) and low nanomolar ALK cellular activity (cell IC<sub>50</sub> = 10 nM). Compound <b>2m</b> had concurrent improvements in both enzymatic (7-fold) and cellular (12-fold) activities when compared to its direct R′ desmethoxy analogue <b>2j</b> (IC<sub>50</sub> = 3.4 nM; cell IC<sub>50</sub> = 120 nM); these analogues proved the most definitive comparators from this series in showing overall potency improvement contributed by the R′ = methoxy group. Analogue <b>2m</b> also displayed the best overall kinase selectivity for the series with an IR/ALK ratio of 173, again illustrating the effectiveness of the R′ = methoxy.</div><div class="NLM_p">Following the publication of apo and ligand bound crystal structures of ALK, an additional modeling study demonstrated a complementary fit of <b>2m</b> in the ALK binding pocket, supported by two favorable hydrogen bonding interactions at the hinge (Met-1199) and one with the salt-bridge Lys-1150 (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Noteworthy, the binding mode of <b>2m</b> was also consistent with the DAP bound ALK structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XB7">2XB7</a>) in the Protein Data Bank (PDB).</div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Glide/XP generated binding mode of compound <b>2m</b> docked in the ALK binding pocket, with the ALK structure retrieved from the PDB (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LCT">3LCT</a>). Only the key residues of the ALK protein were made visible for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The last significant SAR observation was that olefin linked analogues <b>8</b> proved considerably less potent when compared to their respective ethylene linked macrocycles <b>2</b> [<b>8d</b> (ALK IC<sub>50</sub> = 392 nM) relative to <b>2d</b> (ALK IC<sub>50</sub> = 92 nM), <b>8g</b> (ALK IC<sub>50</sub> = 259 nM) relative to <b>2g</b> (ALK IC<sub>50</sub> = 3 nM), <b>8m</b> (ALK IC<sub>50</sub> = 7 nM, cell IC<sub>50</sub> = 120 nM) relative to <b>2m</b> (ALK IC<sub>50</sub> = 0.5 nM, cell IC<sub>50</sub> = 10 nM)]. A possible explanation for the loss of activity for analogues <b>8</b> may pertain to the olefinic sp<sup>2</sup> carbons adding further constraint to the macrocycle, leading to a less desirable conformer.</div><div class="NLM_p">In conclusion, the synthetic and medicinal chemistry objectives outlined for macrocycles <b>2</b> were accomplished successfully. We demonstrated that conformationally constrained macrocycles <b>2</b> could be synthesized efficiently as inverted “U” shaped conformer mimics of DAPs <b>1</b> by employing a Heck reaction for the macrocyclization followed by selective diimide olefin reductions (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Subsequent comparison of ALK biological results for DAPs <b>1b</b> and <b>1c</b> relative to their respective constrained macrocycles <b>2d</b> and <b>2g</b> showed ALK activities to be fairly consistent, with a potential indication of improved kinase selectivity for the macrocycles. The similarity of biological activities between these directly related constrained macrocycles with their acyclic DAP parents is also good complementary evidence to the recently published DAP/ALK solid state cocrystal findings that an inverted “U” shaped conformer of DAPs is a preferred biologically active conformation. Finally, macrocycle <b>2m</b> was identified as an extremely potent ALK inhibitor with a favorable kinase selectivity profile relative to IR and proved to have the most promising overall profile from our initial set of 13 macrocycles prepared.</div><div class="NLM_p last">In addition to these findings demonstrating that macrocycles <b>2</b> are a useful template as an ALK scaffold, one may further speculate that macrocycles <b>2</b> might prove worthwhile as a scaffold for other therapeutic targets where encouraging activities have been found for DAPs, be it in the kinase area or otherwise.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64463" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64463" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Chemistry</h3><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> lists all final products <b>2</b> and identifies the respective synthetic method(s) followed for their preparations. All final products <b>2</b> were characterized by 400 MHz <sup>1</sup>H NMR (Bruker Avance, in the solvent indicated, with tetramethylsilane as an internal standard), LC/MS (Bruker Esquire 2000 mass spectrometer with the Agilent 1100 HPLC equipped with an Agilent Eclipse XDB-C8, 2 mm × 30 mm 3.5 μm rt column, flow rate of 1.0 mL/min, and a solvent mixture of 10% (0.1% formic acid/water)/90% (acetonitrile/0.1% formic acid)), and HPLC (>98% purity at 215 and 254 nm by two methods, (a) Zorbax RX-C8, 5 mm × 150 mm column, eluting with a mixture of acetonitrile and water containing 0.1% trifluoroacetic acid with a gradient of 10–100% run over 5 min and (b) Agilent Eclipse XD8-C8, 4.6 mm × 150 mm column, eluting with a mixture of acetonitrile and water containing 0.1% trifluoroacetic acid with a gradient of 10–100% run over 20 min). Also, final products <b>2d</b>, <b>2f</b>, <b>2g</b>, <b>2i</b>, <b>2j</b>, <b>2l</b>, and <b>2m</b> were evaluated by high resolution mass spectrum (HRMS) analyses (Waters Synapt G2 Q-TOF mass spectrometer using leucine–enkephalin as a lock-mass standard). These HRMS were carried out internally at Cephalon. Reported melting points were taken on a Mel-Temp apparatus and are uncorrected. All spectral analysis results are included in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</div><div class="NLM_p"><sup>1</sup>H NMR data of key intermediates were also obtained from the 400 MHz NMR instrument and are included in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. When indicated, compounds assayed by thin-layer chromatography were evaluated on Whatman MK6F (1 in. × 3 in. × 250 μm) silica gel plates.</div><div class="NLM_p">A CEM Discover unit was used for microwave assisted reactions.</div><div class="NLM_p last">For purifications, automated normal phase column chromatography was performed on a CombiFlash Companion (ISCO, Inc.) using eluent solvent systems as defined for specific compounds. Reverse phase preparative HPLC was performed on a Gilson GX-281 equipped with Gilson 333 and 334 pumps using a Phenomenex 00F-4454-00-AX Gemini-NX 5 μm C18 column with mixtures of acetonitrile and water, both containing 0.1% trifluoroacetic acid, as the eluent. All reagents were commercially available unless otherwise specified, and all reactions were run under an inert atmosphere of Ar or N<sub>2</sub> unless otherwise specified.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Molecular Modeling</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Conformational Analysis</h4><div class="NLM_p last">Most of the computational work was done using the Schrodinger/Maestro molecular modeling package (Maestro, version 9.1.107, Schrodinger, LLC, New York, NY):<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(1)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Build 3D structures using LigPrep.</p></td></tr><tr class="li1"><td valign="top">(2)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Load all ligands in the Project Table, and select all.</p></td></tr><tr class="li1"><td valign="top">(3)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Set MacroModel Conformational Search Panel for Project Table (selected entries, using the OPLS_2005 force field and water as the implicit solvent, minimization method Polak–Ribiere conjugate gradient (PRCG), maximum iteration of 500, convergence gradient of 0.05, and 1000 steps of mixed torsion low mode sampling).</p></td></tr></table></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Docking Study</h4><div class="NLM_p last">The essential steps in the docking experiment are summarized below:<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(1)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Prepare an ALK structure from the Protein Data Bank (PDB) (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LCT">3LCT</a>)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> using Maestro protein preparation workflow.</p></td></tr><tr class="li1"><td valign="top">(2)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Use the lowest energy conformation of the ligands for the docking study.</p></td></tr><tr class="li1"><td valign="top">(3)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Use Glide/XP flexible docking and keep the top 10 binding poses.</p></td></tr><tr class="li1"><td valign="top">(4)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Select the binding mode using our knowledge based approach.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></p></td></tr></table></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Method A</h3><div id="sec4_3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 2-Methoxy-5-vinylphenylamine (<b>3d</b>)</h4><div class="NLM_p last">To a room temperature (rt) mixture of 5-bromo-2-methoxyphenylamine (<b>3c</b>) (610 mg, 3.0 mmol), potassium carbonate (K<sub>2</sub>CO<sub>3</sub>) (1.73 g, 12.5 mmol), and tetrakis(triphenylphsosphine)palladium(0) (Pd(PPh<sub>3</sub>)<sub>4</sub>) (600 mg, 0.5 mmol) in 1,2-dimethoxyethane (18 mL) and water (3 mL) was added vinylboronic acid dibutyl ester (2.37 mL, 10.8 mmol). The mixture was then warmed to 90 °C for 16 h. The resulting mixture was concentrated under reduced pressure, and the residue was acidified with aqueous 1 N HCl. Attempted extraction with ethyl ether (Et<sub>2</sub>O) or ethyl acetate (EtOAc) yielded a solid between the biphasic mix, which was filtered off. The aqueous phase of the filtrate was neutralized while cooling with 30% NaOH, and the resulting mixture was washed with ethyl acetate (EtOAc) (2×). The latter EtOAc extracts were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield 320 mg (71%) of <b>3d</b> as an oil, which was used for subsequent steps without further manipulation. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 6.79–6.78 (d, 1H), 6.77–6.75 (d, 1H), 6.64–6.61 (m, 1H), 6.58–6.50 (m, 1H), 5.53–5.49 (d, 1H), 5.05–5.02 (d, 1H), 4.91 (bs, 2H), 3.75 (s, 3H).</div></div><div id="sec4_3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (3-Bromophenyl)-(2,5-dichloropyrimidin-4-yl)amine (<b>5a</b>)</h4><div class="NLM_p last">3-Bromoaniline (<b>3a</b>) (790 mg, 4.6 mmol), 2,4,5-trichloropyrimidine (<b>4</b>) (840 mg, 4.58 mmol), and K<sub>2</sub>CO<sub>3</sub> (1.90 g, 14 mmol) in <i>N</i>,<i>N</i>-dimethylformamide (DMF) (20 mL) was warmed to 80 °C for 16 h. The mixture was cooled to rt and then diluted with water (220 mL). The resulting solid was filtered and rinsed with a small amount of water. After air drying, the solid was triturated with ice cold acetonitrile (CH<sub>3</sub>CN) (10 mL), filtered, and rinsed with a small amount of ice cold CH<sub>3</sub>CN to yield 720 mg (49%) of desired <b>5a</b> as a white solid, mp 146–148 °C. LC: 98%. LC/MS: M + H = 320.0. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.60 (s, 1H), 8.43 (s, 1H), 7.89–7.88 (m, 1H), 7.68–7.64 (m, 1H), 7.37–7.36 (m, 2H).</div></div><div id="sec4_3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (2,5-Dichloropyrimidin-4-yl)-3-vinylphenyl)amine (<b>5b</b>)</h4><div class="NLM_p last">Compound <b>5b</b> was prepared in a similar manner as <b>5a</b> after substituting 3-vinylphenylamine (<b>3b</b>) for <b>3a</b>, substituting <i>N</i>,<i>N</i>-diisopropylethylamine (EtN(<i>i</i>-Pr)<sub>2</sub>) for K<sub>2</sub>CO<sub>3</sub>, and altering the reaction temperature from 80 °C to rt. Workup varied in that after 16 h the mixture was diluted with water, which yielded an oil that crystallized to a solid. The solid was filtered, triturated with water, and refiltered to yield desired <b>5b</b> in 87% yield as a white solid, mp 87.5–90 °C. LC: 97%. LC/MS: M + H = 266.0. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.23 (s, 1H), 7.69 (s, 1H), 7.59–7.56 (m, 1H), 7.40–7.37 (m, 1H), 7.28–7.26 (m, 2H), 6.79–6.71 (m, 1H), 5.85–5.80 (d, <i>J</i> = 17.7 Hz, 1H), 5.35–5.33 (d, <i>J</i> = 10.9 Hz, 1H).</div></div><div id="sec4_3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (5-Bromo-2-methoxyphenyl)-(2,5-dichloropyrimidin-4-yl)amine (<b>5c</b>)</h4><div class="NLM_p last">Compound <b>5c</b> was prepared in a similar manner as <b>5a</b> after substituting 5-bromo-2-methoxyphenylamine (<b>3c</b>) for <b>3a</b> and altering the reaction time from 16 to 3 h. Workup varied in that after 16 h the resulting solid in the reaction mixture was filtered, rinsed with DMF, then water. The resulting solid was triturated with CH<sub>3</sub>CN, filtered, and air-dried to yield desired <b>5c</b> in 54% yield as a white solid, mp 205–208 °C. LC: 99%. LC/MS: M + H = 349.9. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.00 (s, 1H), 8.38 (s, 1H), 7.81–7.80 (d, <i>J</i> = 2.48 Hz, 1H), 7.43–7.41 (m, 1H), 7.12–7.10 (d, <i>J</i> = 8.85 Hz, 1H), 3.82 (s, 3H).</div></div><div id="sec4_3_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (2,5-Dichloropyrimidin-4-yl)-(2-methoxy-5-vinylphenyl)amine (<b>5d</b>)</h4><div class="NLM_p last">Compounds <b>3d</b> (970 mg, 6.5 mmol), <b>4</b> (1.2 g, 6.5 mmol), and EtN(<i>i</i>-Pr)<sub>2</sub> (1.2 mL, 7.2 mmol) were combined in DMF (9 mL) at rt and stirred for 72 h. The reaction mixture was then diluted with ice cold water (100 mL). The resulting solid was filtered and rinsed liberally with water. The solid was further purified by trituration with methanol (2×) to yield desired <b>5d</b> in 66% yield as an off white solid. LC: 97%. LC/MS: M + H = 296.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.04 (s, 1H), 8.36 (s, 1H), 7.70 (s, 1H), 7.36–7.35 (d, 1H), 7.13–7.11 (d, 1H), 6.73–6.66 (m, 1H), 5.72–5.68 (d, 1H), 5.19–5.17 (d, 1H), 3.82 (s, 3H).</div></div><div id="sec4_3_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 4-Bromo-2-(2,5-dichloropyrimidin-4-ylamino)benzoic acid methyl ester (<b>5e</b>)</h4><div class="NLM_p last">Compound <b>5e</b> was prepared in a similar manner as <b>5b</b> after substituting 2-amino-4-bromobenzoic acid methyl ester (<b>3e</b>) for <b>3b</b>. In addition, rather than use of DMF as solvent, <b>4</b> (10 equiv) was used as the solvent as well as reactant, and the mixture was warmed to 120 °C rather than 80 °C for 16 h. The workup also varied in that the excess <b>4</b> was removed under high vacuum, and the residue was then treated with 1:1 MeOH/water. The resulting solid was filtered, retriturated with 1:1 MeOH/water, and refiltered, and the resulting solid was triturated in MeOH at 50 °C. After the mixture was filtered, the solid was rinsed liberally with MeOH. After air drying, <b>5e</b> was recovered in 52% yield as a brown solid. LC/MS: M + H = 377.9. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.25 (s, 1H), 8.84–8.83 (d, <i>J</i> = 1.89 Hz, 1H), 8.60 (s, 1H), 7.97–7.95 (d, <i>J</i> = 8.52 Hz, 1H), 7.50–7.47 (m, 1H), 3.90 (s, 3H).</div></div><div id="sec4_3_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> [5-Bromo-2-(propane-2-sulfonyl)phenyl]-(2,5-dichloropyrimidin-4-yl)amine (<b>5f</b>)</h4><div class="NLM_p last">A mixture of <b>3f</b> (310 mg, 1.11 mmol) and <b>4</b> (153 μL, 1.34 mmol) in DMF (2 mL) at 0 °C was treated with neat NaH (89 mg, 2.2 mmol, 60% oil dispersion) over 30 s. After an hour at 0 °C, additional <b>4</b> (150 μL, 1.30 mmol) was added followed by neat NaH (160 mg, 4 mmol, 60% oil dispersion). After another hour the mixture was treated with saturated aqueous NH<sub>4</sub>Cl, then diluted with water. The resulting brownish solid was filtered and washed liberally with water. The solid was then rinsed with ice cold CH<sub>3</sub>CN (3 mL). The resulting 415 mg (87%) of tannish solid <b>5f</b> was used for subsequent steps without further manipulation. LC: 100%. LC/MS: M + H = 425.9. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.87 (s, 1H), 8.68 (bs, 1H), 8.60 (s, 1H), 7.82–7.79 (d, <i>J</i> = 8.49 Hz, 1H), 7.69–7.67 (d, <i>J</i> = 7.89 Hz, 1H), 3.59–3.56 (m, 1H), 1.18–1.17 (d, <i>J</i> = 7.76 Hz, 6 H).</div></div><div id="sec4_3_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>N</i>-[4-Bromo-2-(2,5-dichloropyrimidin-4-ylamino)phenyl]-<i>N</i>-methylmethanesulfonamide (<b>5g</b>)</h4><div class="NLM_p last">Compounds <b>3g</b> (550 mg, 2.0 mmol) and <b>4</b> (678 μL, 5.9 mmol) were combined with EtN(<i>i</i>-Pr)<sub>2</sub> (940 μL, 5.4 mmol) in <i>N</i>-methylpyrrolidinone (5 mL) and warmed to 100 °C for 2 days. The resulting mixture was concentrated under high vacuum and the residue treated with 1:1 H<sub>2</sub>O/CH<sub>3</sub>CN (8 mL). The resulting solid was filtered and rinsed with ice cold 1:1 H<sub>2</sub>O/CH<sub>3</sub>CN (2 mL), then with MeOH, yielding 587 mg (70%) of desired <b>5g</b> as a tannish solid, which was used for subsequent steps without further manipulation. LC: 95%. LC/MS: M + H = 426.9. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.04 (s, 1H), 8.49 (s, 1H), 8.11 (s, 1H), 7.65–7.63 (d, <i>J</i> = 8.57 Hz, 1H), 7.56–7.54 (d, <i>J</i> = 8.50 Hz, 1H), 3.18 (s, 3H), 3.06 (s, 3H).</div></div><div id="sec4_3_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (2,5-Dichloropyrimidin-4-yl)-[2-(propane-2-sulfonyl)-5-vinylphenyl]amine (<b>5h</b>)</h4><div class="NLM_p last">Compound <b>5h</b> was prepared in a similar manner as <b>5e</b> after substituting <b>3h</b> for <b>3e</b>. The workup varied in that after concentration of the reaction mixture the residue was partitioned between CHCl<sub>3</sub> (2×) and water. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the crude product in the filtrate was adsorbed directly onto silica gel. The crude material was purified via normal phase chromatography (EtOAc/hexane eluent) to give desired <b>5h</b> in 51% yield as a yellow solid. LC: 100%. LC/MS: M + H = 372.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.79 (s, 1H), 8.55–8.32 (d, 1H), 7.85–7.83 (bs, 1H), 6.89–6.82 (m, 1H), 6.07–6.03 (d, 1H), 5.57–5.54 (d, 1H), 3.52 (bm, 1H), 1.17–1.15 (d, 6H).</div></div><div id="sec4_3_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-[2-(2,5-Dichloropyrimidin-4-ylamino)-4-vinylphenyl]-<i>N</i>-methylmethanesulfonamide (<b>5i</b>)</h4><div class="NLM_p last">Compound <b>5i</b> was prepared in a similar manner as <b>5e</b> after substituting <b>3i</b> for <b>3e</b>. The workup varied in that after concentration of the reaction mixture the residue was partitioned between EtOAc and water. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the crude product in the filtrate was adsorbed directly onto silica gel. The crude material was purified via normal phase chromatography (EtOAc/hexane eluent) to give desired <b>5i</b> in 50% yield as a yellow solid. LC: 93%. LC/MS: M + H = 373.2. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.04 (s, 1H, exchangeable), 8.45 (s, 1H), 7.93 (s, 1H), 7.64–7.62 (d, 1H), 7.47–7.45 (d, 1H), 6.82–6.75 (m, 1H), 5.91–5.87 (d, 1H), 5.40–5.37 (d, 1H), 3.17 (s, 3H), 3.04 (s, 3H).</div></div><div id="sec4_3_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>(4)-(3-Bromophenyl)-5-chloro-<i>N</i>(2)-(3-vinylphenyl)pyrimidine-2,4-diamine (<b>7a</b>)</h4><div class="NLM_p last"><b>5a</b> (318 mg, 1.0 mmol), 3-vinylphenylamine (<b>6a</b>) (119 mg, 1.0 mmol), and 4.0 M HCl in dioxane (275 μL, 1.10 mmol) were combined in 2-methoxyethanol (10 mL) and warmed to 110 °C for 16 h. The resulting solution was concentrated under reduced pressure, and the residue was partitioned between CHCl<sub>3</sub> and saturated aqueous NaHCO<sub>3</sub>. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was triturated with CH<sub>3</sub>CN, filtered, and rinsed with a small amount of CH<sub>3</sub>CN to yield 297 mg (74%) of desired <b>7a</b> as an off white solid, mp 142–145 °C. LC: 96%. LC/MS: M + H = 402.9. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.12 (s, 1H), 7.84 (s, 1H), 7.57–7.55 (d, <i>J</i> = 8.33 Hz, 1H), 7.51–7.49 (m, 2H), 7.34–7.28 (m, 2H), 7.24–7.20 (m, 1H), 7.15–7.13 (d, <i>J</i> = 7.60 Hz, 1H), 7.07 (bs, 1H), 7.01 (bs, 1H), 6.71–6.64 (m, 1H), 5.72–5.67 (d, <i>J</i> = 17.69 Hz, 1H), 5.26–5.23 (d, <i>J</i> = 11.11 Hz, 1H).</div></div><div id="sec4_3_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>(2)-(3-Bromo-4-morpholin-4-ylphenyl)-5-chloro-<i>N</i>(4)-3-vinylphenyl)pyrimidine-2,4-diamine (<b>7b</b>)</h4><div class="NLM_p last">Compound <b>7b</b> was prepared in a similar manner as <b>7a</b> after substituting <b>5b</b> for <b>5a</b> and 3-bromo-4-morpholin-4-ylphenylamine (<b>6b</b>) for <b>6a</b>. Also, EtOAc was used for the extractive workup rather than CHCl<sub>3</sub>. The desired product <b>7b</b> was isolated in 71% as a white solid, mp 142–144 °C. LC: 91%. LC/MS: M + H = 406.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.37 (s, 1H), 8.86 (s, 1H), 8.16 (s, 1H), 7.85 (s, 1H), 7.70 (s, 1H), 7.63–7.60 (m, 2H), 7.38–7.34 (t, 1H), 7.28–7.26 (d, 1H), 6.99–6.96 (d, 1H), 6.76–6.68 (m, 1H), 5.81–5.77 (d, 1H), 5.27–5.24 (d, 1H), 3.73–3.71 (m, 4H), 2.88–2.86 (m, 4H).</div></div><div id="sec4_3_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>(2)-[3-Bromo-4-(2-pyrrolidin-1-ylethoxy)phenyl]-5-chloro-<i>N</i>(4)-(3-vinylphenyl)pyrimidine-2,4-diamine (<b>7c</b>)</h4><div class="NLM_p last">Compound <b>7c</b> was prepared in a similar manner as <b>7b</b> after substituting <b>6c</b> for <b>6b</b> and substituting methanesulfonic acid for 4.0 M HCl in dioxane. Also, CHCl<sub>3</sub> was used for the extractive workup rather than EtOAc. The desired product <b>7c</b> was isolated in 52% as a white solid. LC/MS: M + H = 515.4</div></div><div id="sec4_3_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>(2)-[3-Bromo-4-(4-methylpiperain-1-yl)phenyl]-5-chloro-<i>N</i>(4)-(3-vinylphenyl)pyrimidine-2,4-diamine (<b>7d</b>)</h4><div class="NLM_p last">Compound <b>7d</b> was prepared in a similar manner as <b>7b</b> after substituting <b>6d</b> for <b>6b</b>. Also, CHCl<sub>3</sub> was used for the extractive workup rather than EtOAc. The desired product <b>7d</b> was isolated in 62% as a tan solid, mp 149–153 °C. LC: 93%. LC/MS: M + H = 501.0. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.35 (s, 1H), 8.85 (s, 1H), 8.16 (s, 1H), 7.83 (s, 1H), 7.70 (s, 1H), 7.61–7.58 (m, 2H), 7.37–7.33 (t, 1H), 7.28–7.26 (d, 1H), 6.97–6.95 (d, 1H), 6.75–6.68 (m, 1H), 5.81–5.77 (d, 1H), 5.27–5.24 (d, 1H), 2.87 (s, 4H), 2.46 (s, 4H), 2.23 (s, 3H).</div></div><div id="sec4_3_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>(4)-(5-Bromo-2-methoxyphenyl]-5-chloro-<i>N</i>(2)-(3-vinylphenyl)pyrimidine-2,4-diamine (<b>7e</b>)</h4><div class="NLM_p last">Compound <b>7e</b> was prepared in a similar manner as <b>7a</b> after substituting <b>5c</b> for <b>5a</b> and heating the mixture for 8 h rather than 16 h. The desired product <b>7e</b> was isolated in 76% as a white solid, mp 183–185 °C. LC: 97%. LC/MS: M + H = 432.9. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.44 (s, 1H), 8.26 (s, 1H), 8.19 (s, 1H), 8.09 (bs, 1H), 7.56–7.54 (m, 2H), 7.36–7.33 (m, 1H), 7.22–7.18 (m, 1H), 7.11–7.08 (d, <i>J</i> = 8.78 Hz, 1H), 7.06–7.04 (d, <i>J</i> = 7.71 Hz, 1H), 6.61–6.54 (m, 1H), 5.68–5.64 (d, <i>J</i> = 17.55 Hz, 1H), 5.22–5.19 (d, <i>J</i> = 10.96 Hz, 1H), 3.83 (s, 3H).</div></div><div id="sec4_3_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>(2)-[3-Bromo-4-morpholin-4-ylphenyl]-5-chloro-<i>N</i>(4)-(2-methoxy-5-vinylphenyl)pyrimidine-2,4-diamine (<b>7f</b>)</h4><div class="NLM_p last">Compound <b>7f</b> was prepared in a similar manner as <b>7b</b> after substituting <b>5d</b> for <b>5b</b> and after altering the solvent system from 2-methoxyethanol to a 1:1 mixture of <i>tert</i>-butyl alcohol/1,2-dimethoxyethane (120 mL of solvent for a mmol reaction). The reaction mixture was warmed for 6 days at 85 °C, followed by the standard workup using EtOAc for the extractive workup. Some desired <b>7f</b> crystallized relatively pure from EtOAc on concentrating the filtrate, amd the remainder was purified via normal phase chromatography to yield the desired product <b>7f</b> in 55% overall yield as a yellow tinted solid, mp 186–190 °C. LC: 100%. LC/MS: M + H = 518.0. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.36 (s, 1H), 8.23 (s, 1H), 8.16 (s, 1H), 7.95 (s, 1H), 7.8 (s, 1H), 7.58–7.57 (m, 1H), 7.33–7.32 (m, 1H), 7.13–7.11 (d, 1H), 6.96–6.94 (d, 1H), 6.7–6.6 (m, 1H), 5.67–5.62 (d, 1H), 5.13–5.10 (d, 1H), 3.85 (s, 3H), 3.74–3.71 (m, 4H), 2.88–2.85 (m, 4H).</div></div><div id="sec4_3_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>(2)-[3-Bromo-4-(4-methylpiperazin-1-yl)phenyl]-5-chloro-<i>N</i>(4)-(2-methoxy-5-vinylphenyl)pyrimidine-2,4-diamine (<b>7g</b>)</h4><div class="NLM_p last">Compound <b>7g</b> was prepared in a similar manner as <b>7f</b> after substituting <b>6d</b> for <b>6b</b>. After the reaction mixture was concentrated, the crude mix was purified straightaway via preparative HPLC. The purest fractions were then partitioned between EtOAc and saturated aqueous NaHCO<sub>3</sub>. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give desired <b>7g</b> in 20% yield. This material was used without further manipulation for subsequent cyclization to <b>8g</b>. LC: 93%. LC/MS: M + H = 531.0.</div></div><div id="sec4_3_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-Bromo-2-(5-chloro-2-[4-(4-methylpiperazin-1-yl)-3-vinylphenylamino]pyrimidin-4-ylamino)benzoic Acid Methyl Ester (<b>7h</b>)</h4><div class="NLM_p last">Compound <b>7h</b> was prepared in a similar manner as <b>7a</b> after substituting <b>5e</b> for <b>5a</b> and after substituting <b>6e</b> for <b>6a</b>. Also, methanesulfonic acid was used rather than 4.0 M HCl in dioxane. The desired product <b>7h</b> was isolated in 52% as a tan solid and was used for subsequent cyclization to <b>8h</b> without further manipulation. LC: 98%. LC/MS: M + H = 559.0. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.04 (s, 1H), 9.49 (s, 1H), 8.98 (s, 1H), 8.30 (s, 1H), 7.95–7.93 (d, <i>J</i> = 8.56 Hz, 1H), 7.60–7.56 (m, 2H), 7.35–7.32 (d, <i>J</i> = 10.16 Hz, 1H), 7.07–7.05 (d, <i>J</i> = 8.57 Hz, 1H), 7.01–6.93 (m, 1H), 5.58–5.53 (d, <i>J</i> = 17.37 Hz, 1H), 5.21–5.18 (d, <i>J</i> = 11.81 Hz, 1H), 3.91 (s, 3H), 2.84 (s, 4H), 2.5 (bs, 4H + DMSO), 2.23 (s, 3H).</div></div><div id="sec4_3_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>(4)-[5-Bromo-2-(propane-2-sulfonyl)phenyl]-5-chloro-<i>N</i>(2)-[4-(4-methylpiperazin-1-yl)-3-vinylphenyl]pyrimidine-2,4-diamine (<b>7i</b>)</h4><div class="NLM_p last">Compounds <b>5f</b> (150 mg, 0.35 mmol) and <b>6e</b> (77 mg, 0.35 mmol) and methanesulfonic acid (33 μL, 0.50 mmol) were combined in 2-methoxyethanol (4 mL) and warmed to 110 °C for 3 h. The resulting solution was concentrated under reduced pressure and the residue partitioned between CHCl<sub>3</sub> (2×) and saturated aqueous NaHCO<sub>3</sub>. The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The 270 mg of remaining brown oil was dissolved in CH<sub>3</sub>CN (3 mL). The solid which crystallized was filtered and rinsed with a small amount of ice cold CH<sub>3</sub>CN to yield 90 mg (40%) of desired <b>7i</b> as a light brown solid, which was used without further manipulation for its subsequent cyclization to <b>8i</b>. LC: 92%. LC/MS: M + H = 607.0.</div></div><div id="sec4_3_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-(4-Bromo-2-{5-chloro-2-[4-(4-methylpiperazin-1-yl)-3-vinylphenylamino]pyrimidin-4-ylamino}phenyl)-<i>N</i>-methylmethanesulfonamide (<b>7j</b>)</h4><div class="NLM_p last">Compounds <b>5g</b> (213 mg, 0.50 mmol) and <b>6e</b>(109 mg, 0.50 mmol) and methanesulfonic acid (46 μL, 0.71 mmol) were combined in 2-methoxyethanol (6 mL) and warmed to 110 °C for 4 h. The resulting solution was concentrated under reduced pressure and the residue partitioned between EtOAc (2×) and saturated aqueous NaHCO<sub>3</sub>. The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The remaining brown oil was dissolved in CH<sub>3</sub>CN (3 mL). The solid which crystallized was filtered and rinsed with a small amount of ice cold CH<sub>3</sub>CN to yield 118 mg (39%) of desired <b>7j</b> as an off white solid, which was used without further manipulation for its subsequent cyclization to <b>8j</b>. LC: 92%. LC/MS: M + H = 608.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.40 (s, 1H), 8.45 (s, 1H), 8.39 (s, 1H), 8.23 (s, 1H), 7.60–7.58 (m, 3H), 7.41–7.39 (d, <i>J</i> = 8.60 Hz, 1H), 7.05–7.03 (d, <i>J</i> = 8.32 Hz, 1H), 7.00–6.92 (m, 1H), 5.55–5.51 (d, <i>J</i> = 17.81 Hz, 1H), 5.21–5.18 (d, <i>J</i> = 11.24 Hz, 1H), 3.19 (s, 3H), 3.12 (s, 3H), 2.83 (bs, 4H), 2.50 (bs, 4H + DMSO), 2.24 (s, 3H).</div></div><div id="sec4_3_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>(2)-[5-Bromo-2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]-5-chloro-<i>N</i>(4)-(3-vinylphenyl)pyrimidine-2,4-diamine (<b>7k</b>)</h4><div class="NLM_p last">Compound <b>7k</b> was prepared in a similar manner as <b>7a</b> after substituting <b>5b</b> for <b>5a</b>, substituting <b>6f</b> for <b>6a</b>, and heating the mixture for 8 h rather than 16 h. The workup also varied in that after concentrating the reaction mixture, the crude mix was purified straightaway via preparative HPLC. The purest fractions were then partitioned between EtOAc and saturated aqueous NaHCO<sub>3</sub>. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give desired <b>7k</b> as an oil in 10% yield. This material was used without further manipulation for its subsequent cyclization to <b>8k</b>. LC: 95%. LC/MS: M + H = 530.9.</div></div><div id="sec4_3_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>(2)-[5-Bromo-2-methoxy-4-(4-methylpiperazin-1-yl)phenyl]-5-chloro-<i>N</i>(4)-[2-(propane-2-sulfonyl)-5-vinylphenyl]pyrimidine-2,4-diamine (<b>7l</b>)</h4><div class="NLM_p last">Compounds <b>5h</b> (200 mg, 0.54 mmol) and <b>6f</b> (177 mg, 0.59 mmol) and methanesulfonic acid (45.3 μL, 0.70 mmol) were combined in 2-methoxyethanol (3 mL) and warmed to 105 °C for 3 h. The resulting solution was concentrated under reduced pressure, dissolved in DMSO, and purified via preparative HPLC. The purest fractions of desired <b>7l</b> were combined and partitioned between EtOAc (2×) and saturated aqueous NaHCO<sub>3</sub>. The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The 215 mg of yellow residue was triturated with ice cold CH<sub>3</sub>CN, filtered, and rinsed with a small amount of ice cold CH<sub>3</sub>CN to yield 70 mg (20%) of desired <b>7l</b> as an off white solid, which was used without further manipulation for its subsequent cyclization to <b>8l</b>. LC: 99%. LC/MS: M + H = 637.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.48 (s, 1H, exchangeable), 8.53 (s, 1H), 8.46 (s, 1H, exchangeable), 8.32 (s, 1H), 7.78–7.76 (m, 2H), 7.49–7.47 (d, <i>J</i> = 7.64 Hz, 1H), 6.80 (s, 1H), 6.67–6.57 (m, 1H), 5.87–5.83 (d, <i>J</i> = 17.72 Hz, 1H), 5.40–5.37 (d, <i>J</i> = 10.85 Hz, 1H), 3.78 (s, 3H), 3.46–3.41 (m, 1H), 2.97 (s, 4H), 2.5 (s, 4H + DMSO), 2.24 (s, 3H), 1.18–1.16 (d, <i>J</i> = 6.68 Hz, 6H).</div></div><div id="sec4_3_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-(2-{2-[5-Bromo-2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino]-5-chloropyrimidin-4-ylamino}-4-vinylphenyl)-<i>N</i>-methylmethanesulfonamide (<b>7m</b>)</h4><div class="NLM_p last">Compounds <b>5i</b> (192 mg, 0.52 mmol) and <b>6f</b> (170 mg, 0.57 mmol) and methanesulfonic acid (43.4 μL, 0.67 mmol) were combined in 2-methoxyethanol (3 mL) and warmed to 105 °C for 4 h. The resulting solution was concentrated under reduced pressure, dissolved in DMSO, and purified via preparative HPLC. The purest fractions of desired <b>7m</b> were combined and partitioned between EtOAc (2×) and saturated aqueous NaHCO<sub>3</sub>. The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The 270 mg of yellow residue was triturated with ice cold CH<sub>3</sub>CN, filtered, and rinsed with a small amount of ice cold CH<sub>3</sub>CN to yield 110 mg (34%) of desired <b>7m</b> as an off white solid, which was used without further manipulation for its subsequent cyclization to <b>8m</b>. LC: 98%. LC/MS: M + H = 638.0. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.41 (s, 1H, exchangeable), 8.23 (s, 1H, exchangeable), 8.21 (s, 1H), 8.18 (s, 1H), 7.82 (s, 1H), 7.58–7.56 (d, <i>J</i> = 8.25 Hz, 1H), 7.36–7.34 (d, <i>J</i> = 8.04 Hz, 1H), 6.81 (s, 1H), 6.61–6.54 (m, 1H), 5.77–5.72 (d, <i>J</i> = 17.69 Hz, 1H), 5.27–5.25 (d, <i>J</i> = 10.77 Hz, 1H), 3.79 (s, 3H), 3.18 (s, 3H), 3.10 (s, 3H), 2.98 (s, 4H), 2.5 (s, 4H + DMSO), 2.24 (s, 3H).</div></div><div id="sec4_3_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>(2)-(3-Bromo-4-morpholin-4-ylphenyl)-5-chloro-<i>N</i>(4)-{2-methoxy-5-[1-(2-methoxyethoxy)ethyl]phenyl}pyrimidine-2,4-diamine (<b>7n</b>)</h4><div class="NLM_p last"><b>7n</b> is the side product that was isolated from initial reaction toward <b>7f</b> when 2-methoxyethanol was used as solvent. LC: 95%. LC/MS: M + H = 594.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.39 (s, 1H), 8.49 (s, 1H), 8.15 (s, 1H), 7.70–7.68 (m, 2H), 7.52–7.49 (m, 1H), 7.19–7.16 (m, 1H), 7.13–7.11 (d, <i>J</i> = 8.56 Hz, 1H), 6.98–6.95 (d, <i>J</i> = 8.80 Hz, 1H), 4.40–4.36 (m, 1H), 3.80 (s, 3H), 3.73–3.71 (m, 4H), 3.38–3.30 (m, 4H), 3.18 (s, 3H), 2.87–2.85 (m, 4H), 1.31–1.30 (d, <i>J</i> = 6.41 Hz, 3H).</div></div><div id="sec4_3_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> (14<i>Z</i>)-6-Chloro-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene (<b>8a</b>)</h4><div class="NLM_p last">Palladium acetate (Pd(OAc)<sub>2</sub>) (40 mg, 0.2 mmol), tri-<i>o</i>-tolylphosphine (240 mg, 0.79 mmol), and DAP <b>7a</b> (150 mg, 0.37 mmol) were combined with CH<sub>3</sub>CN (4 mL) and triethylamine (Et<sub>3</sub>N) (300 μL, 2 mmol). The mixture was treated under microwave irradiation at 120 °C for 30 min. After the mixture was cooled, the resulting solid was filtered and rinsed with ice cold CH<sub>3</sub>CN to yield 78 mg (65%) of desired <b>8a</b> as an off white solid, mp >250 °C. TLC: 25% EtOAc/hexane <i>R<sub>f</sub></i> = 0.25; 5:1 CH<sub>2</sub>Cl<sub>2</sub>/MeOH <i>R<sub>f</sub></i> = 0.85. LC: 96%. LC/MS: M + H = 321.2. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.37 (s, 1H, exchangeable), 9.12 (s, 1H, exchangeable), 8.94 (s, 1H), 8.65 (s, 1H), 8.15 (s, 1H), 7.32–7.28 (m, 1H), 7.22–7.19 (m, 2H), 7.04 (bm, 2H), 6.93–6.91 (d, <i>J</i> = 7.6 Hz, 1H), 6.64–6.55 (m, 2H).</div></div><div id="sec4_3_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (14<i>Z</i>)-6-Chloro-17-(morpholin-4-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene (<b>8b</b>)</h4><div class="NLM_p last">Compound <b>8b</b> was prepared in a similar manner as <b>8a</b> after substituting <b>7b</b> for <b>7a</b>. In addition, after the CH<sub>3</sub>CN trituration, the sample was also triturated with ethyl ether (Et<sub>2</sub>O). The desired product <b>8b</b> was isolated in 43% yield as an off white solid, mp 267–270 °C. LC: 95%. LC/MS: M + H = 406.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.18 (s, 1H), 9.03 (s, 1H), 8.65 (s, 1H), 8.44–8.43 (d, 1H), 8.10 (s, 1H), 7.27–7.23 (t, 1H), 7.18–7.16 (d, 1H), 7.01–6.97 (m, 2H), 6.95–6.93 (d, 1H), 6.85–6.82 (d, 1H), 6.72–6.68 (d, 1H), 3.76–3.75 (m, 4H), 2.84 (m, 4H).</div></div><div id="sec4_3_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (14<i>Z</i>)-6-Chloro-17-[2-(pyrrolidin-1-yl)ethoxy]-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene (<b>8c</b>)</h4><div class="NLM_p last">Compound <b>8c</b> was prepared in a similar manner as <b>8a</b> after substituting <b>7c</b> for <b>7a</b>. The desired product <b>8c</b> was isolated in 62% yield as a copper colored solid. LC: 100%. LC/MS: M + H = 434.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.7 (bs, 1H), 9.24 (s, 1H), 9.11 (s, 1H), 8.63 (s, 1H), 8.51 (d, 1H), 8.12 (s, 1H), 7.29–7.25 (t, 1H), 7.21–7.19 (d, 1H), 7.04–6.99 (m, 2H), 6.96–6.94 (d, 1H), 6.89–6.86 (d, 1H), 6.73–6.70 (d, 1H), 4.28–4.26 (m, 2H), 3.64–3.56 (bm, 2H + water), 3.18 (m, 2H), 2.07 (bm, 2H), 1.91–1.89 (m, 2H).</div></div><div id="sec4_3_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (14<i>Z</i>)-6-Chloro-17-(4-methylpiperazin-1-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene (<b>8d</b>)</h4><div class="NLM_p">Compound <b>8d</b> was prepared in a similar manner as <b>8a</b> after substituting <b>7d</b> for <b>7a</b>. The desired product <b>8d</b> was isolated in 75% yield as an off white solid. LC: 92%, LC/MS: M + H = 419.1.</div><div class="NLM_p last">A 25 mg sample of the 92% pure material was further purified via preparative HPLC to return 17 mg of <b>8d</b> as a TFA salt white lyophylate, which was the sample used for biological testing. LC: 100%. LC/MS: M + H = 419.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.58 (bs, 1H), 9.29 (s, 1H), 9.12 (s, 1H), 8.61 (s, 1H), 8.45–8.44 (d, 1H), 8.12 (s, 1H), 7.29–7.25 (t, 1H), 7.20–7.18 (d, 1H), 7.02–6.97 (m, 3H), 6.83–6.80 (d, 1H), 6.75–6.72 (d, 1H), 3.74 (bs, H<sub>2</sub>O), 3.54–3.51 (d, 2H), 3.29–3.22 (m, 4H), 2.93–2.89 (m, 5H).</div></div><div id="sec4_3_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (14<i>Z</i>)-10-Methoxy-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene (<b>8e</b>)</h4><div class="NLM_p last">Compound <b>8e</b> was prepared in a similar manner as <b>8a</b> after substituting <b>7e</b> for <b>7a</b>. The workup varied slightly in that the initial solid collected was dissolved in tetrahydrofuran (THF), filtered, and the filtrate was concentrated under reduced pressure. The resulting solid was triturated in CH<sub>3</sub>CN, filtered, and rinsed with CH<sub>3</sub>CN followed by Et<sub>2</sub>O. The desired product <b>8e</b> was isolated in 51% yield as a tannish solid, mp 273–275 °C. LC: 99%. LC/MS: M + H = 351.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.49 (s, 1H), 8.99 (s, 1H), 8.80 (bs, 1H), 8.21 (s, 1H), 7.83 (s, 1H), 7.25–7.21 (m, 1H), 7.08–7.04 (m, 3H), 6.94–6.92 (d, <i>J</i> = 7.37 Hz, 1H), 6.55–6.44 (m, 2H), 3.91 (s, 3H).</div></div><div id="sec4_3_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (14<i>Z</i>)-6-Chloro-10-methoxy-17-(morpholin-4-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene (<b>8f</b>)</h4><div class="NLM_p last">Compound <b>8f</b> was prepared in a similar manner as <b>8a</b> after substituting <b>7f</b> for <b>7a</b>. The desired product <b>8f</b> was isolated in 53% yield as a gray solid. LC: 87%. LC/MS: M + H = 436.2.</div></div><div id="sec4_3_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (14<i>Z</i>)-6-Chloro-10-methoxy-17-(4-methylpiperazin-1-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene (<b>8g</b>)</h4><div class="NLM_p">Compound <b>8g</b> was prepared in a similar manner as <b>8a</b> after substituting <b>7g</b> for <b>7a</b>. The desired product <b>8g</b> was isolated in 94% yield as an off white solid. LC: 94%, M + H = 449.1.</div><div class="NLM_p last">A small sample of the 94% pure material was further purified via preparative HPLC to return pure <b>8g</b> as a TFA salt white lyophylate, which was the sample used for biological testing. LC: 99%. LC/MS: M + H = 449.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.6 (bs, 1H), 9.38 (s, 1H), 9.04–9.03 (d, 1H), 8.41–8.40 (d, 1H), 8.19 (d, 1H), 7.84 (s, 1H), 7.11–7.01 (m, 4H), 6.68–6.60 (m, 2H), 3.90 (s, 3H), 3.5–3.2 (bm, 6H + H<sub>2</sub>O), 2.96–2.89 (m, 5H).</div></div><div id="sec4_3_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Methyl (14<i>Z</i>)-6-Chloro-17-(4-methylpiperazin-1-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene-10-carboxylate (<b>8h</b>)</h4><div class="NLM_p last">Compound <b>8h</b> was prepared in a similar manner as <b>8a</b> after substituting <b>7h</b> for <b>7a</b>. The desired product <b>8h</b> was isolated in 54% yield as a bronze solid. LC: 100%. LC/MS: M + H = 477.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 10.72 (s, 1H), 9.59 (s, 1H), 9.42 (s, 1H), 8.39 (s, 1H), 8.23 (s, 1H), 7.97–7.95 (d, 1H), 7.13–7.06 (m, 2H), 7.01–6.99 (d, 1H), 6.94–6.90 (d, 1H), 6.68–6.65 (d, 1H), 3.91 (s, 3H), 2.86 (s, 4H), 2.50 (s, 4H + DMSO), 2.25 (s, 3H).</div></div><div id="sec4_3_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> (14<i>Z</i>)-6-Chloro-10-(propane-2-sulfonyl)-17-(4-methylpiperazin-1-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene Trifluoroacetate (1:1) (<b>8i</b>)</h4><div class="NLM_p last">Pd(OAc)<sub>2</sub> (48 mg, 0.21 mmol), tri-<i>o</i>-tolylphosphine (275 mg, 0.90 mmol), and DAP <b>7i</b> (160 mg, 0.26 mmol) were combined with CH<sub>3</sub>CN (4 mL) and Et<sub>3</sub>N (250 μL, 1.8 mmol). The mixture was treated under microwave irradiation at 120 °C for 120 min. After cooling, the resulting mixture was filtered and the filtrate was concentrated under reduced pressure. The concentrated residue was partitioned between 1 N HCl and EtOAc (2×). The aqueous phase was cooled and neutralized with KOH solution until ∼pH 7 and then diluted with saturated aqueous NaHCO<sub>3</sub>. The resulting basic solution was extracted with CHCl<sub>3</sub> (2×). The combined CHCl<sub>3</sub> extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified via preparative HPLC and the purest fractions were combined and lyophilized to yield desired <b>8i</b> as its TFA salt in 32% yield. This material was carried on for subsequent conversion to <b>2i</b> without further manipulation. LC: 100%. LC/MS: M + H = 525.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.65 (bs, 1H), 9.55 (s, 1H), 9.48 (s, 1H), 9.26–9.25 (d, 1H), 8.46–8.45 (d, 1H), 8.28 (s, 1H), 7.77–7.75 (d, 1H), 7.33–7.31 (m, 1H), 7.12–7.05 (m, 2H), 7.02–6.98 (d, 1H), 6.77–6.74 (d, 1H), 4.1 (bs, H<sub>2</sub>O), 3.54–3.51 (d, 2H), 3.42–3.38 (m, 1H), 3.30–3.22 (m, 4H), 2.96–2.89 (m, 5H), 1.17–1.15 (d, 6H).</div></div><div id="sec4_3_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> (14<i>Z</i>)-6-Chloro-10-(2-methanesulfonylmethylamino)-17-(4-methylpiperazin-1-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene Trifluoroacetate (1:1) (<b>8j</b>)</h4><div class="NLM_p last">Pd(OAc)<sub>2</sub> (24 mg, 0.10 mmol), tri-<i>o</i>-tolylphosphine (140 mg, 0.45 mmol), and DAP <b>7j</b> (80 mg, 0.13 mmol) were combined with CH<sub>3</sub>CN (2 mL) and Et<sub>3</sub>N (120 μL, 0.9 mmol). The mixture was treated under microwave irradiation at 120 °C for 45 min. By LC analysis, the reaction had not proceeded to completion, so the reaction mixture was filtered and the solution recharged with second portions of Pd(OAc)<sub>2</sub> (35 mg, 0.16 mmol), tri-<i>o</i>-tolylphosphine (170 mg, 0.56 mmol), and Et<sub>3</sub>N (160 μL, 1.1 mmol). The mixture was again treated under microwave irradiation at 120 °C for 120 min. After cooling, the resulting mixture was filtered and the filtrate was concentrated under reduced pressure. The concentrated residue was partitioned between 1 N HCl (1.4 mL) and EtOAc (2×). The aqueous phase was purified directly via preparative HPLC and the purest fractions were combined and lyophilized to yield desired <b>8j</b> as its TFA salt in 37% yield. This material was carried on for subsequent conversion to <b>2j</b> without further manipulation. LC: 100%. LC/MS: M + H = 526.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.80 (bs, 1H), 9.42 (s, 1H), 8.89 (s, 1H), 8.42 (s, 1H), 8.23 (s, 1H), 8.20 (s, 1H), 7.58–7.56 (d, 1H), 7.20–7.18 (d, 1H), 7.07–7.01 (m, 2H), 6.88–6.84 (d, 1H), 6.74–6.71 (d, 1H), 3.53–3.51 (d, 2H), 3.35–3.21 (m, 7H), 3.09 (s, 3H), 2.97–2.91 (m, 2H), 2.89 (s, 3H).</div></div><div id="sec4_3_4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> (14<i>Z</i>)-6-Chloro-17-(4-methylpiperazin-1-yl)-19-methoxy-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene (<b>8k</b>)</h4><div class="NLM_p last">Compound <b>8k</b> was prepared in a similar manner as <b>8a</b> after substituting <b>7k</b> for <b>7a</b>. The workup varied slightly in that no product precipitated from the reaction mixture; therefore, the reaction mixture was concentrated under reduced pressure. The residue was partitioned between 1 N HCl and EtOAc (2×). The aqueous phase was neutralized and extracted with CHCl<sub>3</sub> (3×). The CHCl<sub>3</sub> extracts were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give crude <b>8k</b> in 51% yield, which was carried on for subsequent reduction toward <b>2k</b> without further manipulation. LC/MS: M + H = 449.0.</div></div><div id="sec4_3_4_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> (14<i>Z</i>)-6-Chloro-10-(propane-2-sulfonyl)-17-(4-methylpiperazin-1-yl)-19-methoxy-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene (<b>8l</b>)</h4><div class="NLM_p last">Pd(OAc)<sub>2</sub> (6.5 mg, 0.03 mmol) was dissolved in CH<sub>3</sub>CN (3 mL). Then tri-<i>o</i>-tolylphosphine (55 mg, 0.18 mmol) was added and the mixture was stirred at rt for 15 min under Ar. DAP <b>7l</b> (60 mg, 0.094 mmol) and Et<sub>3</sub>N (92 μL, 0.66 mmol) were added to the resulting reaction mixture. The mixture was treated under microwave irradiation at 120 °C for 15 min. After cooling, the resulting solution was filtered through a Phenomenex Strat-X-C cation catch and release resin, which was then rinsed twice with CH<sub>3</sub>CN followed by MeOH. The resin cartridge was transferred to a new filter flask, and the resin was rinsed twice with 2 M NH<sub>3</sub> in MeOH. The latter methanol solution was concentrated under reduced pressure to give a yellow residue. This material was treated with CH<sub>3</sub>CN (2 mL) to yield a yellow solid, which was filtered and rinsed with a small amount of ice cold CH<sub>3</sub>CN to give 33 mg (63%) of desired <b>8l</b> as a yellow solid. LC: 97%. LC/MS: M + H = 555.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.49 (s, 1H, exchangeable), 9.27 (s, 1H), 8.42 (s, 1H), 8.25 (s, 1H), 8.16 (s, 1H, exchangeable), 7.74–7.72 (d, <i>J</i> = 8.21 Hz, 1H), 7.28–7.26 (d, 8.00 Hz, 1H), 6.92–6.89 (d, <i>J</i> = 13.08 Hz, 1H), 6.72 (s, 1H), 6.62–6.58 (d, <i>J</i> = 13.20 Hz, 1H), 3.87 (s, 3H), 3.40–3.37 (m, 1H), 2.92 (s, 4H), 2.54 (s, 4H), 2.25 (s, 3H), 1.17–1.15 (d, <i>J</i> = 6.76 Hz, 6H).</div></div><div id="sec4_3_4_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> (14<i>Z</i>)-6-Chloro-10-(2-methanesulfonylmethylamino)-17-(4-methylpiperazin-1-yl)-19-methoxy-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene (<b>8m</b>)</h4><div class="NLM_p last">Pd(OAc)<sub>2</sub> (6.5 mg, 0.03 mmol) was dissolved in CH<sub>3</sub>CN (3 mL). Then tri-<i>o</i>-tolylphosphine (55 mg, 0.18 mmol) was added and the mixture was stirred at rt for 15 min under Ar. DAP <b>7m</b> (90 mg, 0.14 mmol) and Et<sub>3</sub>N (300 μL, 2 mmol) were added to the resulting reaction mixture. The mixture was treated under microwave irradiation at 120 °C for 15 min. After cooling, the resulting solution was filtered through a Phenomenex Strat-X-C cation catch and release resin, which was then rinsed twice with CH<sub>3</sub>CN followed by MeOH. The resin cartridge was transferred to a new filter flask, and the resin was rinsed twice with 2 M NH<sub>3</sub> in MeOH. The latter methanol solution was concentrated under reduced pressure to give a yellow residue. This material was treated with CH<sub>3</sub>CN (2 mL) to yield a yellow solid, which was filtered and rinsed with a small amount of ice cold CH<sub>3</sub>CN to give 57 mg (72%) of desired <b>8m</b> as a yellow solid, mp 278–280 °C. LC: 97%. LC/MS: M + H = 556.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.90 (s, 1H), 8.37 (s, 1H), 8.21 (s, 1H), 8.18 (s, 1H, exchangeable), 8.02 (s, 1H, exchangeable), 7.57–7.55 (d, <i>J</i> = 8.25 Hz, 1H), 7.15–7.13 (d, <i>J</i> = 8.08 Hz, 1H), 6.78–6.75 (d, <i>J</i> = 13.0 Hz, 1H), 6.99 (s, 1H), 6.58–6.55 (d, <i>J</i> = 13.1 Hz, 1H), 3.85 (s, 3H), 3.21 (s, 3H), 3.08 (s, 3H), 2.92 (bm, 4H), 2.5 (4H + DMSO), 2.25 (s, 3H).</div></div><div id="sec4_3_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 6-Chloro-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene (<b>2a</b>)</h4><div class="NLM_p last">Compound <b>8a</b> (50 mg, 0.2 mmol) was combined with platinum dioxide (PtO<sub>2</sub>) (10 mg, 0.04 mmol) in THF (6 mL), and the mixture was blanketed under H<sub>2</sub> at atmospheric pressure. After being stirred at rt for 5 days the mixture was carefully filtered, rinsed with a small amount of THF, and the filtrate was subsequently concentrated. The residue was purified via preparative HPLC to yield after lyophylization 16 mg (30%) of desired <b>2a</b> as a white lyophylate. LC: 99%. LC/MS: M + H = 323.2. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.27 (s, 1H), 9.03 (s, 1H), 8.15 (s, 1H), 7.98 (s, 1H), 7.81 (s, 1H), 7.27–7.23 (m, 1H), 7.14–7.10 (m, 2H), 7.02–7.00 (d, <i>J</i> = 8.6 Hz, 1 H), 6.94–6.92 (d, <i>J</i> = 9.1 Hz, 1H), 6.82–6.80 (d, <i>J</i> = 7.4 Hz, 1H), 2.90 (s, 4H).</div></div><div id="sec4_3_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 6-Chloro-17-(morpholin-4-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene (<b>2b</b>)</h4><div class="NLM_p last">At rt, dipotassium azodicarboxylate<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (784 mg, 4.0 mmol) was added to a solution of <b>8b</b> (70 mg, 0.172 mmol) in pyridine (10 mL). The resulting mixture was treated with acetic acid (AcOH) (0.56 mL, 9.8 mmol). After 3 days the reaction mixture was treated with additional portions of dipotassium azodicarboxylate (330 mg, 1.7 mmol) and AcOH (0.28 mL, 4.9 mmol) and warmed to 35 °C for 2 days (LC supported reaction, >95% complete). The mixture was then combined with water, and the resulting solid was collected. This solid was dissolved in DMSO and purified via preparative HPLC to yield 28 mg (31%) of desired <b>2b</b> as a white lyophylate. LC: 100%. LC/MS: M + H = 408.2. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.47 (bs, 2H), 8.16 (s, 1H), 7.95–7.94 (d, 1H), 7.80 (s, 1H), 7.25–7.21 (t, 1H), 7.05–7.00 (m, 3H), 6.91–6.88 (m, 1H), 3.76–3.74 (m, 4H), 3.02–2.96 (m, 4H), 2.78–2.77 (m, 4H).</div></div><div id="sec4_3_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 6-Chloro-17-[2-(pyrrolidin-1-yl)ethoxy]-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Trifluoroacetate (1:1) (<b>2c</b>)</h4><div class="NLM_p last">Compound <b>2c</b> was prepared in a similar manner as <b>2b</b> after substituting <b>8c</b> for <b>8b</b>. The workup varied slightly in that after the addition of water no solid precipitated, so the aqueous solution was partitioned between saturated aqueous NaHCO<sub>3</sub> and EtOAc. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified via preparative HPLC. The desired product <b>2c</b> was isolated as a TFA salt, white lyophylate in 40% yield. LC: 100%. LC/MS: M + H = 436.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.7 (bs, 1H), 9.16 (s, 1H), 9.05 (s, 1H), 8.09 (s, 1H), 7.82 (s, 1H), 7.80 (s, 1H), 7.23–7.19 (t, 1H), 7.07–7.05 (d, 1H), 6.97–6.95 (d, 1H), 6.88 (m, 2H), 4.25–4.23 (m, 2H), 3.64 (bs, 2H + H<sub>2</sub>O), 3.20 (m, 2H), 2.91 (s, 4H), 2.08 (m, 2H), 1.91 (m, 2H).</div></div><div id="sec4_3_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 6-Chloro-17-(4-methylpiperazin-1-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Trifluoroacetate (1:1) (<b>2d</b>)</h4><div class="NLM_p last">Compound <b>2d</b> was prepared in a similar manner as <b>2b</b> after substituting <b>8d</b> for <b>8b</b>. The workup followed was akin to that for <b>2c</b>. The desired product <b>2d</b> was isolated in 63% yield as a TFA salt, white lyophylate. LC: 99%, M + H = 421.0. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.7 (bs, 1H), 9.40 (s, 1H), 9.27 (s, 1H), 8.14 (s, 1H), 8.03–8.02 (d, 1H), 7.82 (s, 1H), 7.26–7.22 (t, 1H), 7.07–7.05 (d, 1H), 7.02–7.01 (d, 1H), 7.00 (s, 1H), 6.93–6.90 (m, 1H), 3.52–3.49 (d, 2H), 3.26–3.2 (m, 2H), 3.09–3.05 (d, 2H), 2.99–2.90 (m, 9H). HRMS calcd for C<sub>23</sub>H<sub>25</sub>ClN<sub>6</sub> (MH<sup>+</sup>): 421.1907. Found: 421.1913.</div></div><div id="sec4_3_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 10-Methoxy-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene (<b>2e</b>)</h4><div class="NLM_p last">Compound <b>2e</b> was prepared in a similar manner as <b>2a</b> after substituting <b>8e</b> for <b>8a</b>. The crude product was dissolved in a small amount of warmed DMSO and purified via preparative HPLC. The purest fractions were combined and partitioned between CHCl<sub>3</sub> and saturated aqueous NaHCO<sub>3</sub>. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was triturated with CH<sub>3</sub>CN, filtered, and rinsed with ice cold CH<sub>3</sub>CN to give desired product <b>2e</b> in 50% yield as a white solid, mp 252–254 °C. LC: 98%. LC/MS: M + H = 353.2. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.33 (s, 1H), 8.15 (s, 1H), 7.95 (s, 1H), 7.86 (s, 1H), 7.81 (s, 1H), 7.17–7.13 (t, 3H), 7.00 (s, 2H), 6.95–6.93 (d, 1H), 6.87–6.84 (d, 1H), 3.85 (s, 3H), 2.82 (s, 4H).</div></div><div id="sec4_3_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 6-Chloro-10-methoxy-17-(morpholin-4-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Trifluoroacetate (1:1) (<b>2f</b>)</h4><div class="NLM_p last">Compound <b>2f</b> was prepared in a similar manner as <b>2b</b> after substituting <b>8f</b> for <b>8b</b>. The desired product <b>2f</b> was isolated in 19% yield as a TFA salt, white lyophylate. LC: 99%. LC/MS: M + H = 438.2. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.38 (bs, 1H), 8.20 (bs, 1H), 8.16 (s, 1H), 7.93 (s, 1H), 7.87–7.86 (d, 1H), 7.05–6.90 (m, 4H), 3.84 (s, 3H), 3.76–3.74 (m, 4H), 3.5 (bs, H<sub>2</sub>O), 2.96–2.89 (M, 4H), 2.80–2.78 (m, 4H). HRMS calcd for C<sub>23</sub>H<sub>24</sub>ClN<sub>5</sub>O<sub>2</sub> (MH<sup>+</sup>): 438.1697. Found: 438.1698.</div></div><div id="sec4_3_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 6-Chloro-10-methoxy-17-(4-methylpiperazin-1-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Trifluoroacetate (1:1) (<b>2g</b>)</h4><div class="NLM_p last">Compound <b>2g</b> was prepared in a similar manner as <b>2b</b> after substituting <b>8g</b> for <b>8b</b>. The workup followed was akin to that for <b>2c</b>. The desired product <b>2g</b> was isolated in 41% yield as a white lyophylate. LC: 99%. LC/MS: M + H = 451.2. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.6 (bs, 1H), 9.38 (s, 1H), 8.15 (s, 1H), 8.04 (bs, 1H), 7.95 (bs, 1H), 7.92–7.91 (d, 1H), 7.06–7.03 (d, 1H), 6.98–6.92 (m, 3H), 3.83 (s, 3H), 3.61 (bs, H<sub>2</sub>O), 3.53–3.50 (d, 2H), 3.25–3.22 (m, 2H), 3.10–3.07 (d, 2H), 2.99–2.96 (d, 2H), 2.92–2.87 (m, 7H). HRMS calcd for C<sub>24</sub>H<sub>27</sub>ClN<sub>6</sub>O (MH<sup>+</sup>): 451.2013. Found: 451.2015.</div></div><div id="sec4_3_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 6-Chloro-10-(propane-2-sulfonyl)-17-(4-methylpiperazin-1-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene (<b>2i</b>)</h4><div class="NLM_p last">Compound <b>2i</b> was prepared in a similar manner as <b>2b</b> after substituting <b>8i</b> for <b>8b</b>. The workup followed was akin to that for <b>2c</b> except that after the extractive workup the resulting crude material was not purified via preparative HPLC but rather via crystallization from CH<sub><b>3</b></sub>CN. The desired product <b>2i</b> was isolated in 50% yield as a yellow tinted solid, mp >250 °C. LC: 98%. LC/MS: M + H = 527.2. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.47 (s, 1H), 9.27 (s, 1H), 8.36–8.35 (d, 1H), 8.25 (s, 1H), 7.99–7.97 (d, 1H), 7.71–7.69 (d, 1H), 7.28–7.26 (m, 1H), 7.04–7.02 (d, 1H), 6.95–6.92 (m, 1H), 3.31 (bs, 1H + H<sub>2</sub>O), 3.04–2.98 (m, 4H), 2.81–2.79 (m, 4H), 2.5 (bs, 4H + DMSO), 2.25 (s, 3H), 1.14–1.12 (d, 6H). HRMS calcd for C<sub>26</sub>H<sub>31</sub>ClN<sub>6</sub>O<sub>2</sub>S (MH<sup>+</sup>): 527.1996. Found: 527.2007.</div></div><div id="sec4_3_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 6-Chloro-10-(2-methanesulfonylmethylamino)-17-(4-methylpiperazin-1-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Trifluoroacetate (1:1) (<b>2j</b>)</h4><div class="NLM_p last">Compound <b>2j</b> was prepared in a similar manner as <b>2b</b> after substituting <b>8j</b> for <b>8b</b>. The workup followed was akin to that for <b>2c</b>. The desired product <b>2j</b> was isolated in 72% yield as a white lyophylate. LC: 100%. LC/MS: M + H = 528.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.58 (bs, 1H), 9.38 (s, 1H), 8.21 (s, 1H), 8.18 (s, 1H), 8.10 (s, 1H), 8.02 (s, 1H), 7.53–7.51 (d, <i>J</i> = 8.09 Hz, 1H), 7.14–7.12 (d, <i>J</i> = 8.12 Hz, 1H), 7.06–7.04 (d, <i>J</i> = 8.43 Hz, 1H), 6.96–6.94 (d, <i>J</i> = 8.48 Hz, 1H), 3.53–3.50 (d, 2H), 3.25–3.22 (m, 2H), 3.19 (s, 3H), 3.11–2.91 (m, 14H). HRMS calcd for C<sub>25</sub>H<sub>30</sub>ClN<sub>7</sub>O<sub>2</sub>S (MH<sup>+</sup>): 528.1948. Found: 528.1951.</div></div><div id="sec4_3_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 6-Chloro-17-(4-methylpiperazin-1-yl)-19-methoxy-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Trifluoroacetate (1:1) (<b>2k</b>)</h4><div class="NLM_p last">Compound <b>2k</b> was prepared in a similar manner as <b>2b</b> after substituting <b>8k</b> for <b>8b</b>. The workup followed was akin to that for <b>2c</b>. The desired product <b>2k</b> was isolated in 40% yield as a TFA salt, white lyophylate. LC: 99%. LC/MS: M + H = 451.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.7 (bs, 1H), 9.36 (s, 1H), 8.14 (s, 1H), 8.12 (s, 1H), 7.90 (s, 1H), 7.76 (s, 1H), 7.25–7.21 (t, 1H), 7.05–7.03 (d, 1H), 7.00–6.98 (d, 1H), 6.69 (s, 1H), 3.81 (s, 3H), 3.70 (bs, water), 3.53 (d, 2H), 3.27–3.24 (m, 2H), 3.14–3.11 (d, 2H), 3.01–2.98 (d, 2H), 2.94 (s, 3H), 2.92–2.91 (d, 4H).</div></div><div id="sec4_3_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 6-Chloro-10-(propane-2-sulfonyl)-17-(4-methylpiperazin-1-yl)-19-methoxy-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Trifluoroacetate (1:1) (<b>2l</b>)</h4><div class="NLM_p last">Compound <b>2l</b> was prepared in a similar manner as <b>2b</b> after substituting <b>8l</b> for <b>8b</b>. The workup followed was akin to that for <b>2c</b>. The desired product <b>2l</b> was isolated in 53% yield as a white lyophylate. LC: 99%. LC/MS: M + H = 557.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.71 (bs, 1H, exchangeable), 9.30 (s, 1H, exchangeable), 8.38 (bs, 2H, 1 exchangeable), 7.86 (s, 1H), 7.70–7.68 (d, <i>J</i> = 8.17 Hz, 1H), 7.22–7.20 (d, <i>J</i> = 8.16 Hz, 1H), 6.73 (s, 1H), 3.81 (s, 3H), 3.54–3.51 (d, 2H), 3.40–3.33 (m, 1H), 3.29–3.21 (m, 2H), 3.19–3.15 (d, 2H), 3.05–2.91 (m, 9H), 1.13–1.11 (d, <i>J</i> = 6.77 Hz, 6H). HRMS calcd for C<sub>27</sub>H<sub>33</sub>ClN<sub>6</sub>O<sub>3</sub>S (MH<sup>+</sup>): 557.2102. Found: 557.2101.</div></div><div id="sec4_3_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 6-Chloro-10-(2-methanesulfonylmethylamino)-17-(4-methylpiperazin-1-yl)-19-methoxy-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Trifluoroacetate (1:1) (<b>2m</b>)</h4><div class="NLM_p last">Compound <b>2m</b> was prepared in a similar manner as <b>2b</b> after substituting <b>8m</b> for <b>8b</b>. The workup followed was akin to that for <b>2c</b>. The desired product <b>2m</b> was isolated in 74% yield as a white lyophylate. LC: 99%. LC/MS: M + H = 558.0. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.83 (bs, 1H, exchangeable), 8.32 (s, 1H, exchangeable), 8.25 (s, 1H, exchangeable), 8.19 (s, 1H), 8.04 (s, 1H), 7.85 (s, 1H), 7.51–7.49 (d, <i>J</i> = 8.21 Hz, 1H), 7.11–7.09 (d, <i>J</i> = 8.20 Hz, 1H), 6.72 (s, 1H), 3.81 (s, 3H), 3.54–3.51 (d, 2H), 3.28–3.21 (m, 2H), 3.18–3.14 (m, 5H), 3.04–2.92 (m, 12H). HRMS calcd for C<sub>26</sub>H<sub>32</sub>ClN<sub>7</sub>O<sub>3</sub>S (MH<sup>+</sup>): 558.2054. Found: 558.2050.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Method B</h3><div id="sec4_4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 1-[3-(2-Bromo-4-nitrophenoxy)propyl]pyrrolidine (<b>10a</b>)</h4><div class="NLM_p last">A mixture of 2-bromo-1-fluoro-4-nitrobenzene (1.10 g, 5.0 mmol), <i>N</i>-β-hydroxyethylpyrrolidine (6.0 mL, 52 mmol), and K<sub>2</sub>CO<sub>3</sub> (1.38 g, 10 mmol) was warmed to 100 °C for 24 h. The mixture was cooled to rt and diluted with water. The resulting solid was filtered, rinsed with water, and air-dried to yield 1.32 g (84%) of <b>10a</b> as a copper colored solid. LC: 93%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.43–8.42 (d, 1H), 8.28–8.25 (m, 1H), 7.36–7.34 (d, 1H), 4.36–4.31 (t, 2H), 2.88–2.86 (t, 2H), 2.58–2.55 (m, 4H), 1.70–1.67 (m, 4H).</div></div><div id="sec4_4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 1-(2-Bromo-4-nitrophenyl)-4-methylpiperazine (<b>10b</b>)</h4><div class="NLM_p last">Compound <b>10b</b> was prepared in a similar manner as <b>10a</b> after substituting 1-methylpiperazine for <i>N</i>-β-hydroxyethylpyrrolidine. In addition, no K<sub>2</sub>CO<sub>3</sub> was used, and the reaction was run at 90 °C rather than 100 °C. The desired product <b>10b</b> was isolated in 97% yield as a yellow solid. LC: 98%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.38–8.37 (d, 1H), 8.21–8.18 (m, 1H), 7.29–7.27 (d, 1H), 3.18–3.16 (bm, 4H), 2.50 (s, 4H + DMSO), 2.25 (s, 3H).</div></div><div id="sec4_4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 1-Bromo-2-fluoro-4-methoxy-5-nitrobenzene (<b>10c</b>) and 1-Bromo-4-fluoro-2-methoxy-5-nitrobenzene (<b>10d</b>)</h4><div class="NLM_p last">1-Bromo-2,4-difluoro-5-nitrobenzene (960 mg, 4.0 mmol) was dissolved in MeOH (20 mL). The mixture was cooled to 0 °C and treated with 0.5 M sodium methoxide in MeOH solution (8.1 mL, 4 mmol). After 2 h the reaction solution was concentrated under reduced pressure and the residue was partitioned between EtOAc and water. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give 833 mg (83%) of yellowish oil. <sup>1</sup>H NMR spectral analysis supported that the product was a mixture of <b>10c</b> and <b>10d</b> (∼1:2 ratio). The assignments of the respective regioisomers were determined based on further analysis of a purified <b>10e</b> analogue, generated from the subsequent step to this reaction. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.41–8.39 (d, 0.63H), 8.36–8.34 (d, 0.26H), 7.57–7.54 (d, 0.30H), 7.45–7.42 (d, 0.70H), 4.01 (s, 2.2H), 3.95 (s, 0.9H).</div></div><div id="sec4_4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 1-(2-Bromo-5-methoxy-4-nitrophenyl)-4-methylpiperazine (<b>10e</b>)</h4><div class="NLM_p last">The 833 mg mixture of <b>10c</b> and <b>10d</b> was treated at rt with 1-methylpiperazine (10 mL, 100 mmol). After 3 h the mixture was diluted with water and then extracted with EtOAc. The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield 1.13 g of oil. This material was purified via preparative HPLC to separate <b>10e</b> from its respective regioisomer. The purifed fractions of <b>10e</b> from the HPLC were partitioned between EtOAc and saturated aqueous NaHCO<sub>3</sub>. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give 0.26 g (24%) of desired <b>10e</b> as an oil, which crystallized upon sitting. Free basing of the purified regioisomer of <b>10e</b>, i.e., 1-(4-bromo-5-methoxy-2-nitrophenyl)-4-methylpiperazine, resulted in a return of 0.56 g (51%) of this side product. Preliminary analysis of <b>10e</b>: LC, 100%. LC/MS: M + H = 330.0.</div></div><div id="sec4_4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 1-Methyl-4-(4-nitro-2-vinylphenyl)piperazine (<b>11</b>)</h4><div class="NLM_p last">Compound <b>11</b> was prepared in a similar manner as <b>3d</b> after substituting <b>10b</b> for <b>3c</b>. In addition, the reaction was only heated for 5 h. The workup varied in that after concentration of the reaction mixture under reduced pressure, it was partitioned between EtOAc and 1 N HCl. The aqueous phase was basified with 8 N KOH while cooling. The resulting solid was filtered off, rinsed with ice cold water, and air-dried yielding <b>11</b> in 70% yield as a yellow solid. LC: 98%. LC/MS M + H = 248.1, <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.24–8.23 (d, 1H), 8.12–8.09 (m, 1H), 7.18–7.16 (d, 1H), 6.82–6.75 (m, 1H), 5.97–5.93 (d, 1H), 5.46–5.43 (d, 1H), 3.08–3.06 (m, 4H), 2.50 (s, 4H + DMSO), 2.25 (s, 3H).</div></div><div id="sec4_4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 3-Bromo-4-(2-pyrrolidin-1-ylethoxy)phenylamine (<b>6c</b>)</h4><div class="NLM_p last">Compound <b>10a</b> (0.74 g, 2.3 mmol) was combined with Raney nickel (120 mg) in ethanol (EtOH) (50 mL), and the mixture was warmed to reflux. Hydrazine hydrate (1.0 mL, 2 mmol) was added dropwise to the refluxing solution, and the elevated temperature was maintained for 1 h. After cooling, the reaction mixture was filtered and the filtrate concentrated under reduced pressure to yield 0.58 g (87%) of <b>6c</b> as a brown oil, which was used without further manipulation. LC/MS: M + H = 285.3. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.6.92–6.91 (d, 1H, <i>J</i> = 2.74 Hz), 6.79–6.77 (d, 1H, <i>J</i> = 8.64 Hz), 6.60–6.57 (m, 1H), 4.10–4.07 (t, 2H), 3.48 (bs, 2H), 2.94–2.91 (t, 2H), 2.68–2.65 (m, 4H), 1.84–1.80 (m, 4H).</div></div><div id="sec4_4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 3-Bromo-4-(4-methylpiperazin-1-yl)phenylamine (<b>6d</b>)</h4><div class="NLM_p last">Compound <b>6d</b> was prepared in a similar manner as <b>6c</b> after substituting <b>10b</b> for <b>10a</b>. The crude material was triturated with water to give <b>6d</b> as a light brown solid in 93% yield, which was used without further manipulation. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 6.90–6.88 (d, 1H), 6.82–6.81 (d, 1H), 6.54–6.51 (m, 1H), 5.03 (s, 2H), 2.79–2.77 (m, 4H), 2.43 (bm, 2H), 2.21 (s, 3H).</div></div><div id="sec4_4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 4-(4-Methylpiperazin-1-yl)-3-vinylphenylamine (<b>6e</b>)</h4><div class="NLM_p last">Iron (2.93 g, 52 mmol) was added at rt to a stirring solution of <b>11</b> (1.95 g, 7.9 mmol) in THF (30 mL) and acetic acid (60 mL). The mixture was warmed to 35 °C and stirred for 16 h. The mixture was then cooled to rt, filtered, and the resulting solution was concentrated under reduced pressure. The residue was partitioned between CHCl<sub>3</sub> (2×) and saturated aqueous NaHCO<sub>3</sub>. The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield 1.71 g (100%) of <b>6e</b> as a yellow tinted oil, which crystallized upon sitting. This material was used for subsequent steps without further manipulation. LC/MS: M + H = 218.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 7.04–6.96 (m, 1H), 6.82–6.80 (d, 1H), 6.75–6.74 (d, 1H), 6.50–6.48 (m, 1H), 5.59–5.54 (m, 1H), 5.17–5.14 (m, 1H), 4.77 (s, 2H), 2.27–2.70 (m, 4H), 2.43 (s, 4H), 2.20 (s, 3H).</div></div><div id="sec4_4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 5-Bromo-2-methoxy-4-(4-methylpiperazin-1-yl)phenylamine (<b>6f</b>)</h4><div class="NLM_p last">Compound <b>6f</b> was prepared in a similar manner as <b>6c</b> after substituting <b>10e</b> for <b>10a</b>. After workup a mass return of 100% was returned, but <sup>1</sup>H NMR and LC/MS confirmed the crude to be 80% <b>6f</b>, with a 20% impurity of the des-Br analogue of <b>6f</b>. This crude material was used for subsequent reactions without further manipulation. It was also found that <b>6f</b> could be prepared pure in 96% yield cleanly by following the procedure akin to <b>6e</b> after substituting <b>10e</b> for <b>11</b>. LC/MS: M + H = 302.0. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 6.93 (s, 1H), 6.62 (s, 1H), 3.85 (s, 3H), 3.66 (s, 2H), 2.99 (bs, 4H), 2.61–2.59 (bm, 4H), 2.38 (s, 3H).</div></div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Method C</h3><div id="sec4_4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> (14<i>Z</i>)-6-Chloro-17-(4-methylpiperazin-1-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene-10-carboxylic Acid (<b>8n</b>)</h4><div class="NLM_p last">A solution of LiOH (11 mg, 0.46 mmol) in water (0.6 mL) was added to a solution of 8 h (29 mg, 0.06 mmol) in MeOH (6 mL), and the resulting mixture was warmed to 65 °C for 16 h. After cooling to 0 °C, the mixture was treated with 1 N HCl (0.46 mL, 0.46 mmol), then concentrated under reduced pressure and used directly for the subsequent reaction toward <b>8o</b> without further manipulation. LC: 100%. LC/MS: M + H = 463.1.</div></div><div id="sec4_4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> (14<i>Z</i>)-6-Chloro-10-(<i>N</i>-methylcarboxamido)-17-(4-methylpiperazin-1-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,14,16,18-decaene (<b>8o</b>)</h4><div class="NLM_p"><i>N</i>-(3-Dimethylaminopropyl)-<i>N</i>′ethylcarbodiimide hydrochloride (150 mg, 0.8 mmol) was added to a rt mixture of <b>8n</b> (28 mg, 0.06 mmol), 1-hydroxybenzotriazole (11 mg, 0.084 mmol), methylammonium chloride (100 mg, 1 mmol), and triethylamine (100 μL, 0.7 mmol). After 7 days the reaction mixture was partitioned between EtOAc (2×) and saturated aqueous NaHCO<sub>3</sub>. The organic phases were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield 28 mg (98%) of <b>8o</b>, which was used toward <b>2h</b> without further manipulation. LC: 98%. LC/MS: M + H = 476.2.</div><div class="NLM_p last">A small sample of the 98% pure material was further purified via preparative HPLC to return pure <b>8o</b> as a TFA salt white lyophylate. LC: 100%. LC/MS: M + H = 476.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.55 (s, 1H), 9.55 (bs, 1H), 9.40 (s, 1H), 9.39 (s, 1H), 8.76–8.74 (m, 1H), 8.46–8.45 (d, 1H), 8.19 (s, 1H), 7.77–7.75 (d, 1H), 7.13–7.04 (m, 3H), 6.91–6.87 (d, 1H), 6.70–6.66 (d, 1H), 3.5 (d, 2H), 3.35–3.2 (bm, 4H + H<sub>2</sub>O), 2.95–2.89 (m, 5H), 2.81–2.80 (d, 3H).</div></div><div id="sec4_4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 6-Chloro-10-(<i>N</i>-methylcarboxamido)-17-(4-methylpiperazin-1-yl)-2,4,8,22-tetraazatetracyclo[14.3.1.1<sup>3,7</sup>.1<sup>9,13</sup>]docosa-1(20),3(22),4,6,9(21),10,12,16,18-nonaene Trifluoroacetate (1:1) (<b>2h</b>)</h4><div class="NLM_p last">Compound <b>2h</b> was prepared in a similar manner as <b>2b</b> after substituting <b>8o</b> for <b>8b</b>. The workup followed was akin to that for <b>2c</b>. The desired product <b>2h</b> was isolated in 20% yield as a TFA salt, white lyophylate. LC: 100%. LC/MS: M + H = 478.2. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 11.2 (s, 1H), 9.61 (bs, 1H), 9.38 (s, 1H), 8.66–8.65 (m, 1H), 8.40 (s, 1H), 8.18 (s, 1H), 8.08 (s, 1H), 7.70–7.67 (d, 1H), 7.08–6.96 (m, 3H), 3.53 (d, 2H), 3.26–3.23 (m, 2H), 3.12–3.09 (d, 2H), 3.0–2.93 (m, 6H), 2.91 (d, 3H), 2.79 (d, 3H).</div></div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Method D</h3><div id="sec4_4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 4-Bromo-1-isopropylsulfanyl-2-nitrobenzene (<b>13</b>)</h4><div class="NLM_p last">2-Propanethiol (0.76 mL, 8 mmol) was added to a rt solution of 4-bromo-1-fluoro-2-nitrobenzene (<b>12</b>) (1.10 g, 5.0 mmol) in EtOH (5 mL), and the resulting solution was warmed at 50 °C for 4 days. After cooling to rt, the solution was treated with water (15 mL). The resulting yellow solid was filtered and rinsed liberally with water. After air drying there remained 1.35 g (98%) of desired <b>13</b> as a yellow solid. This material was used for the subsequent step without further manipulation. LC: 96%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.30–8.29 (d, 1H), 7.90–7.87 (m, 1H), 7.67–7.64 (d, 1H), 3.76–3.73 (m, 1H), 1.30–1.28 (d, 6H).</div></div><div id="sec4_4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 4-Bromo-2-nitro-1-(propane-2-sulfonyl)benzene (<b>14</b>)</h4><div class="NLM_p last"><i>m</i>-Chloroperbenzoic acid (1.18 g, 6.84 mmol) was added neat to a 0 °C solution of <b>13</b> (0.55 g, 2.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL). The reaction was warmed to rt and stirred for 16 h. The reaction solution was concentrated under reduced pressure, and the residual white solid was treated with saturated aqueous NaHCO<sub>3</sub> (40 mL). After being stirred for 10 min, the mixture was filtered and the resulting solid was washed liberally with water. After air drying there remained 0.56 g (91%) of desired <b>14</b> as a white solid. This material was used for the subsequent step without further manipulation. LC: 95%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.49–8.48 (d, 1H), 8.19–8.16 (m, 1H), 7.97–7.95 (d, 1H), 3.77–3.73 (m, 1H), 1.27–1.26 (d, 6H).</div></div><div id="sec4_4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 5-Bromo-2(propane-2-sulfonyl)phenylamine (<b>3f</b>)</h4><div class="NLM_p last">Iron (710 mg, 13 mmol) was added at rt to a stirring solution of <b>14</b> (539 mg, 1.75 mmol) in THF (10 mL) and acetic acid (14 mL). The mixture was warmed to 35 °C and stirred for 2 h. The mixture was then cooled to rt, filtered, and the resulting solution was concentrated under reduced pressure. The residue was partitioned between CHCl<sub>3</sub> (2×) and saturated aqueous NaHCO<sub>3</sub>. The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield 334 mg (69%) of <b>3f</b> as a clear oil, which crystallized to a white solid upon sitting. This material was used for its subsequent step without further manipulation. LC: 97%. LC/MS: M + H = 279.8.</div></div><div id="sec4_4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 2-Nitro-1-(propane-2-sulfonyl)-4-vinylbenzene (<b>15</b>)</h4><div class="NLM_p last">Compound <b>15</b> was prepared in a similar manner as <b>3d</b> after substituting <b>14</b> for <b>3a</b>. The workup varied in that after concentration of the reaction mixture, the residue was partitioned between EtOAc (2×) and water. The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and the filtrate was adsorbed directly onto silica gel under reduced pressure. The residue was purified via normal phase chromatography (EtOAc/hexane eluent) to give desired <b>15</b> in 55% yield. LC: 99%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.26 (s, 1H), 8.02–7.98 (m, 2H), 6.95–6.87 (m, 1H), 6.27–6.23 (d, 1H), 5.67–5.64 (d, 1H), 3.78–3.70 (m, 1H), 1.28–1.26 (d, 6H).</div></div><div id="sec4_4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 2-(Propane-2-sulfonyl)-5-vinylphenylamine (<b>3h</b>)</h4><div class="NLM_p last">Compound <b>3h</b> was prepared in a similar manner as <b>6e</b> after substituting <b>15</b> for <b>11</b>. The workup was similar except that EtOAc was used for extractions rather than CHCl<sub>3</sub>. Compound <b>3h</b> was recovered in 99% yield as a brown oil and used directly after workup for subsequent steps without further manipulation. LC/MS: M + H = 226.0 . <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.62–7.60 (d, 1H), 6.89–6.87 (d, 1H), 6.72 (s, 1H), 6.68–6.61 (m, 1H), 5.86–5.82 (d, 1H), 5.42–5.39 (d, 1H), 5.08 (bs, 2H), 3.37–3.30 (m, 1H), 1.34–1.32 (d, 6H).</div></div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Method E</h3><div id="sec4_4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>N</i>-(4-Bromo-2-nitrophenyl)methanesulfonamide (<b>17</b>)</h4><div class="NLM_p last">Potassium nitrate (0.34 g, 3.36 mmol) was added neat to a 0 °C solution of <i>N</i>-(4-bromophenyl)methanesulfonamide (<b>16</b>) (0.75 g, 3.0 mmol) in CH<sub>3</sub>CN (20 mL) and trifluoroacetic anhydride (2.6 mL). After 2 h the 0 °C reaction mixture was slowly treated with saturated aqueous NaHCO<sub>3</sub> until the reaction mixture was basic. The resulting solid was filtered and rinsed liberally with ice cold water. After air drying there remained 0.75 g (85%) of desired <b>17</b> as a yellow solid, which was used for the subsequent step without further manipulation. LC: 98%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.88 (s, 1H), 8.23 (s, 1H), 7.95–7.93 (d, 1H), 7.59–7.57 (d, 1H), 3.152 (s, 3H).</div></div><div id="sec4_4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>N</i>-(4-Bromo-2-nitrophenyl)-<i>N</i>-methylmethanesulfonamide (<b>18</b>)</h4><div class="NLM_p last">Methyl iodide (430 μL, 6.9 mmol) was added to a mixture of <b>17</b> (0.68 g, 2.3 mmol) and K<sub>2</sub>CO<sub>3</sub> (1.3 g, 9.2 mmol) in DMF (10 mL). After 16 h the reaction mixture was treated with water (20 mL). The resulting solid was filtered, rinsed liberally with water, and air-dried to yield 0.68 g (96%) of desired <b>18</b> as a white solid, which was used for the subsequent step without further manipulation. LC: 100%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.23 (s, 1H), 8.02–8.00 (d, 1H), 7.80–7.77 (d, 1H), 3.26 (s, 3H), 3.06 (s, 3H).</div></div><div id="sec4_4_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>N</i>-(2-Amino-4-bromophenyl)-<i>N</i>-methylmethanesulfonamide (<b>3g</b>)</h4><div class="NLM_p last">Compound <b>3g</b> was prepared in a similar manner as <b>3f</b> after substituting <b>18</b> for <b>11</b>. The workup was similar except that EtOAc was used for extractions rather than CHCl<sub>3</sub>. Compound <b>3g</b> was recovered in 98% yield as a clear oil and used directly for subsequent steps without further manipulation. LC: 93%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 7.14–7.12 (d, 1H), 6.92 (s, 1H), 6.69–6.67 (d, 1H), 5.43 (s, 2H), 3.05 (s, 6H).</div></div><div id="sec4_4_6_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>N</i>-Methyl-<i>N</i>-(2-nitro-4-vinylphenyl)methanesulfonamide (<b>19</b>)</h4><div class="NLM_p last">Compound <b>19</b> was prepared in a similar manner as <b>3d</b> after substituting <b>18</b> for <b>3a</b>. The workup varied in that after concentration of the reaction mixture, the residue was partitioned between EtOAc (2×) and water. The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and the crude product in the filtrate was adsorbed directly onto silica gel under reduced pressure. The residue was purified via normal phase chromatography (EtOAc/hexane eluent) to give desired <b>19</b> in 69% yield. LC: 98%. LC/MS: M + 23 = 279.0.</div></div><div id="sec4_4_6_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> <i>N</i>-(2-Amino-4-vinylphenyl)-<i>N</i>-methylmethanesulfonamide (<b>3i</b>)</h4><div class="NLM_p last">Compound <b>3i</b> was prepared in a similar manner as <b>6e</b> after substituting <b>19</b> for <b>11</b>. The workup was similar except that EtOAc was used for extractions rather than CHCl<sub>3</sub>. Compound <b>3i</b> was recovered in 99% yield as a brown oil and used directly after workup for subsequent steps without further manipulation. LC: 97%. LC/MS: M + 23 = 249.0. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 7.11–7.09 (d, 1H), 6.85–6.83 (m, 2H), 6.66–6.59 (m, 1H), 5.74–5.70 (d, 1H), 5.29–5.27 (d, 1H), 4.24 (bs, 2H), 3.25 (s, 3H), 2.98 (s, 3H).</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Method F</h3><div id="sec4_5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> (2,5-Dichloropyrimidin-4-yl)phenylamine (<b>21a</b>)</h4><div class="NLM_p last">Compound <b>21a</b> was prepared in a similar manner as <b>5a</b> after substituting aniline (<b>20a</b>) for <b>3a</b>, substituting EtN(<i>i</i>-Pr)<sub>2</sub> for K<sub>2</sub>CO<sub>3</sub>, and altering the reaction temperature from 80 °C to rt. Workup varied in that after 16 h the reaction was diluted with water, which yielded an oil that crystallized to a solid. The solid was filtered and rinsed liberally with water to yield desired <b>21a</b> in 81% yield as a white solid. LC: 99%. LC/MS: M + H = 240.0. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.20 (s, 1H), 7.64–7.61 (m, 2H), 7.43–7.38 (m, 2H), 7.25 (bs, 1H), 7.23–7.16 (m, 1H).</div></div><div id="sec4_5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> (2,5-Dichloropyrimidin-4-yl)-(2-methoxyphenyl)amine (<b>21b</b>)</h4><div class="NLM_p last">Compound <b>21b</b> was prepared in a similar manner as <b>5a</b> after substituting <i>o</i>-anisidine (<b>20b</b>) for <b>3a</b>. Workup varied in that after 16 h the reaction was diluted with water, which yielded an oil that crystallized to a solid. The solid was filtered, then triturated with MeOH, refiltered, and rinsed with a small amount of MeOH to yield desired <b>21b</b> in 31% yield as a white solid. LC: 100%. LC/MS: M + H = 270.0. <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ 8.52–8.49 (m, 1H), 8.19 (s, 1H), 8.14 (bs, 1H), 7.15–7.03 (m, 2H), 6.96–6.94 (m, 1H), 3.96 (s, 3H).</div></div><div id="sec4_5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 5-Chloro-<i>N</i>(2)-[4-(4-methylpiperazin-1-yl)phenyl]-<i>N</i>(4)-phenylpyrimidine-2,4-diamine Trifluoroacetate (1:1) (<b>1b</b>)</h4><div class="NLM_p last">Compound <b>1b</b> was prepared in a similar manner as <b>7a</b> after substituting <b>21a</b> for <b>5a</b> and 4-(4-methylpiperazin-1-yl)phenylamine (<b>22</b>) for <b>6a</b>. Also, the mixture was heated for 48 h rather than 16 h. After workup the crude product was isolated as a purple tinted solid. This material was purified via preparative reverse phase HPLC to yield the desired product <b>1b</b> as a TFA salt in 71% as a white lyophylate. LC: 100%. LC/MS: M + H = 395.0. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.79 (bs, 1H), 9.37 (s, 1H), 8.98 (s, 1H), 8.15 (s, 1H), 7.68–7.66 (d, <i>J</i> =  7.90 Hz, 2H), 7.48–7.46 (d, <i>J</i> =  8.92 Hz, 2H), 7.38–7.34 (m, 2H), 7.17–7.13 (m, 1H), 6.88–6.86 (d, <i>J</i> = 9.00 Hz, 2H), 3.74–3.71 (m, 2H), 3.54–3.51 (m, 2H), 3.18 (bm, 2H), 2.92–2.87 (m, 5H).</div></div><div id="sec4_5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 5-Chloro-<i>N</i>(4)-(2-methoxyphenyl)-<i>N</i>(2)-[4-(4-methylpiperazin-1-yl)phenyl]pyrimidine-2,4-diamine Fumarate (1:1) (<b>1c</b>)</h4><div class="NLM_p last">Compounds <b>21b</b> (81 mg, 0.30 mmol) and <b>22</b> (57 mg, 0.30 mmol) and 10-camphorsulfonic acid (77 mg, 0.33 mmol) were combined in isopropanol (3 mL) with two drops of water, and the entire mixture was warmed under microwave conditions at 110 °C for 1 h. An attempt to partition the reaction mixture between EtOAc and saturated aqueous NaHCO<sub>3</sub> led to a solid precipitating. This solid was filtered and rinsed with a small amount of water to yield 40 mg of crude product after drying. The crude product was dissolved in a small amount of warm methanol and combined with a warm ethanol (1 mL) solution of fumaric acid (12 mg, 0.10 mmol). The resulting warm solution was filtered, and on cooling a solid precipitated. The solid was filtered, rinsed with a small amount of ice cold ethanol, and air-dried to yield 17 mg (13%) of <b>1c</b> as a slightly purple tinted solid, mp 242–244 °C. LC: 100%. LC/MS: M + H = 425.1. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 9.13 (s, 1H), 8.10–8.07 (m, 3H), 7.42–7.40 (d, <i>J</i> = 8.59 Hz, 2H), 7.15–7.13 (m, 2H), 6.96 (m, 1H), 6.82–6.79 (d, <i>J</i> = 8.85 Hz, 2H), 6.60 (s, 2H), 3.86 (s, 3H), 3.32 (bs, 4H + H<sub>2</sub>O), 3.06 (bs, 4H), 2.26 (s, 3H).</div></div></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Biology. Kinase Enzyme and Cellular Assays and Related Determinations of Binding and Inhibitory Activity</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> ALK Assay</h4><div class="NLM_p last">Compounds were tested for their ability to inhibit the kinase activity of baculovirus-expressed human ALK cytoplasmic domain using a modification of the assay protocol reported for trkA.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Phosphorylation of the substrate, phospholipase C-γ (PLC-γ) generated as a fusion protein with glutathione <i>S</i>-transferase (GST),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> was detected with a europium-labeled anti-phosphotyrosine antibody and measured by time-resolved fluorescence (TRF). Briefly, each 96-well plate was coated with 100 μL/well of 10 μg/mL substrate solution (recombinant GST-PLCγ) in Tris-buffered saline (TBS). The ALK assay mixture (total volume of 100 μL/well) consisting of 20 mM HEPES (pH 7.2), 1 μM ATP, 5 mM MnCl<sub>2</sub>, 0.1% BSA, and test compound (diluted in DMSO, 2.5% DMSO final in assay) was then added to the assay plate. Enzyme (50 ng/mL ALK) was added, and the reaction was allowed to proceed at 37 °C for 15 min. Detection of the phosphorylated product was performed by adding 100 μL/well Eu-N1 labeled PT66 antibody diluted 1:5000 in 0.25% BSA in TBS containing 0.1% Tween-20 (TBS-T). Incubation at 37 °C then proceeded for 1 h, followed by addition of 100 μL of enhancement solution. The plate was gently agitated, and after 30 min, the fluorescence of the resulting solution was measured using the PerkinElmer EnVision 2102 (or 2104) multilabel plate reader (PerkinElmer, Waltham, MA). Data analysis was performed using ActivityBase (IDBS, Guilford, U.K.). IC<sub>50</sub> values were calculated by plotting percent inhibition versus log<sub>10</sub> of the concentration of compound and fitting to the nonlinear regression sigmoidal dose–response (variable slope) equation in XLFit (IDBS, Guilford, U.K.).</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> IR Kinase Assay</h4><div class="NLM_p last">The IR kinase assay was performed using the TRF assay as described above for ALK. The nucleotide substrate ATP was used at 20 μM, and recombinant human baculovirus-expressed IR cytoplasmic domain was added to the assay at a final concentration of 20 ng/mL. In place of Eu-N1 labeled PT66 antibody, Eu-N1 labeled PY100 antibody (diluted 1:10000 in antibody dilution buffer) was utilized for detection.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> NPM-ALK Cellular Assay</h3><div class="NLM_p">The cellular IC<sub>50</sub> values of NPM-ALK tyrosine phosphoryation for compounds were generated with a sandwich ELISA assay. The 96-well FluoroNunc Maxisorp white plates (Nunc, no. 437796) were incubated with Goat anti-mouse IgG (Southern Biotech, catalog no. 1070-01) at 1:200 dilution (495 ng/well, 100 μL/well) in 0.1 M sodium bicarbonate for 1.5 h at 25 °C. After being washed with TBS containing 0.05% Tween (TBST), the plates were incubated with mouse ALK antibody (Zymed, catalog no. 35-4300) at 1:500 dilution (100 ng/well, 100 μL/well) in Superblock buffer (Pierce, catalog no. 37545) for 1.5 h at 25 °C. After being washed with TBST, the plates were incubated in Superblock buffer (200 μL/well) for 1 h or overnight at at 4 °C. NPM-ALK positive ALCL Sup-M2 cells seeded in complete RPMI medium at 1 × 10<sup>5</sup> cells/well (100 μL) in 96-well V-bottom plates (Costar, plate no. 3896 and lid no. 3930) were treated with CEP compounds for 2–3 h. The plates were centrifuged at 233<i>g</i> (Allegra X-15R centrifuge with SX4750 rotor, Beckman Coulter) for 5 min and washed with PBS two times (200 μL/well). An amount of 100 μL of cell lysis buffer [10 mM Tris, pH 7.5, 1% Triton X-100, 50 mM sodium chloride, 20 mM sodium fluoride, 2 mM sodium pyrophosphate, 0.1% BSA, plus freshly prepared 1 mM activated sodium vanadate, 1 mM DTT, and 1 mM PMSF and the protease inhibitor cocktail III (1:100 dilution, catalog no. 539134, Calbiochem, La Jolla, CA)] was added into each well. After being kept on a microplate shaker at a speed of 400 for 10 min at 4 °C, the plates were centrifuged at 2450<i>g</i> (Allegra X-15R centrifuge with SX4750 rotor, Beckman Coulter) for 10 min at 4 °C. An amount of 40 μL of the cell lysates was transferred into the precoated FluoroNunc Maxisorp 96-well white plates, and the plates were incubated overnight at 4 °C. After being washed with TBST, the plates were incubated with phospho-ALK antibody (Cell Signaling Technology, catalog no. 3341) at 1:750 (100 μL/well) dilution in Superblock for 1 h at 37 °C. After being washed with TBST, the plates were incubated with alkaline phosphatase labeled goat anti-rabbit antibody (Southern Biotech, catalog no. 4050-04) at 1:2000 (100 μL/well) dilution in TBS/2% BSA for 1 h at 37 °C. After being washed with TBST and then TBS, the plates were incubated with the substrate 4-methylumbelliferyl phosphate (0.02 mg/mL, 100 μL/well) dissolved in DEA/MgCl<sub>2</sub> buffer for 20 min at 37 °C. The plates were read with a CytoFluor at excitation filter of 360 nm, emission filter of 460 nm, and gain of 65.</div><div class="NLM_p last">Data analysis was performed using ActivityBase (IDBS, Guilford, U.K.), and the IC<sub>50</sub> values were calculated by plotting percent inhibition versus log<sub>10</sub> of the concentration of compound.</div></div></div><div class="NLM_back"><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24245" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24245" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henry J. Breslin</span> - <span class="hlFld-Affiliation affiliation">Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380-4245, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c48c86b6a1b7a8adaaf2f484a3a9a5ada8eaa7aba9"><span class="__cf_email__" data-cfemail="9ed6dcecfbedf2f7f0a8aedef9f3fff7f2b0fdf1f3">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brandon M. Lane</span> - <span class="hlFld-Affiliation affiliation">Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380-4245, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory R. Ott</span> - <span class="hlFld-Affiliation affiliation">Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380-4245, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arup K. Ghose</span> - <span class="hlFld-Affiliation affiliation">Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380-4245, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thelma S. Angeles</span> - <span class="hlFld-Affiliation affiliation">Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380-4245, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark S. Albom</span> - <span class="hlFld-Affiliation affiliation">Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380-4245, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mangeng Cheng</span> - <span class="hlFld-Affiliation affiliation">Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380-4245, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weihua Wan</span> - <span class="hlFld-Affiliation affiliation">Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380-4245, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">R. Curtis Haltiwanger</span> - <span class="hlFld-Affiliation affiliation">Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380-4245, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin J. Wells-Knecht</span> - <span class="hlFld-Affiliation affiliation">Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380-4245, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bruce D. Dorsey</span> - <span class="hlFld-Affiliation affiliation">Cephalon, Inc., 145 Brandywine
Parkway, West Chester, Pennsylvania 19380-4245, United States</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="testing" data-doi="10.1021/jm201333e" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="ack" id="ACK-d4160e5321-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i100">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53160" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53160" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We appreciate the encouraging and helpful discussions with Amos B. Smith III during the course of this work and the assistance of Craig Zificsak in nomenclature assignments.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i101" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i101"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i102" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i102"> Abbreviations Used</h2><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">ALK</td><td class="NLM_def"><p class="first last">analplastic lymphoma kinase</p></td></tr><tr><td class="NLM_term">IR</td><td class="NLM_def"><p class="first last">insulin receptor</p></td></tr><tr><td class="NLM_term">NPM-ALK</td><td class="NLM_def"><p class="first last">nucleophosmin-anaplastic lymphoma kinase</p></td></tr><tr><td class="NLM_term">NSCLC</td><td class="NLM_def"><p class="first last">non-small-cell lung cancer</p></td></tr><tr><td class="NLM_term">EML4-ALK</td><td class="NLM_def"><p class="first last">echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase</p></td></tr><tr><td class="NLM_term">TPM3-ALK</td><td class="NLM_def"><p class="first last">tropomyosin 3-anaplastic lymphoma kinase</p></td></tr><tr><td class="NLM_term">DAP</td><td class="NLM_def"><p class="first last">2,4-diaminopyrimidine</p></td></tr><tr><td class="NLM_term">PPZ</td><td class="NLM_def"><p class="first last">piperazine</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high resolution mass spectrum</p></td></tr><tr><td class="NLM_term">PRCG</td><td class="NLM_def"><p class="first last">Polak–Ribiere conjugate gradient</p></td></tr><tr><td class="NLM_term">PLC-γ</td><td class="NLM_def"><p class="first last">phospholipase C-γ</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione <i>S</i>-transferase</p></td></tr><tr><td class="NLM_term">TRF</td><td class="NLM_def"><p class="first last">time-resolved fluorescence</p></td></tr><tr><td class="NLM_term">TBS-T</td><td class="NLM_def"><p class="first last">Tween-20</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i103">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13112" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13112" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 20 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>American Cancer Society. <a href="http://www.cancer.org" class="extLink">http://www.cancer.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=American+Cancer+Society.+http%3A%2F%2Fwww.cancer.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span> <span class="citation_source-book">CANCER: Principles and Practice of Oncology</span>, <span class="NLM_edition">8</span>th ed.; <span class="NLM_contrib-group">Devita, V. T.,  Jr., Lawrence, T. A., Rosenberg, S. A.</span>, Eds.; <span class="NLM_publisher-name">Lippincott, Williams & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=V.+T.+Devita&author=T.+A.+Lawrence&author=S.+A.+Rosenberg&title=CANCER%3A+Principles+and+Practice+of+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DCANCER%253A%2520Principles%2520and%2520Practice%2520of%2520Oncology%26aulast%3DDevita%26aufirst%3DV.%2BT.%26pub%3DLippincott%252C%2520Williams%2520%2526%2520Wilkins%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&issue=1&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lgNzpzuCA3eGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26issue%3D1%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">The (un)targeted cancer kinome</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1038%2Fnchembio.297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=20154661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=166-169&issue=3&author=O.+Fedorovauthor=S.+Muellerauthor=S.+Knapp&title=The+%28un%29targeted+cancer+kinome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The (un)targeted cancer kinome</span></div><div class="casAuthors">Fedorov, Oleg; Mueller, Susanne; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">166-169</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review and discussion.  The complexity of cancer signaling and the resulting difficulties in target selection have strongly biased kinase drug discovery towards clin. validated targets.  Recently, novel kinase targets that are uncharacterized have emerged from genome sequencing and RNAi studies.  Chem. probes are urgently needed to functionally annotate these kinases and to stimulate new drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwcnq0-qjPirVg90H21EOLACvtfcHk0lh-mn5I3bx4wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbk%253D&md5=198ae8d39d40247e17aef5e9de0f2a99</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.297%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMueller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520%2528un%2529targeted%2520cancer%2520kinome%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D3%26spage%3D166%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0lh-mn5I3bx4wQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lu, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jong, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dia, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span> </span><span class="NLM_article-title">Differential induction of glioblastoma migration and growth by two forms of pleiotrophin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">26953</span><span class="NLM_x">–</span> <span class="NLM_lpage">26964</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=26953-26964&author=K.+V.+Luauthor=K.+A.+Jongauthor=G.+Y.+Kimauthor=J.+Singhauthor=E.+Q.+Diaauthor=K.+Yoshimotoauthor=M.+Y.+Wangauthor=T.+F.+Cloughesyauthor=S.+F.+Nelsonauthor=P.+S.+Mischel&title=Differential+induction+of+glioblastoma+migration+and+growth+by+two+forms+of+pleiotrophin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DK.%2BV.%26aulast%3DJong%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DG.%2BY.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DDia%26aufirst%3DE.%2BQ.%26aulast%3DYoshimoto%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DM.%2BY.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DNelson%26aufirst%3DS.%2BF.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26atitle%3DDifferential%2520induction%2520of%2520glioblastoma%2520migration%2520and%2520growth%2520by%2520two%2520forms%2520of%2520pleiotrophin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D26953%26epage%3D26964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">George, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froehling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, W.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrady, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zozulya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregor, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A.</span><span> </span><span class="NLM_article-title">Activating mutations in ALK provide a therapeutic target in neuroblastoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=975-978&author=R.+E.+Georgeauthor=T.+Sandaauthor=M.+Hannaauthor=S.+Froehlingauthor=W.+Lutherauthor=J.+Zhangauthor=Y.+Ahnauthor=W.+Zhouauthor=W.+B.+Londonauthor=P.+McGradyauthor=L.+Xueauthor=S.+Zozulyaauthor=V.+E.+Gregorauthor=T.+R.+Webbauthor=N.+S.+Grayauthor=D.+G.+Gillilandauthor=L.+Dillerauthor=H.+Greulichauthor=S.+W.+Morrisauthor=M.+Meyersonauthor=A.+Look&title=Activating+mutations+in+ALK+provide+a+therapeutic+target+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26aulast%3DSanda%26aufirst%3DT.%26aulast%3DHanna%26aufirst%3DM.%26aulast%3DFroehling%26aufirst%3DS.%26aulast%3DLuther%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLondon%26aufirst%3DW.%2BB.%26aulast%3DMcGrady%26aufirst%3DP.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DZozulya%26aufirst%3DS.%26aulast%3DGregor%26aufirst%3DV.%2BE.%26aulast%3DWebb%26aufirst%3DT.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DDiller%26aufirst%3DL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DLook%26aufirst%3DA.%26atitle%3DActivating%2520mutations%2520in%2520ALK%2520provide%2520a%2520therapeutic%2520target%2520in%2520neuroblastoma%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D975%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmer, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span> </span><span class="NLM_article-title">Fusion of a Kinase Gene, ALK, to a Nucleolar Protein Gene, NPM, in Non-Hodgkin’s Lymphoma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=1281-1284&author=S.+W.+Morrisauthor=M.+N.+Kirsteinauthor=M.+B.+Valentineauthor=K.+G.+Dittmerauthor=D.+N.+Shapiroauthor=D.+L.+Saltmanauthor=A.+T.+Look&title=Fusion+of+a+Kinase+Gene%2C+ALK%2C+to+a+Nucleolar+Protein+Gene%2C+NPM%2C+in+Non-Hodgkin%E2%80%99s+Lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DValentine%26aufirst%3DM.%2BB.%26aulast%3DDittmer%26aufirst%3DK.%2BG.%26aulast%3DShapiro%26aufirst%3DD.%2BN.%26aulast%3DSaltman%26aufirst%3DD.%2BL.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DFusion%2520of%2520a%2520Kinase%2520Gene%252C%2520ALK%252C%2520to%2520a%2520Nucleolar%2520Protein%2520Gene%252C%2520NPM%252C%2520in%2520Non-Hodgkin%25E2%2580%2599s%2520Lymphoma%26jtitle%3DScience%26date%3D1994%26volume%3D263%26spage%3D1281%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Palmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernersson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabbe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, B.</span><span> </span><span class="NLM_article-title">Anaplastic Lymphoma Kinase: Signalling in Development and Disease</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2009&pages=345-361&author=R.+H.+Palmerauthor=E.+Vernerssonauthor=C.+Grabbeauthor=B.+Hallberg&title=Anaplastic+Lymphoma+Kinase%3A+Signalling+in+Development+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DR.%2BH.%26aulast%3DVernersson%26aufirst%3DE.%26aulast%3DGrabbe%26aufirst%3DC.%26aulast%3DHallberg%26aufirst%3DB.%26atitle%3DAnaplastic%2520Lymphoma%2520Kinase%253A%2520Signalling%2520in%2520Development%2520and%2520Disease%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D420%26spage%3D345%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, S.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurashina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1038%2Fnature05945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=17625570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVSrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=561-566&author=M.+Sodaauthor=Y.+L.+Choiauthor=M.+Enomotoauthor=S.+Takadaauthor=Y.+Yamashitaauthor=S.+Ishikawaauthor=S.-i.+Fujiwaraauthor=H.+Watanabeauthor=K.+Kurashinaauthor=H.+Hatanakaauthor=M.+Bandoauthor=S.+Ohnoauthor=Y.+Ishikawaauthor=H.+Aburataniauthor=T.+Nikiauthor=Y.+Soharaauthor=Y.+Sugiyamaauthor=H.+Mano&title=Identification+of+the+transforming+EML4-ALK+fusion+gene+in+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer</span></div><div class="casAuthors">Soda, Manabu; Choi, Young Lim; Enomoto, Munehiro; Takada, Shuji; Yamashita, Yoshihiro; Ishikawa, Shunpei; Fujiwara, Shin-ichiro; Watanabe, Hideki; Kurashina, Kentaro; Hatanaka, Hisashi; Bando, Masashi; Ohno, Shoji; Ishikawa, Yuichi; Aburatani, Hiroyuki; Niki, Toshiro; Sohara, Yasunori; Sugiyama, Yukihiko; Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue">7153</span>),
    <span class="NLM_cas:pages">561-566</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Improvement in the clin. outcome of lung cancer is likely to be achieved by identification of the mol. events that underlie its pathogenesis.  Here we show that a small inversion within chromosome 2p results in the formation of a fusion gene comprising portions of the echinoderm microtubule-assocd. protein-like 4 (EML4) gene and the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer (NSCLC) cells.  Mouse 3T3 fibroblasts forced to express this human fusion tyrosine kinase generated transformed foci in culture and s.c. tumors in nude mice.  The EML4-ALK fusion transcript was detected in 6.7% (5 out of 75) of NSCLC patients examd.; these individuals were distinct from those harboring mutations in the epidermal growth factor receptor gene.  Our data demonstrate that a subset of NSCLC patients may express a transforming fusion kinase that is a promising candidate for a therapeutic target as well as for a diagnostic mol. marker in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomhAXuLtrJ6rVg90H21EOLACvtfcHk0lgT_s6s2aKtIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVSrtrs%253D&md5=7f567e80814b9ccc87e5bceeebb467a7</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1038%2Fnature05945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05945%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DEnomoto%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DS.-i.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DKurashina%26aufirst%3DK.%26aulast%3DHatanaka%26aufirst%3DH.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DNiki%26aufirst%3DT.%26aulast%3DSohara%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520the%2520transforming%2520EML4-ALK%2520fusion%2520gene%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DNature%26date%3D2007%26volume%3D448%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koivunen, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zejnullahu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifshits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducko, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcoux, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaenne, P. A.</span><span> </span><span class="NLM_article-title">EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4275</span><span class="NLM_x">–</span> <span class="NLM_lpage">4283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1158%2F1078-0432.CCR-08-0168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=18594010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFyks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=4275-4283&author=J.+P.+Koivunenauthor=C.+Mermelauthor=K.+Zejnullahuauthor=C.+Murphyauthor=E.+Lifshitsauthor=A.+J.+Holmesauthor=H.+G.+Choiauthor=J.+Kimauthor=D.+Chiangauthor=R.+Thomasauthor=J.+Leeauthor=W.+G.+Richardsauthor=D.+J.+Sugarbakerauthor=C.+Duckoauthor=N.+Lindemanauthor=J.+P.+Marcouxauthor=J.+A.+Engelmanauthor=N.+S.+Grayauthor=C.+Leeauthor=M.+Meyersonauthor=P.+A.+Jaenne&title=EML4-ALK+fusion+gene+and+efficacy+of+an+ALK+kinase+inhibitor+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer</span></div><div class="casAuthors">Koivunen, Jussi P.; Mermel, Craig; Zejnullahu, Kreshnik; Murphy, Carly; Lifshits, Eugene; Holmes, Alison J.; Choi, Hwan Geun; Kim, Jhingook; Chiang, Derek; Thomas, Roman; Lee, Jinseon; Richards, William G.; Sugarbaker, David J.; Ducko, Christopher; Lindeman, Neal; Marcoux, J. Paul; Engelman, Jeffrey A.; Gray, Nathanael S.; Lee, Charles; Meyerson, Matthew; Jaenne, Pasi A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4275-4283</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The EML4-ALK fusion gene has been detected in ∼7% of Japanese non-small cell lung cancers (NSCLC).  We detd. the frequency of EML4-ALK in Caucasian NSCLC and in NSCLC cell lines.  We also detd. whether TAE684, a specific ALK kinase inhibitor, would inhibit the growth of EML4-ALK-contg. cell lines in vitro and in vivo.  We screened 305 primary NSCLC [both U.S. (n = 138) and Korean (n = 167) patients] and 83 NSCLC cell lines using reverse transcription-PCR and by exon array analyses.  We evaluated the efficacy of TAE684 against NSCLC cell lines in vitro and in vivo.  We detected four different variants, including two novel variants, of EML4-ALK using reverse transcription-PCR in 8 of 305 tumors (3%) and 3 of 83 (3.6%) NSCLC cell lines.  All EML4-ALK-contg. tumors and cell lines were adenocarcinomas.  EML4-ALK was detected more frequently in NSCLC patients who were never or light (<10 pack-years) cigarette smokers compared with current/former smokers (6% vs. 1%; P = 0.049).  TAE684 inhibited the growth of one of three (H3122) EML4-ALK-contg. cell lines in vitro and in vivo, inhibited Akt phosphorylation, and caused apoptosis.  In another EML4-ALK cell line, DFCI032, TAE684 was ineffective due to coactivation of epidermal growth factor receptor and ERBB2.  The combination of TAE684 and CL-387,785 (epidermal growth factor receptor/ERBB2 kinase inhibitor) inhibited growth and Akt phosphorylation and led to apoptosis in the DFCI032 cell line.  EML4-ALK is found in the minority of NSCLC.  ALK kinase inhibitors alone or in combination may nevertheless be clin. effective treatments for NSCLC patients whose tumors contain EML4-ALK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOXKywqERg6rVg90H21EOLACvtfcHk0lgT_s6s2aKtIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFyks7s%253D&md5=6e29703c783e6a29cf77e3c4b93fc15f</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0168%26sid%3Dliteratum%253Aachs%26aulast%3DKoivunen%26aufirst%3DJ.%2BP.%26aulast%3DMermel%26aufirst%3DC.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DMurphy%26aufirst%3DC.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DHolmes%26aufirst%3DA.%2BJ.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26aulast%3DDucko%26aufirst%3DC.%26aulast%3DLindeman%26aufirst%3DN.%26aulast%3DMarcoux%26aufirst%3DJ.%2BP.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DJaenne%26aufirst%3DP.%2BA.%26atitle%3DEML4-ALK%2520fusion%2520gene%2520and%2520efficacy%2520of%2520an%2520ALK%2520kinase%2520inhibitor%2520in%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D4275%26epage%3D4283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Elenitoba-Johnson, K. S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crockett, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwood, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. S.</span><span> </span><span class="NLM_article-title">Proteomic identification of oncogenic chromosomal translocation partners encoding chimeric anaplastic lymphoma kinase fusion proteins</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">7402</span><span class="NLM_x">–</span> <span class="NLM_lpage">7407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=7402-7407&author=K.+S.+J.+Elenitoba-Johnsonauthor=D.+K.+Crockettauthor=J.+A.+Schumacherauthor=S.+D.+Jensonauthor=C.+M.+Coffinauthor=A.+L.+Rockwoodauthor=M.+S.+Lim&title=Proteomic+identification+of+oncogenic+chromosomal+translocation+partners+encoding+chimeric+anaplastic+lymphoma+kinase+fusion+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElenitoba-Johnson%26aufirst%3DK.%2BS.%2BJ.%26aulast%3DCrockett%26aufirst%3DD.%2BK.%26aulast%3DSchumacher%26aufirst%3DJ.%2BA.%26aulast%3DJenson%26aufirst%3DS.%2BD.%26aulast%3DCoffin%26aufirst%3DC.%2BM.%26aulast%3DRockwood%26aufirst%3DA.%2BL.%26aulast%3DLim%26aufirst%3DM.%2BS.%26atitle%3DProteomic%2520identification%2520of%2520oncogenic%2520chromosomal%2520translocation%2520partners%2520encoding%2520chimeric%2520anaplastic%2520lymphoma%2520kinase%2520fusion%2520proteins%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D7402%26epage%3D7407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span> </span><span class="NLM_article-title">Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3314</span><span class="NLM_x">–</span> <span class="NLM_lpage">3322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1158%2F1535-7163.MCT-07-0365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=18089725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=3314-3322&author=J.+G.+Christensenauthor=H.+Y.+Zouauthor=M.+E.+Arangoauthor=Q.+Liauthor=J.+H.+Leeauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=G.+R.+Altonauthor=B.+Mroczkowskiauthor=G.+Los&title=Cytoreductive+antitumor+activity+of+PF-2341066%2C+a+novel+inhibitor+of+anaplastic+lymphoma+kinase+and+c-Met%2C+in+experimental+models+of+anaplastic+large-cell+lymphoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma</span></div><div class="casAuthors">Christensen, James G.; Zou, Helen Y.; Arango, Maria E.; Li, Qiuhua; Lee, Joseph H.; McDonnell, Scott R.; Yamazaki, Shinji; Alton, Gordon R.; Mroczkowski, Barbara; Los, Gerrit</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">3314-3322</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A t(2;5) chromosomal translocation resulting in expression of an oncogenic kinase fusion protein known as nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) has been implicated in the pathogenesis of anaplastic large-cell lymphoma (ALCL).  PF-2341066 was recently identified as a p.o. bioavailable, small-mol. inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK fusion protein.  PF-2341066 also potently inhibited NPM-ALK phosphorylation in Karpas299 or SU-DHL-1 ALCL cells (mean IC50 value, 24 nmol/L).  In biochem. and cellular screens, PF-2341066 was shown to be selective for c-Met and ALK at pharmacol. relevant concns. across a panel of >120 diverse kinases.  PF-2341066 potently inhibited cell proliferation, which was assocd. with G1-S-phase cell cycle arrest and induction of apoptosis in ALK-pos. ALCL cells (IC50 values, ∼30 nmol/L) but not ALK-neg. lymphoma cells.  The induction of apoptosis was confirmed using terminal deoxyribonucleotide transferase-mediated nick-end labeling and Annexin V staining (IC50 values, 25-50 nmol/L).  P.o. administration of PF-2341066 to severe combined immunodeficient-Beige mice bearing Karpas299 ALCL tumor xenografts resulted in dose-dependent antitumor efficacy with complete regression of all tumors at the 100 mg/kg/d dose within 15 days of initial compd. administration.  A strong correlation was obsd. between antitumor response and inhibition of NPM-ALK phosphorylation and induction of apoptosis in tumor tissue.  In addn., inhibition of key NPM-ALK signaling mediators, including phospholipase C-γ, signal transducers and activators of transcription 3, extracellular signal-regulated kinases, and Akt by PF-2341066 were obsd. at concns. or dose levels, which correlated with inhibition of NPM-ALK phosphorylation and function.  Collectively, these data illustrate the potential clin. utility of inhibitors of NPM-ALK in treatment of patients with ALK-pos. ALCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptqY0tUwGnurVg90H21EOLACvtfcHk0li1Q__PUYwJ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrrL&md5=04fbbaf43ca527408bde8cabcd38e1fd</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0365%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DAlton%26aufirst%3DG.%2BR.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DLos%26aufirst%3DG.%26atitle%3DCytoreductive%2520antitumor%2520activity%2520of%2520PF-2341066%252C%2520a%2520novel%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520and%2520c-Met%252C%2520in%2520experimental%2520models%2520of%2520anaplastic%2520large-cell%2520lymphoma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D3314%26epage%3D3322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span> </span><span class="NLM_article-title">An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4408</span><span class="NLM_x">–</span> <span class="NLM_lpage">4417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1158%2F0008-5472.CAN-06-4443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=17483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4408-4417&author=H.+Y.+Zouauthor=Q.+Liauthor=J.+H.+Leeauthor=M.+E.+Arangoauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=T.+B.+Koudriakovaauthor=G.+Altonauthor=J.+J.+Cuiauthor=P.-P.+Kungauthor=M.+D.+Nambuauthor=G.+Losauthor=S.+L.+Benderauthor=B.+Mroczkowskiauthor=J.+G.+Christensen&title=An+orally+available+small-molecule+inhibitor+of+c-Met%2C+PF-2341066%2C+exhibits+cytoreductive+antitumor+efficacy+through+antiproliferative+and+antiangiogenic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms</span></div><div class="casAuthors">Zou, Helen Y.; Li, Qiuhua; Lee, Joseph H.; Arango, Maria E.; McDonnell, Scott R.; Yamazaki, Shinji; Koudriakova, Tatiana B.; Alton, Gordon; Cui, Jingrong J.; Kung, Pei-Pei; Nambu, Mitchell D.; Los, Gerrit; Bender, Steven L.; Mroczkowski, Barbara; Christensen, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4408-4417</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), have been implicated in the progression of several human cancers and are attractive therapeutic targets.  PF-2341066 was identified as a potent, orally bioavailable, ATP-competitive small-mol. inhibitor of the catalytic activity of c-Met kinase.  PF-2341066 was selective for c-Met (and anaplastic lymphoma kinase) compared with a panel of >120 diverse tyrosine and serine-threonine kinases.  PF-2341066 potently inhibited c-Met phosphorylation and c-Met-dependent proliferation, migration, or invasion of human tumor cells in vitro (IC50 values, 5-20 nmol/L).  In addn., PF-2341066 potently inhibited HGF-stimulated endothelial cell survival or invasion and serum-stimulated tubulogenesis in vitro, suggesting that this agent also exhibits antiangiogenic properties.  PF-2341066 showed efficacy at well-tolerated doses, including marked cytoreductive antitumor activity, in several tumor models that expressed activated c-Met.  The antitumor efficacy of PF-2341066 was dose dependent and showed a strong correlation to inhibition of c-Met phosphorylation in vivo.  Near-maximal inhibition of c-Met activity for the full dosing interval was necessary to maximize the efficacy of PF-2341066.  Addnl. mechanism-of-action studies showed dose-dependent inhibition of c-Met-dependent signal transduction, tumor cell proliferation (Ki67), induction of apoptosis (caspase-3), and redn. of microvessel d. (CD31).  These results indicated that the antitumor activity of PF-2341066 may be mediated by direct effects on tumor cell growth or survival as well as antiangiogenic mechanisms.  Collectively, these results show the therapeutic potential of targeting c-Met with selective small-mol. inhibitors for the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEAWtGPOBHC7Vg90H21EOLACvtfcHk0li1Q__PUYwJ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D&md5=798bf93e6cf8d5e9897e27485cba9002</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4443%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DKoudriakova%26aufirst%3DT.%2BB.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%2BL.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DAn%2520orally%2520available%2520small-molecule%2520inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520exhibits%2520cytoreductive%2520antitumor%2520efficacy%2520through%2520antiproliferative%2520and%2520antiangiogenic%2520mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4408%26epage%3D4417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span> An Investigational Drug, PF-02341066 Is Being Studied versus Standard of Care in Patients with Advanced Non-Small Cell Lung Cancer with a Specific Gene Profile Involving the Anaplastic Lymphoma Kinase (ALK) Gene. <a href="http://www.clinicaltrials.gov/ct2/show/NCT00932893" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT00932893</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+An+Investigational+Drug%2C+PF-02341066+Is+Being+Studied+versus+Standard+of+Care+in+Patients+with+Advanced+Non-Small+Cell+Lung+Cancer+with+a+Specific+Gene+Profile+Involving+the+Anaplastic+Lymphoma+Kinase+%28ALK%29+Gene.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT00932893."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G. R.</span><span> </span><span class="NLM_article-title">Inhibitors of anaplastic lymphoma kinase: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1653</span><span class="NLM_x">–</span> <span class="NLM_lpage">1681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1517%2F13543776.2010.527332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=20961208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1653-1681&issue=12&author=K.+L.+Milkiewiczauthor=G.+R.+Ott&title=Inhibitors+of+anaplastic+lymphoma+kinase%3A+a+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of anaplastic lymphoma kinase: a patent review</span></div><div class="casAuthors">Milkiewicz, Karen L.; Ott, Gregory R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1653-1681</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that belongs to the insulin receptor superfamily.  Aberrant ALK activity has been implicated in the oncogenesis of human cancers as a fusion protein in anaplastic large cell lymphoma, inflammatory myofibroblastic tumor, diffuse large B-cell lymphoma, systemic histiocytosis and NSCLC or through mutations in the full length protein in hereditary familial neuroblastoma.  Thus, abrogation of ALK signaling through direct kinase inhibition has become an attractive therapeutic intervention point for a subset of genetically defined human cancers.  Areas covered in this review: This manuscript provides a comprehensive review of the patent literature pertaining to ALK inhibitors and outlines their potential as anticancer therapeutic agents.  What the reader will gain: The reader will gain an understanding of the major structural classes of ALK inhibitors and insights into the future of this class of drugs.  Take home message: Multiple small-mol. ALK inhibitors have been reported with diverse chem. architecture, potency, kinase selectivity profiles and activity against potential resistance.  The breadth of inhibitors combined with the recent discoveries of the involvement of ALK in lung, breast and colorectal cancers has kept the field advancing at a rapid pace.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocXB5-B6Du8LVg90H21EOLACvtfcHk0li_o6UOUUl7Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7bF&md5=32d9d90cf43bba8dfef6385e6494cc0a</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.527332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.527332%26sid%3Dliteratum%253Aachs%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DOtt%26aufirst%3DG.%2BR.%26atitle%3DInhibitors%2520of%2520anaplastic%2520lymphoma%2520kinase%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26issue%3D12%26spage%3D1653%26epage%3D1681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mesaros, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugan, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzalone, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quail, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span> </span><span class="NLM_article-title">Novel 2,3,4,5-tetrahydro-benzo[<i>d</i>]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=463-466&issue=6&author=E.+F.+Mesarosauthor=J.+P.+Burkeauthor=J.+D.+Parrishauthor=B.+J.+Duganauthor=A.+V.+Anzaloneauthor=T.+S.+Angelesauthor=M.+S.+Albomauthor=L.+D.+Aimoneauthor=M.+R.+Quailauthor=W.+Wanauthor=L.+Luauthor=Z.+Huangauthor=M.+A.+Atorauthor=B.+A.+Ruggeriauthor=M.+Chengauthor=G.+R.+Ottauthor=B.+D.+Dorsey&title=Novel+2%2C3%2C4%2C5-tetrahydro-benzo%5Bd%5Dazepine+derivatives+of+2%2C4-diaminopyrimidine%2C+selective+and+orally+bioavailable+ALK+inhibitors+with+antitumor+efficacy+in+ALCL+mouse+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMesaros%26aufirst%3DE.%2BF.%26aulast%3DBurke%26aufirst%3DJ.%2BP.%26aulast%3DParrish%26aufirst%3DJ.%2BD.%26aulast%3DDugan%26aufirst%3DB.%2BJ.%26aulast%3DAnzalone%26aufirst%3DA.%2BV.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DQuail%26aufirst%3DM.%2BR.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DNovel%25202%252C3%252C4%252C5-tetrahydro-benzo%255Bd%255Dazepine%2520derivatives%2520of%25202%252C4-diaminopyrimidine%252C%2520selective%2520and%2520orally%2520bioavailable%2520ALK%2520inhibitors%2520with%2520antitumor%2520efficacy%2520in%2520ALCL%2520mouse%2520models%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D6%26spage%3D463%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marsault, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. L.</span><span> </span><span class="NLM_article-title">Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2004</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1012374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1961-2004&author=E.+Marsaultauthor=M.+L.+Peterson&title=Macrocycles+are+great+cycles%3A+applications%2C+opportunities%2C+and+challenges+of+synthetic+macrocycles+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery</span></div><div class="casAuthors">Marsault, Eric; Peterson, Mark L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1961-2004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles occupy a unique segment of chem. space.  In the past decade, their chem. diversity expanded significantly, supported by advances in bioinformatics and synthetic methodol.  As a consequence, this structural type has now been successfully tested on most biol. target classes.  The goal of this article is to put into perspective the current applications, opportunities, and challenges assocd. with synthetic macrocycles in drug discovery.  Accordingly, the first part of this article is dedicated to the drug discovery aspects of macrocycles and highlights salient features of their medicinal chem.  This section is organized by target class, a choice aimed at providing the reader an appreciation of the structural diversity generated for each class.  To give the reader an appreciation of the tools available to construct macrocyclic scaffolds, the site and method of the pivotal macrocyclization step are indicated in the figures.  Readers are referred to the source articles for further details.  In the second part, the technologies and synthetic approaches that already have demonstrated utility or possess a high potential for macrocycle-based drug discovery are discussed.  Finally, a perspective on the future of synthetic macrocycles in medicinal chem. is offered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygQLE6JraHrVg90H21EOLACvtfcHk0li_o6UOUUl7Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D&md5=97c1120896e90a85790a9ac1274259f3</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fjm1012374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012374%26sid%3Dliteratum%253Aachs%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26atitle%3DMacrocycles%2520are%2520great%2520cycles%253A%2520applications%252C%2520opportunities%252C%2520and%2520challenges%2520of%2520synthetic%2520macrocycles%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1961%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Williams, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaraj, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaraman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasha, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethirajulu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span> </span><span class="NLM_article-title">Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4638</span><span class="NLM_x">–</span> <span class="NLM_lpage">4658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4638-4658&author=A.+D.+Williamsauthor=A.C.-H.+Leeauthor=S.+Blanchardauthor=A.+Poulsenauthor=E.+L.+Teoauthor=H.+Nagarajauthor=E.+Tanauthor=D.+Chenauthor=M.+Williamsauthor=E.+T.+Sunauthor=K.+C.+Gohauthor=W.+C.+Ongauthor=S.+K.+Gohauthor=S.+Hartauthor=R.+Jayaramanauthor=M.+K.+Pashaauthor=K.+Ethirajuluauthor=J.+M.+Woodauthor=B.+W.+Dymock&title=Discovery+of+the+macrocycle+11-%282-pyrrolidin-1-yl-ethoxy%29-14%2C19-dioxa-5%2C7%2C26-triaza-tetracyclo%5B19.3.1.1%282%2C6%29.1%288%2C12%29%5Dheptacosa-1%2825%29%2C2%2826%29%2C3%2C5%2C8%2C10%2C12%2827%29%2C16%2C21%2C23-decaene+%28SB1518%29%2C+a+potent+Janus+kinase+2%2FFms-like+tyrosine+kinase-3+%28JAK2%2FFLT3%29+inhibitor+for+the+treatment+of+myelofibrosis+and+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DA.C.-H.%26aulast%3DBlanchard%26aufirst%3DS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DTeo%26aufirst%3DE.%2BL.%26aulast%3DNagaraj%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DE.%2BT.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DOng%26aufirst%3DW.%2BC.%26aulast%3DGoh%26aufirst%3DS.%2BK.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DPasha%26aufirst%3DM.%2BK.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DDiscovery%2520of%2520the%2520macrocycle%252011-%25282-pyrrolidin-1-yl-ethoxy%2529-14%252C19-dioxa-5%252C7%252C26-triaza-tetracyclo%255B19.3.1.1%25282%252C6%2529.1%25288%252C12%2529%255Dheptacosa-1%252825%2529%252C2%252826%2529%252C3%252C5%252C8%252C10%252C12%252827%2529%252C16%252C21%252C23-decaene%2520%2528SB1518%2529%252C%2520a%2520potent%2520Janus%2520kinase%25202%252FFms-like%2520tyrosine%2520kinase-3%2520%2528JAK2%252FFLT3%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520myelofibrosis%2520and%2520lymphoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4638%26epage%3D4658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Driggers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrett, N. K.</span><span> </span><span class="NLM_article-title">The exploration of macrocycles for drug discovery—an underexploited structural class</span> <span class="citation_source-journal">Nat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">608</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1038%2Fnrd2590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFShsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=608-624&author=E.+M.+Driggersauthor=S.+P.+Haleauthor=J.+Leeauthor=N.+K.+Terrett&title=The+exploration+of+macrocycles+for+drug+discovery%E2%80%94an+underexploited+structural+class"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">The exploration of macrocycles for drug discovery - an underexploited structural class</span></div><div class="casAuthors">Driggers, Edward M.; Hale, Stephen P.; Lee, Jinbo; Terrett, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">608-624</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products comprised of a macrocycle ring structure have proven their therapeutic applications as antibiotics, immunosuppressants as well as anticancer agents.  Despite this, macrocyclic compds. remain under-explored.  Terrett and colleagues review the properties and features of current macrocycle drugs, emphasizing the vast potential of synthetic macrocycles in drug discovery.  Macrocyclic natural products have evolved to fulfil numerous biochem. functions, and their profound pharmacol. properties have led to their development as drugs.  A macrocycle provides diverse functionality and stereochem. complexity in a conformationally pre-organized ring structure.  This can result in high affinity and selectivity for protein targets, while preserving sufficient bioavailability to reach intracellular locations.  Despite these valuable characteristics, and the proven success of more than 100 marketed macrocycle drugs derived from natural products, this structural class has been poorly explored within drug discovery.  This is in part due to concerns about synthetic intractability and non-drug-like properties.  This Review describes the growing body of data in favor of macrocyclic therapeutics, and demonstrates that this class of compds. can be both fully drug-like in its properties and readily prepd. owing to recent advances in synthetic medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDtW8LpE4ru7Vg90H21EOLACvtfcHk0lhXsrWbGH3PPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFShsbc%253D&md5=16e091818053e5b163b81078a8d03094</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1038%2Fnrd2590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2590%26sid%3Dliteratum%253Aachs%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DHale%26aufirst%3DS.%2BP.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26atitle%3DThe%2520exploration%2520of%2520macrocycles%2520for%2520drug%2520discovery%25E2%2580%2594an%2520underexploited%2520structural%2520class%26jtitle%3DNat.%2520Rev.%26date%3D2008%26volume%3D7%26spage%3D608%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Freyne, E. J. E.; Willems, M.; Embrechts, W. C. J.; Van Emelen, K.; Van Brandt, S. F. A.; Rombouts, F. J. R.</span><span> </span><span class="NLM_article-title">2,4 (4,6) Pyrimidine Derivatives</span>. WO 2006061415, June 15,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=E.+J.+E.+Freyne&author=M.+Willems&author=W.+C.+J.+Embrechts&author=K.+Van+Emelen&author=S.+F.+A.+Van+Brandt&author=F.+J.+R.+Rombouts&title=2%2C4+%284%2C6%29+Pyrimidine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFreyne%26aufirst%3DE.%2BJ.%2BE.%26atitle%3D2%252C4%2520%25284%252C6%2529%2520Pyrimidine%2520Derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Bossi, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccardo, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi Borgia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogliatto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, J. A.</span><span> </span><span class="NLM_article-title">Crystal structures of anaplastic lymphoma kinase in complex with ATP-competitive inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">32</span><span class="NLM_x">) </span> <span class="NLM_fpage">6813</span><span class="NLM_x">–</span> <span class="NLM_lpage">6825</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi1005514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6813-6825&issue=32&author=R.+T.+Bossiauthor=M.+B.+Saccardoauthor=E.+Ardiniauthor=M.+Menichincheriauthor=L.+Rusconiauthor=P.+Magnaghiauthor=P.+Orsiniauthor=N.+Avanziauthor=A.+Lombardi+Borgiaauthor=M.+Nesiauthor=T.+Bandieraauthor=G.+Fogliattoauthor=J.+A.+Bertrand&title=Crystal+structures+of+anaplastic+lymphoma+kinase+in+complex+with+ATP-competitive+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbi1005514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1005514%26sid%3Dliteratum%253Aachs%26aulast%3DBossi%26aufirst%3DR.%2BT.%26aulast%3DSaccardo%26aufirst%3DM.%2BB.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DLombardi%2BBorgia%26aufirst%3DA.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26atitle%3DCrystal%2520structures%2520of%2520anaplastic%2520lymphoma%2520kinase%2520in%2520complex%2520with%2520ATP-competitive%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26issue%3D32%26spage%3D6813%26epage%3D6825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Combs, A. P.; Sparks, R. B.; Yue, E. W.; Feng, H.; Bower, M. J.; Zhu, W.</span><span> </span><span class="NLM_article-title">Macrocyclic Compounds as Kinase Inhibitors and Their Preparation, Pharmaceutical Compositions and Their Use in the Treatment of JAK/ALK-Associated Diseases</span>. WO 2009132202, October 29,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+P.+Combs&author=R.+B.+Sparks&author=E.+W.+Yue&author=H.+Feng&author=M.+J.+Bower&author=W.+Zhu&title=Macrocyclic+Compounds+as+Kinase+Inhibitors+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Their+Use+in+the+Treatment+of+JAK%2FALK-Associated+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DMacrocyclic%2520Compounds%2520as%2520Kinase%2520Inhibitors%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Their%2520Use%2520in%2520the%2520Treatment%2520of%2520JAK%252FALK-Associated%2520Diseases%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Mulvihill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coate, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeld-Franklin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigro, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirrit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinig, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolz, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, P. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, N. W.</span><span> </span><span class="NLM_article-title">Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-<i>a</i>]pyrazines as potent insulin-like growth factor (IGF-IR) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=1359-1375&author=M.+J.+Mulvihillauthor=Q.-S.+Jiauthor=H.+R.+Coateauthor=A.+Cookeauthor=H.+Dongauthor=L.+Fengauthor=K.+Foremanauthor=M.+Rosenfeld-Franklinauthor=A.+Hondaauthor=G.+Makauthor=K.+M.+Mulvihillauthor=A.+L.+Nigroauthor=M.+O%E2%80%99Connorauthor=C.+Pirritauthor=A.+G.+Steinigauthor=K.+Siuauthor=K.+M.+Stolzauthor=Y.+Sunauthor=P.+A.+R.+Tavaresauthor=Y.+Yaoauthor=N.+W.+Gibson&title=Novel+2-phenylquinolin-7-yl-derived+imidazo%5B1%2C5-a%5Dpyrazines+as+potent+insulin-like+growth+factor+%28IGF-IR%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMulvihill%26aufirst%3DM.%2BJ.%26aulast%3DJi%26aufirst%3DQ.-S.%26aulast%3DCoate%26aufirst%3DH.%2BR.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DForeman%26aufirst%3DK.%26aulast%3DRosenfeld-Franklin%26aufirst%3DM.%26aulast%3DHonda%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DMulvihill%26aufirst%3DK.%2BM.%26aulast%3DNigro%26aufirst%3DA.%2BL.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%26aulast%3DPirrit%26aufirst%3DC.%26aulast%3DSteinig%26aufirst%3DA.%2BG.%26aulast%3DSiu%26aufirst%3DK.%26aulast%3DStolz%26aufirst%3DK.%2BM.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DTavares%26aufirst%3DP.%2BA.%2BR.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26atitle%3DNovel%25202-phenylquinolin-7-yl-derived%2520imidazo%255B1%252C5-a%255Dpyrazines%2520as%2520potent%2520insulin-like%2520growth%2520factor%2520%2528IGF-IR%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D1359%26epage%3D1375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambing, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michellys, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spraggon, G.</span><span> </span><span class="NLM_article-title">Crystal structure of the anaplastic lymphoma kinase (Alk) catalytic domain</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2010&pages=425-437&author=C.+C.+Leeauthor=Y.+Jiaauthor=N.+Liauthor=X.+Sunauthor=K.+Ngauthor=E.+Ambingauthor=M.+Y.+Gaoauthor=S.+Huaauthor=C.+Chenauthor=S.+Kimauthor=P.+Y.+Michellysauthor=S.+A.+Lesleyauthor=J.+Harrisauthor=G.+Spraggon&title=Crystal+structure+of+the+anaplastic+lymphoma+kinase+%28Alk%29+catalytic+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DNg%26aufirst%3DK.%26aulast%3DAmbing%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DM.%2BY.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DMichellys%26aufirst%3DP.%2BY.%26aulast%3DLesley%26aufirst%3DS.%2BA.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DSpraggon%26aufirst%3DG.%26atitle%3DCrystal%2520structure%2520of%2520the%2520anaplastic%2520lymphoma%2520kinase%2520%2528Alk%2529%2520catalytic%2520domain%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D430%26spage%3D425%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5149</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800475y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5149-5171&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=D.+A.+Pippinauthor=J.+M.+Salvinoauthor=J.+P.+Mallamo&title=Knowledge+based+prediction+of+ligand+binding+modes+and+rational+inhibitor+design+for+kinase+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Pippin, Douglas A.; Salvino, Joseph M.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5149-5171</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review describing the use of Protein Data Bank (PDB) entries specifically for kinase inhibitor drug discovery.  Topics discussed include: the current state of structure-aided ligand design, kinase structure queries and extn. from the PDB, alignment of protein structures, structural classification of ligands, anal. of ligands and binding modes, and ligand design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDINDYVE15cbVg90H21EOLACvtfcHk0ljR3-bdk7NMyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM&md5=a1afc4d6c7f6fa4dd6aa9da8d78f1ee3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm800475y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800475y%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge%2520based%2520prediction%2520of%2520ligand%2520binding%2520modes%2520and%2520rational%2520inhibitor%2520design%2520for%2520kinase%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5149%26epage%3D5171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Beruben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platzer, N.</span><span> </span><span class="NLM_article-title">Stereodefined substituted cyclopropyl zinc reagents from gem-bismetallics</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2488</span><span class="NLM_x">–</span> <span class="NLM_lpage">2501</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00113a032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=2488-2501&author=D.+Berubenauthor=I.+Marekauthor=J.+F.+Normantauthor=N.+Platzer&title=Stereodefined+substituted+cyclopropyl+zinc+reagents+from+gem-bismetallics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjo00113a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00113a032%26sid%3Dliteratum%253Aachs%26aulast%3DBeruben%26aufirst%3DD.%26aulast%3DMarek%26aufirst%3DI.%26aulast%3DNormant%26aufirst%3DJ.%2BF.%26aulast%3DPlatzer%26aufirst%3DN.%26atitle%3DStereodefined%2520substituted%2520cyclopropyl%2520zinc%2520reagents%2520from%2520gem-bismetallics%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D2488%26epage%3D2501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hamersma, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, E. I.</span><span> </span><span class="NLM_article-title">Diimide reductions using potassium azodicarboxylate</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3985</span><span class="NLM_x">–</span> <span class="NLM_lpage">3988</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01022a532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1965&pages=3985-3988&author=J.+W.+Hamersmaauthor=E.+I.+Snyder&title=Diimide+reductions+using+potassium+azodicarboxylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Fjo01022a532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01022a532%26sid%3Dliteratum%253Aachs%26aulast%3DHamersma%26aufirst%3DJ.%2BW.%26aulast%3DSnyder%26aufirst%3DE.%2BI.%26atitle%3DDiimide%2520reductions%2520using%2520potassium%2520azodicarboxylate%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1965%26volume%3D30%26spage%3D3985%26epage%3D3988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionne, C. A.</span><span> </span><span class="NLM_article-title">Enzyme-linked immunosorbent assay for trkA tyrosine kinase activity</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=1996&pages=49-55&issue=1&author=T.+S.+Angelesauthor=C.+Stefflerauthor=B.+A.+Bartlettauthor=R.+L.+Hudkinsauthor=R.+M.+Stephensauthor=D.+R.+Kaplanauthor=C.+A.+Dionne&title=Enzyme-linked+immunosorbent+assay+for+trkA+tyrosine+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DSteffler%26aufirst%3DC.%26aulast%3DBartlett%26aufirst%3DB.%2BA.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DStephens%26aufirst%3DR.%2BM.%26aulast%3DKaplan%26aufirst%3DD.%2BR.%26aulast%3DDionne%26aufirst%3DC.%2BA.%26atitle%3DEnzyme-linked%2520immunosorbent%2520assay%2520for%2520trkA%2520tyrosine%2520kinase%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D1996%26volume%3D236%26issue%3D1%26spage%3D49%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Rotin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daum, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase Cγ</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1992&pages=559-567&issue=2&author=D.+Rotinauthor=B.+Margolisauthor=M.+Mohammadiauthor=R.+J.+Dalyauthor=G.+Daumauthor=N.+Liauthor=E.+H.+Fischerauthor=W.+H.+Burgessauthor=A.+Ullrichauthor=J.+Schlessinger&title=SH2+domains+prevent+tyrosine+dephosphorylation+of+the+EGF+receptor%3A+identification+of+Tyr992+as+the+high-affinity+binding+site+for+SH2+domains+of+phospholipase+C%CE%B3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRotin%26aufirst%3DD.%26aulast%3DMargolis%26aufirst%3DB.%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DDaum%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DFischer%26aufirst%3DE.%2BH.%26aulast%3DBurgess%26aufirst%3DW.%2BH.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DSH2%2520domains%2520prevent%2520tyrosine%2520dephosphorylation%2520of%2520the%2520EGF%2520receptor%253A%2520identification%2520of%2520Tyr992%2520as%2520the%2520high-affinity%2520binding%2520site%2520for%2520SH2%2520domains%2520of%2520phospholipase%2520C%25CE%25B3%26jtitle%3DEMBO%2520J.%26date%3D1992%26volume%3D11%26issue%3D2%26spage%3D559%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b'],'ref8':['cit8'],'ref9':['cit9a','cit9b','cit9c'],'ref10':['cit10a','cit10b'],'ref11':['cit11a','cit11b','cit11c'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 28 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Paula C. Ortet, Samantha N. Muellers, Lauren A. Viarengo-Baker, Kristina Streu, Blair R. Szymczyna, Aaron B. Beeler, Karen N. Allen, <span class="NLM_string-name hlFld-ContribAuthor">Adrian Whitty</span>. </span><span class="cited-content_cbyCitation_article-title">Recapitulating the Binding Affinity of Nrf2 for KEAP1 in a Cyclic Heptapeptide, Guided by NMR, X-ray Crystallography, and Machine Learning. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2021,</strong> <em>143 </em>
                                    (10)
                                     , 3779-3793. <a href="https://doi.org/10.1021/jacs.0c09799" title="DOI URL">https://doi.org/10.1021/jacs.0c09799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.0c09799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.0c09799%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DRecapitulating%252Bthe%252BBinding%252BAffinity%252Bof%252BNrf2%252Bfor%252BKEAP1%252Bin%252Ba%252BCyclic%252BHeptapeptide%25252C%252BGuided%252Bby%252BNMR%25252C%252BX-ray%252BCrystallography%25252C%252Band%252BMachine%252BLearning%26aulast%3DOrtet%26aufirst%3DPaula%2BC.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D13092020%26date%3D08032021%26volume%3D143%26issue%3D10%26spage%3D3779%26epage%3D3793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ted W. Johnson, Rebecca A. Gallego, <span class="NLM_string-name hlFld-ContribAuthor">Martin P. Edwards</span>. </span><span class="cited-content_cbyCitation_article-title">Lipophilic Efficiency as an Important Metric in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6401-6420. <a href="https://doi.org/10.1021/acs.jmedchem.8b00077" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00077%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLipophilic%252BEfficiency%252Bas%252Ban%252BImportant%252BMetric%252Bin%252BDrug%252BDesign%26aulast%3DJohnson%26aufirst%3DTed%2BW.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D16012018%26date%3D17042018%26date%3D28032018%26volume%3D61%26issue%3D15%26spage%3D6401%26epage%3D6420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujun  Zhao</span>, <span class="hlFld-ContribAuthor ">Longchuan  Bai</span>, <span class="hlFld-ContribAuthor ">Liu  Liu</span>, <span class="hlFld-ContribAuthor ">Donna  McEachern</span>, <span class="hlFld-ContribAuthor ">Jeanne A.  Stuckey</span>, <span class="hlFld-ContribAuthor ">Jennifer L.  Meagher</span>, <span class="hlFld-ContribAuthor ">Chao-Yie  Yang</span>, <span class="hlFld-ContribAuthor ">Xu  Ran</span>, <span class="hlFld-ContribAuthor ">Bing  Zhou</span>, <span class="hlFld-ContribAuthor ">Yang  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaoqin  Li</span>, <span class="hlFld-ContribAuthor ">Bo  Wen</span>, <span class="hlFld-ContribAuthor ">Ting  Zhao</span>, <span class="hlFld-ContribAuthor ">Siwei  Li</span>, <span class="hlFld-ContribAuthor ">Duxin  Sun</span>, and <span class="hlFld-ContribAuthor ">Shaomeng  Wang</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (9)
                                     , 3887-3901. <a href="https://doi.org/10.1021/acs.jmedchem.7b00193" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00193</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00193%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDiscovery%252Bof%252B4-%2525286-Methoxy-2-methyl-4-%252528quinolin-4-yl%252529-9H-pyrimido%25255B4%25252C5-b%25255Dindol-7-yl%252529-3%25252C5-dimethylisoxazole%252B%252528CD161%252529%252Bas%252Ba%252BPotent%252Band%252BOrally%252BBioavailable%252BBET%252BBromodomain%252BInhibitor%26aulast%3DZhao%26aufirst%3DYujun%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04022017%26date%3D02052017%26date%3D11052017%26volume%3D60%26issue%3D9%26spage%3D3887%26epage%3D3901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuewu  Liang</span>, <span class="hlFld-ContribAuthor ">Jie  Zang</span>, <span class="hlFld-ContribAuthor ">Mengyuan  Zhu</span>, <span class="hlFld-ContribAuthor ">Qianwen  Gao</span>, <span class="hlFld-ContribAuthor ">Binghe  Wang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>, and <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Antitumor Evaluation of 4-Amino-(1H)-pyrazole Derivatives as JAKs Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (10)
                                     , 950-955. <a href="https://doi.org/10.1021/acsmedchemlett.6b00247" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00247</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00247%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BAntitumor%252BEvaluation%252Bof%252B4-Amino-%2525281H%252529-pyrazole%252BDerivatives%252Bas%252BJAKs%252BInhibitors%26aulast%3DLiang%26aufirst%3DXuewu%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D14072016%26date%3D23082016%26date%3D24082016%26date%3D13102016%26date%3D23082016%26volume%3D7%26issue%3D10%26spage%3D950%26epage%3D955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory R.  Ott</span>, <span class="hlFld-ContribAuthor ">Mangeng  Cheng</span>, <span class="hlFld-ContribAuthor ">Keith S.  Learn</span>, <span class="hlFld-ContribAuthor ">Jason  Wagner</span>, <span class="hlFld-ContribAuthor ">Diane E.  Gingrich</span>, <span class="hlFld-ContribAuthor ">Joseph G.  Lisko</span>, <span class="hlFld-ContribAuthor ">Matthew  Curry</span>, <span class="hlFld-ContribAuthor ">Eugen F.  Mesaros</span>, <span class="hlFld-ContribAuthor ">Arup K.  Ghose</span>, <span class="hlFld-ContribAuthor ">Matthew R.  Quail</span>, <span class="hlFld-ContribAuthor ">Weihua  Wan</span>, <span class="hlFld-ContribAuthor ">Lihui  Lu</span>, <span class="hlFld-ContribAuthor ">Pawel  Dobrzanski</span>, <span class="hlFld-ContribAuthor ">Mark S.  Albom</span>, <span class="hlFld-ContribAuthor ">Thelma S.  Angeles</span>, <span class="hlFld-ContribAuthor ">Kevin  Wells-Knecht</span>, <span class="hlFld-ContribAuthor ">Zeqi  Huang</span>, <span class="hlFld-ContribAuthor ">Lisa D.  Aimone</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Bruckheimer</span>, <span class="hlFld-ContribAuthor ">Nathan  Anderson</span>, <span class="hlFld-ContribAuthor ">Jay  Friedman</span>, <span class="hlFld-ContribAuthor ">Sandra V.  Fernandez</span>, <span class="hlFld-ContribAuthor ">Mark A.  Ator</span>, <span class="hlFld-ContribAuthor ">Bruce A.  Ruggeri</span>, and <span class="hlFld-ContribAuthor ">Bruce D.  Dorsey</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (16)
                                     , 7478-7496. <a href="https://doi.org/10.1021/acs.jmedchem.6b00487" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00487</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00487%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BClinical%252BCandidate%252BCEP-37440%25252C%252Ba%252BSelective%252BInhibitor%252Bof%252BFocal%252BAdhesion%252BKinase%252B%252528FAK%252529%252Band%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%26aulast%3DOtt%26aufirst%3DGregory%2BR.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01042016%26date%3D15082016%26date%3D25082016%26volume%3D59%26issue%3D16%26spage%3D7478%26epage%3D7496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ted W.  Johnson</span>, <span class="hlFld-ContribAuthor ">Paul F.  Richardson</span>, <span class="hlFld-ContribAuthor ">Simon  Bailey</span>, <span class="hlFld-ContribAuthor ">Alexei  Brooun</span>, <span class="hlFld-ContribAuthor ">Benjamin J.  Burke</span>, <span class="hlFld-ContribAuthor ">Michael R.  Collins</span>, <span class="hlFld-ContribAuthor ">J. Jean  Cui</span>, <span class="hlFld-ContribAuthor ">Judith G.  Deal</span>, <span class="hlFld-ContribAuthor ">Ya-Li  Deng</span>, <span class="hlFld-ContribAuthor ">Dac  Dinh</span>, <span class="hlFld-ContribAuthor ">Lars D.  Engstrom</span>, <span class="hlFld-ContribAuthor ">Mingying  He</span>, <span class="hlFld-ContribAuthor ">Jacqui  Hoffman</span>, <span class="hlFld-ContribAuthor ">Robert L.  Hoffman</span>, <span class="hlFld-ContribAuthor ">Qinhua  Huang</span>, <span class="hlFld-ContribAuthor ">Robert S.  Kania</span>, <span class="hlFld-ContribAuthor ">John C.  Kath</span>, <span class="hlFld-ContribAuthor ">Hieu  Lam</span>, <span class="hlFld-ContribAuthor ">Justine L.  Lam</span>, <span class="hlFld-ContribAuthor ">Phuong T.  Le</span>, <span class="hlFld-ContribAuthor ">Laura  Lingardo</span>, <span class="hlFld-ContribAuthor ">Wei  Liu</span>, <span class="hlFld-ContribAuthor ">Michele  McTigue</span>, <span class="hlFld-ContribAuthor ">Cynthia L.  Palmer</span>, <span class="hlFld-ContribAuthor ">Neal W.  Sach</span>, <span class="hlFld-ContribAuthor ">Tod  Smeal</span>, <span class="hlFld-ContribAuthor ">Graham L.  Smith</span>, <span class="hlFld-ContribAuthor ">Albert E.  Stewart</span>, <span class="hlFld-ContribAuthor ">Sergei  Timofeevski</span>, <span class="hlFld-ContribAuthor ">Huichun  Zhu</span>, <span class="hlFld-ContribAuthor ">Jinjiang  Zhu</span>, <span class="hlFld-ContribAuthor ">Helen Y.  Zou</span>, and <span class="hlFld-ContribAuthor ">Martin P.  Edwards</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (11)
                                     , 4720-4744. <a href="https://doi.org/10.1021/jm500261q" title="DOI URL">https://doi.org/10.1021/jm500261q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500261q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%25252810R%252529-7-Amino-12-fluoro-2%25252C10%25252C16-trimethyl-15-oxo-10%25252C15%25252C16%25252C17-tetrahydro-2H-8%25252C4-%252528metheno%252529pyrazolo%25255B4%25252C3-h%25255D%25255B2%25252C5%25252C11%25255D-benzoxadiazacyclotetradecine-3-carbonitrile%252B%252528PF-06463922%252529%25252C%252Ba%252BMacrocyclic%252BInhibitor%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252B%252528ALK%252529%252Band%252Bc-ros%252BOncogene%252B1%252B%252528ROS1%252529%252Bwith%252BPreclinical%252BBrain%252BExposure%252Band%252BBroad-Spectrum%252BPotency%252Bagainst%252BALK-Resistant%252BMutations%26aulast%3DJohnson%26aufirst%3DTed%2BW.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D17022014%26date%3D03062014%26date%3D12062014%26date%3D13052014%26volume%3D57%26issue%3D11%26spage%3D4720%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Anthony A.  Estrada</span>, <span class="hlFld-ContribAuthor ">Huifen  Chen</span>, <span class="hlFld-ContribAuthor ">John  Atherall</span>, <span class="hlFld-ContribAuthor ">Charles  Baker-Glenn</span>, <span class="hlFld-ContribAuthor ">Alan  Beresford</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burdick</span>, <span class="hlFld-ContribAuthor ">Mark  Chambers</span>, <span class="hlFld-ContribAuthor ">Sara L.  Dominguez</span>, <span class="hlFld-ContribAuthor ">Jason  Drummond</span>, <span class="hlFld-ContribAuthor ">Andrew  Gill</span>, <span class="hlFld-ContribAuthor ">Tracy  Kleinheinz</span>, <span class="hlFld-ContribAuthor ">Claire E.  Le Pichon</span>, <span class="hlFld-ContribAuthor ">Andrew D.  Medhurst</span>, <span class="hlFld-ContribAuthor ">Xingrong  Liu</span>, <span class="hlFld-ContribAuthor ">John G.  Moffat</span>, <span class="hlFld-ContribAuthor ">Kevin  Nash</span>, <span class="hlFld-ContribAuthor ">Kimberly  Scearce-Levie</span>, <span class="hlFld-ContribAuthor ">Zejuan  Sheng</span>, <span class="hlFld-ContribAuthor ">Daniel G.  Shore</span>, <span class="hlFld-ContribAuthor ">Hervé  Van de Poël</span>, <span class="hlFld-ContribAuthor ">Shuo  Zhang</span>, <span class="hlFld-ContribAuthor ">Haitao  Zhu</span>, and <span class="hlFld-ContribAuthor ">Zachary K.  Sweeney</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Highly Selective, Brain-Penetrant Aminopyrazole LRRK2 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>4 </em>
                                    (1)
                                     , 85-90. <a href="https://doi.org/10.1021/ml3003007" title="DOI URL">https://doi.org/10.1021/ml3003007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml3003007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml3003007%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BHighly%252BSelective%25252C%252BBrain-Penetrant%252BAminopyrazole%252BLRRK2%252BInhibitor%26aulast%3DChan%26aufirst%3DBryan%2BK.%26date%3D2013%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D24092012%26date%3D23112012%26date%3D29112012%26date%3D10012013%26date%3D23112012%26volume%3D4%26issue%3D1%26spage%3D85%26epage%3D90" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhenqiang  Xia</span>, <span class="hlFld-ContribAuthor ">Ridong  Huang</span>, <span class="hlFld-ContribAuthor ">Xinglong  Zhou</span>, <span class="hlFld-ContribAuthor ">Yingying  Chai</span>, <span class="hlFld-ContribAuthor ">Hai  Chen</span>, <span class="hlFld-ContribAuthor ">Lingling  Ma</span>, <span class="hlFld-ContribAuthor ">Quanwei  Yu</span>, <span class="hlFld-ContribAuthor ">Ying  Li</span>, <span class="hlFld-ContribAuthor ">Weimin  Li</span>, <span class="hlFld-ContribAuthor ">Yang  He</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis and bioactivity of pyrrolo[2,3-d]pyrimidine derivatives as tyrosine kinase inhibitors for NSCLC cells with EGFR mutations. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113711. <a href="https://doi.org/10.1016/j.ejmech.2021.113711" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113711%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bsynthesis%252Band%252Bbioactivity%252Bof%252Bpyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bas%252Btyrosine%252Bkinase%252Binhibitors%252Bfor%252BNSCLC%252Bcells%252Bwith%252BEGFR%252Bmutations%26aulast%3DXia%26aufirst%3DZhenqiang%26date%3D2021%26volume%3D224%26spage%3D113711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiu-zheng  Gao</span>, <span class="hlFld-ContribAuthor ">Xu-tao  Lv</span>, <span class="hlFld-ContribAuthor ">Rui-rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Luo</span>, <span class="hlFld-ContribAuthor ">Mu-xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Jia-shu  Chen</span>, <span class="hlFld-ContribAuthor ">Yu-kai  Zhang</span>, <span class="hlFld-ContribAuthor ">Bin  Sun</span>, <span class="hlFld-ContribAuthor ">Jin-yue  Sun</span>, <span class="hlFld-ContribAuthor ">Yu-fa  Liu</span>, <span class="hlFld-ContribAuthor ">Chao  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and in vitro anticancer research of novel tetrandrine and fangchinoline derivatives. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>109 </em>, 104694. <a href="https://doi.org/10.1016/j.bioorg.2021.104694" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104694</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104694%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin%252Bvitro%252Banticancer%252Bresearch%252Bof%252Bnovel%252Btetrandrine%252Band%252Bfangchinoline%252Bderivatives%26aulast%3DGao%26aufirst%3DXiu-zheng%26date%3D2021%26volume%3D109%26spage%3D104694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Feng  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Leucine-rich repeat kinase 2 inhibitors: a patent review (2014-present). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 275-286. <a href="https://doi.org/10.1080/13543776.2020.1729354" title="DOI URL">https://doi.org/10.1080/13543776.2020.1729354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2020.1729354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2020.1729354%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DLeucine-rich%252Brepeat%252Bkinase%252B2%252Binhibitors%25253A%252Ba%252Bpatent%252Breview%252B%2525282014-present%252529%26aulast%3DDing%26aufirst%3DXiao%26date%3D2020%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D275%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yusuke  Sasaki</span>, <span class="hlFld-ContribAuthor ">Hidekazu  Tokuhara</span>, <span class="hlFld-ContribAuthor ">Yusuke  Ohba</span>, <span class="hlFld-ContribAuthor ">Atsutoshi  Okabe</span>, <span class="hlFld-ContribAuthor ">Masaharu  Nakayama</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Robert  Skene</span>, <span class="hlFld-ContribAuthor ">Isaac  Hoffman</span>, <span class="hlFld-ContribAuthor ">Hua  Zou</span>, <span class="hlFld-ContribAuthor ">Masato  Yoshida</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient synthesis of tert-butyl 3-cyano-3-cyclopropyl-2-oxopyrrolidine-4-carboxylates: Highly functionalized 2-pyrrolidinone enabling access to novel macrocyclic Tyk2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (5)
                                     , 126963. <a href="https://doi.org/10.1016/j.bmcl.2020.126963" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.126963</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.126963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.126963%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DEfficient%252Bsynthesis%252Bof%252Btert-butyl%252B3-cyano-3-cyclopropyl-2-oxopyrrolidine-4-carboxylates%25253A%252BHighly%252Bfunctionalized%252B2-pyrrolidinone%252Benabling%252Baccess%252Bto%252Bnovel%252Bmacrocyclic%252BTyk2%252Binhibitors%26aulast%3DSasaki%26aufirst%3DYusuke%26date%3D2020%26volume%3D30%26issue%3D5%26spage%3D126963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue  Dong</span>, <span class="hlFld-ContribAuthor ">Tong  Zhao</span>, <span class="hlFld-ContribAuthor ">Wei  Ai</span>, <span class="hlFld-ContribAuthor ">Waleed A.  Zalloum</span>, <span class="hlFld-ContribAuthor ">Dongwei  Kang</span>, <span class="hlFld-ContribAuthor ">Ting  Wu</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016–2019). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2019,</strong> <em>29 </em>
                                    (11)
                                     , 871-879. <a href="https://doi.org/10.1080/13543776.2019.1676727" title="DOI URL">https://doi.org/10.1080/13543776.2019.1676727</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2019.1676727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2019.1676727%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DNovel%252Burate%252Btransporter%252B1%252B%252528URAT1%252529%252Binhibitors%25253A%252Ba%252Breview%252Bof%252Brecent%252Bpatent%252Bliterature%252B%2525282016%2525E2%252580%2525932019%252529%26aulast%3DDong%26aufirst%3DYue%26date%3D2019%26date%3D2019%26volume%3D29%26issue%3D11%26spage%3D871%26epage%3D879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun-Yan  Sang</span>, <span class="hlFld-ContribAuthor ">Wen-Wen  Qin</span>, <span class="hlFld-ContribAuthor ">Xiu-Juan  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Xu</span>, <span class="hlFld-ContribAuthor ">You-Zhen  Ma</span>, <span class="hlFld-ContribAuthor ">Xing-Rong  Wang</span>, <span class="hlFld-ContribAuthor ">Ling  Hui</span>, <span class="hlFld-ContribAuthor ">Shi-Wu  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and identification of 2,4-bisanilinopyrimidines bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential Aurora A inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (1)
                                     , 65-78. <a href="https://doi.org/10.1016/j.bmc.2018.11.006" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.11.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.11.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bidentification%252Bof%252B2%25252C4-bisanilinopyrimidines%252Bbearing%252B2%25252C2%25252C6%25252C6-tetramethylpiperidine-N-oxyl%252Bas%252Bpotential%252BAurora%252BA%252Binhibitors%26aulast%3DSang%26aufirst%3DChun-Yan%26date%3D2019%26volume%3D27%26issue%3D1%26spage%3D65%26epage%3D78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qinqin  Xia</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Bao</span>, <span class="hlFld-ContribAuthor ">Chuchu  Sun</span>, <span class="hlFld-ContribAuthor ">Di  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaona  Rong</span>, <span class="hlFld-ContribAuthor ">Zhiguo  Liu</span>, <span class="hlFld-ContribAuthor ">Yugui  Gu</span>, <span class="hlFld-ContribAuthor ">Jianmin  Zhou</span>, <span class="hlFld-ContribAuthor ">Guang  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 2-sulfonylindoles as potential anti-inflammatory therapeutic agents for treatment of acute lung injury. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>160 </em>, 120-132. <a href="https://doi.org/10.1016/j.ejmech.2018.10.014" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.10.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.10.014%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B2-sulfonylindoles%252Bas%252Bpotential%252Banti-inflammatory%252Btherapeutic%252Bagents%252Bfor%252Btreatment%252Bof%252Bacute%252Blung%252Binjury%26aulast%3DXia%26aufirst%3DQinqin%26date%3D2018%26volume%3D160%26spage%3D120%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yesu  Addepalli</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Yang</span>, <span class="hlFld-ContribAuthor ">Minghui  Zhou</span>, <span class="hlFld-ContribAuthor ">D. Prabhakar  Reddy</span>, <span class="hlFld-ContribAuthor ">Shao-Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Yun  He</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer activity evaluation of novel azacalix[2]arene[2]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 214-225. <a href="https://doi.org/10.1016/j.ejmech.2018.02.079" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.02.079</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.02.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.02.079%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bactivity%252Bevaluation%252Bof%252Bnovel%252Bazacalix%25255B2%25255Darene%25255B2%25255Dpyrimidines%26aulast%3DAddepalli%26aufirst%3DYesu%26date%3D2018%26volume%3D151%26spage%3D214%26epage%3D225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">2-Aminopyrimidines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 237-283. <a href="https://doi.org/10.1002/9781118686263.ch7" title="DOI URL">https://doi.org/10.1002/9781118686263.ch7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118686263.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118686263.ch7%26sid%3Dliteratum%253Aachs%26atitle%3D2-Aminopyrimidines%26date%3D2018%26date%3D2018%26spage%3D237%26epage%3D283%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPrivileged%252BStructures%252Bin%252BDrug%252BDiscovery%26aulast%3DYet%26aufirst%3DLarry%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shinji  Yamazaki</span>, <span class="hlFld-ContribAuthor ">Justine L.  Lam</span>, <span class="hlFld-ContribAuthor ">Ted W.  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Pharmacokinetic-Pharmacodynamic Evaluation of an Orally Available Novel Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase and c-Ros Oncogene 1. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 519-543. <a href="https://doi.org/10.1002/9781119092599.ch18" title="DOI URL">https://doi.org/10.1002/9781119092599.ch18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119092599.ch18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119092599.ch18%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BPharmacokinetic-Pharmacodynamic%252BEvaluation%252Bof%252Ban%252BOrally%252BAvailable%252BNovel%252BMacrocyclic%252BInhibitor%252Bof%252BAnaplastic%252BLymphoma%252BKinase%252Band%252Bc-Ros%252BOncogene%252B1%26aulast%3DYamazaki%26aufirst%3DShinji%26date%3D2017%26date%3D2017%26spage%3D519%26epage%3D543%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPractical%252BMedicinal%252BChemistry%252Bwith%252BMacrocycles%26aulast%3DMarsault%26aufirst%3DEric%26date%3D2017%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sulman  Basit</span>, <span class="hlFld-ContribAuthor ">Zaman  Ashraf</span>, <span class="hlFld-ContribAuthor ">Kwangho  Lee</span>, <span class="hlFld-ContribAuthor ">Muhammad  Latif</span>. </span><span class="cited-content_cbyCitation_article-title">First macrocyclic 3 rd -generation ALK inhibitor for treatment of ALK/ROS1 cancer: Clinical and designing strategy update of lorlatinib. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>134 </em>, 348-356. <a href="https://doi.org/10.1016/j.ejmech.2017.04.032" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.04.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.04.032%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFirst%252Bmacrocyclic%252B3%252Brd%252B-generation%252BALK%252Binhibitor%252Bfor%252Btreatment%252Bof%252BALK%25252FROS1%252Bcancer%25253A%252BClinical%252Band%252Bdesigning%252Bstrategy%252Bupdate%252Bof%252Blorlatinib%26aulast%3DBasit%26aufirst%3DSulman%26date%3D2017%26volume%3D134%26spage%3D348%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niki  Karachaliou</span>, <span class="hlFld-ContribAuthor ">Mariacarmela  Santarpia</span>, <span class="hlFld-ContribAuthor ">Maria  Gonzalez Cao</span>, <span class="hlFld-ContribAuthor ">Cristina  Teixido</span>, <span class="hlFld-ContribAuthor ">Aaron E.  Sosa</span>, <span class="hlFld-ContribAuthor ">Jordi  Berenguer</span>, <span class="hlFld-ContribAuthor ">Alejandra  Rodriguez Capote</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Altavilla</span>, <span class="hlFld-ContribAuthor ">Rafael  Rosell</span>. </span><span class="cited-content_cbyCitation_article-title">Anaplastic lymphoma kinase inhibitors in phase I and phase II clinical trials for non-small cell lung cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2017,</strong> <em>26 </em>
                                    (6)
                                     , 713-722. <a href="https://doi.org/10.1080/13543784.2017.1324572" title="DOI URL">https://doi.org/10.1080/13543784.2017.1324572</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543784.2017.1324572&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543784.2017.1324572%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DAnaplastic%252Blymphoma%252Bkinase%252Binhibitors%252Bin%252Bphase%252BI%252Band%252Bphase%252BII%252Bclinical%252Btrials%252Bfor%252Bnon-small%252Bcell%252Blung%252Bcancer%26aulast%3DKarachaliou%26aufirst%3DNiki%26date%3D2017%26date%3D2017%26volume%3D26%26issue%3D6%26spage%3D713%26epage%3D722" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minlong  Wang</span>, <span class="hlFld-ContribAuthor ">Peng  Rui</span>, <span class="hlFld-ContribAuthor ">Caixiu  Liu</span>, <span class="hlFld-ContribAuthor ">Ying  Du</span>, <span class="hlFld-ContribAuthor ">Peiwen  Qin</span>, <span class="hlFld-ContribAuthor ">Zhiqiu  Qi</span>, <span class="hlFld-ContribAuthor ">Mingshan  Ji</span>, <span class="hlFld-ContribAuthor ">Xinghai  Li</span>, <span class="hlFld-ContribAuthor ">Zining  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Fungicidal Activity of 2-Substituted Phenyl-2-oxo-, 2-Hydroxy- and 2-Acyloxyethylsulfonamides. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (5)
                                     , 738. <a href="https://doi.org/10.3390/molecules22050738" title="DOI URL">https://doi.org/10.3390/molecules22050738</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22050738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22050738%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BFungicidal%252BActivity%252Bof%252B2-Substituted%252BPhenyl-2-oxo-%25252C%252B2-Hydroxy-%252Band%252B2-Acyloxyethylsulfonamides%26aulast%3DWang%26aufirst%3DMinlong%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D5%26spage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew L.  McIver</span>, <span class="hlFld-ContribAuthor ">Weihe  Zhang</span>, <span class="hlFld-ContribAuthor ">Qingyang  Liu</span>, <span class="hlFld-ContribAuthor ">Xinpeng  Jiang</span>, <span class="hlFld-ContribAuthor ">Michael A.  Stashko</span>, <span class="hlFld-ContribAuthor ">James  Nichols</span>, <span class="hlFld-ContribAuthor ">Michael J.  Miley</span>, <span class="hlFld-ContribAuthor ">Jacqueline  Norris-Drouin</span>, <span class="hlFld-ContribAuthor ">Mischa  Machius</span>, <span class="hlFld-ContribAuthor ">Deborah  DeRyckere</span>, <span class="hlFld-ContribAuthor ">Edgar  Wood</span>, <span class="hlFld-ContribAuthor ">Douglas K.  Graham</span>, <span class="hlFld-ContribAuthor ">H. Shelton  Earp</span>, <span class="hlFld-ContribAuthor ">Dmitri  Kireev</span>, <span class="hlFld-ContribAuthor ">Stephen V.  Frye</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Macrocyclic Pyrimidines as MerTK-Specific Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2017,</strong> <em>12 </em>
                                    (3)
                                     , 207-213. <a href="https://doi.org/10.1002/cmdc.201600589" title="DOI URL">https://doi.org/10.1002/cmdc.201600589</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600589&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600589%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDiscovery%252Bof%252BMacrocyclic%252BPyrimidines%252Bas%252BMerTK-Specific%252BInhibitors%26aulast%3DMcIver%26aufirst%3DAndrew%2BL.%26date%3D2017%26date%3D2017%26volume%3D12%26issue%3D3%26spage%3D207%26epage%3D213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Feng  Ma</span>, <span class="hlFld-ContribAuthor ">Hai-Kui  Yang</span>, <span class="hlFld-ContribAuthor ">Meng-Jin  Hu</span>, <span class="hlFld-ContribAuthor ">Qian  Li</span>, <span class="hlFld-ContribAuthor ">Tian-Zhu  Ma</span>, <span class="hlFld-ContribAuthor ">Zhong-Zhen  Zhou</span>, <span class="hlFld-ContribAuthor ">Rui-Yuan  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-Wei  You</span>, <span class="hlFld-ContribAuthor ">Pei-Liang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis and antiproliferative activity of novel 2,4-diaminopyrimidine derivatives bearing piperidine and piperazine moieties. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>84 </em>, 127-134. <a href="https://doi.org/10.1016/j.ejmech.2014.07.017" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.017%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOne-pot%252Bsynthesis%252Band%252Bantiproliferative%252Bactivity%252Bof%252Bnovel%252B2%25252C4-diaminopyrimidine%252Bderivatives%252Bbearing%252Bpiperidine%252Band%252Bpiperazine%252Bmoieties%26aulast%3DMa%26aufirst%3DWei-Feng%26date%3D2014%26volume%3D84%26spage%3D127%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeong In  Yun</span>, <span class="hlFld-ContribAuthor ">Eun Hye  Yang</span>, <span class="hlFld-ContribAuthor ">Muhammad  Latif</span>, <span class="hlFld-ContribAuthor ">Hyeon Ji  Lee</span>, <span class="hlFld-ContribAuthor ">Kwangho  Lee</span>, <span class="hlFld-ContribAuthor ">Chang-Soo  Yun</span>, <span class="hlFld-ContribAuthor ">Chi Hoon  Park</span>, <span class="hlFld-ContribAuthor ">Chong Ock  Lee</span>, <span class="hlFld-ContribAuthor ">Chong Hak  Chae</span>, <span class="hlFld-ContribAuthor ">Sung Yun  Cho</span>, <span class="hlFld-ContribAuthor ">Hee Jung  Jung</span>, <span class="hlFld-ContribAuthor ">Pilho  Kim</span>, <span class="hlFld-ContribAuthor ">Sang Un  Choi</span>, <span class="hlFld-ContribAuthor ">Hyoung Rae  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 2,4-dianilino-5-fluoropyrimidine derivatives possessing ALK inhibitory activities. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2014,</strong> <em>37 </em>
                                    (7)
                                     , 873-881. <a href="https://doi.org/10.1007/s12272-013-0247-7" title="DOI URL">https://doi.org/10.1007/s12272-013-0247-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-013-0247-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-013-0247-7%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DNovel%252B2%25252C4-dianilino-5-fluoropyrimidine%252Bderivatives%252Bpossessing%252BALK%252Binhibitory%252Bactivities%26aulast%3DYun%26aufirst%3DJeong%2BIn%26date%3D2014%26date%3D2013%26volume%3D37%26issue%3D7%26spage%3D873%26epage%3D881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eugen F  Mesaros</span>, <span class="hlFld-ContribAuthor ">Gregory R  Ott</span>, <span class="hlFld-ContribAuthor ">Bruce D  Dorsey</span>. </span><span class="cited-content_cbyCitation_article-title">Anaplastic lymphoma kinase inhibitors as anticancer therapeutics: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (4)
                                     , 417-442. <a href="https://doi.org/10.1517/13543776.2014.877890" title="DOI URL">https://doi.org/10.1517/13543776.2014.877890</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.877890&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.877890%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DAnaplastic%252Blymphoma%252Bkinase%252Binhibitors%252Bas%252Banticancer%252Btherapeutics%25253A%252Ba%252Bpatent%252Breview%26aulast%3DMesaros%26aufirst%3DEugen%2BF%26date%3D2014%26date%3D2014%26volume%3D24%26issue%3D4%26spage%3D417%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandrine  Vendeville</span>, <span class="hlFld-ContribAuthor ">Maxwell D.  Cummings</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Macrocycles in Small-Molecule Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 371-386. <a href="https://doi.org/10.1016/B978-0-12-417150-3.00023-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-417150-3.00023-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417150-3.00023-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417150-3.00023-5%26sid%3Dliteratum%253Aachs%26atitle%3DSynthetic%252BMacrocycles%252Bin%252BSmall-Molecule%252BDrug%252BDiscovery%26aulast%3DVendeville%26aufirst%3DSandrine%26date%3D2013%26spage%3D371%26epage%3D386%26pub%3DElsevier%26date%3D2013%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamie  Mallinson</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>. </span><span class="cited-content_cbyCitation_article-title">Macrocycles in new drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (11)
                                     , 1409-1438. <a href="https://doi.org/10.4155/fmc.12.93" title="DOI URL">https://doi.org/10.4155/fmc.12.93</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.12.93&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.12.93%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DMacrocycles%252Bin%252Bnew%252Bdrug%252Bdiscovery%26aulast%3DMallinson%26aufirst%3DJamie%26date%3D2012%26volume%3D4%26issue%3D11%26spage%3D1409%26epage%3D1438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazutomo  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Nobuhiro  Oikawa</span>, <span class="hlFld-ContribAuthor ">Takuo  Tsukuda</span>. </span><span class="cited-content_cbyCitation_article-title">Anaplastic Lymphoma Kinase Inhibitors for the Treatment of ALK-Positive Cancers. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 281-293. <a href="https://doi.org/10.1016/B978-0-12-396492-2.00019-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-396492-2.00019-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396492-2.00019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396492-2.00019-9%26sid%3Dliteratum%253Aachs%26atitle%3DAnaplastic%252BLymphoma%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BALK-Positive%252BCancers%26aulast%3DKinoshita%26aufirst%3DKazutomo%26date%3D2012%26spage%3D281%26epage%3D293%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B47%26date%3D2012%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith S.  Learn</span>, <span class="hlFld-ContribAuthor ">Jason C.  Wagner</span>, <span class="hlFld-ContribAuthor ">Mark S.  Albom</span>, <span class="hlFld-ContribAuthor ">Thelma S.  Angeles</span>, <span class="hlFld-ContribAuthor ">Zeqi  Huang</span>, <span class="hlFld-ContribAuthor ">Arup K.  Ghose</span>, <span class="hlFld-ContribAuthor ">Weihua  Wan</span>, <span class="hlFld-ContribAuthor ">Mangeng  Cheng</span>, <span class="hlFld-ContribAuthor ">Bruce D.  Dorsey</span>, <span class="hlFld-ContribAuthor ">Gregory R.  Ott</span>. </span><span class="cited-content_cbyCitation_article-title">Design of 7-amino-6-chloro-3H-imidazo[4,5-b]pyridine scaffold from 5-chloro-2,4-diaminopyrimidine pharmacophore: identification of potent inhibitors of anaplastic lymphoma kinase. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2012,</strong> <em>3 </em>
                                    (9)
                                     , 1138. <a href="https://doi.org/10.1039/c2md20061a" title="DOI URL">https://doi.org/10.1039/c2md20061a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2md20061a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2md20061a%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDesign%252Bof%252B7-amino-6-chloro-3H-imidazo%25255B4%25252C5-b%25255Dpyridine%252Bscaffold%252Bfrom%252B5-chloro-2%25252C4-diaminopyrimidine%252Bpharmacophore%25253A%252Bidentification%252Bof%252Bpotent%252Binhibitors%252Bof%252Banaplastic%252Blymphoma%252Bkinase%26aulast%3DLearn%26aufirst%3DKeith%2BS.%26date%3D2012%26volume%3D3%26issue%3D9%26spage%3D1138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0010.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0011.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0012.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Calculated minimum energy conformation of <b>1c</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Stereoview of superimposed, minimum-energy calculated conformations of <b>1c</b> and <b>2g</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0015.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Method A</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0016.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Method B</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0001.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0002.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Method C<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) LiOH, H<sub>2</sub>O, MeOH; (b) EDAC, HOBt, H<sub>2</sub>NMe; (c) diimide.</p></p></figure><figure data-id="sch5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0003.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Method D<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 2-Propanethiol, EtOH, 50 °C, 72 h; (b) mCPBA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 16 h; (c) vinylboronic acid dibutyl ester, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, glyme, H<sub>2</sub>O, 80 °C; (d) Fe, AcOH, THF, 35 °C, 16 h.</p></p></figure><figure data-id="sch6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0004.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Method E<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (CF<sub>3</sub>CO)<sub>2</sub>O, KNO<sub>3</sub>, CH<sub>3</sub>CN; (b) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF; (c) vinylboronic acid dibutyl ester, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, glyme, H<sub>2</sub>O, 90 °C, 16 h; (d) Fe, AcOH, THF, 35 °C, 16 h.</p></p></figure><figure data-id="sch7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0005.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Method F</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/medium/jm-2011-01333e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Glide/XP generated binding mode of compound <b>2m</b> docked in the ALK binding pocket, with the ALK structure retrieved from the PDB (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LCT">3LCT</a>). Only the key residues of the ALK protein were made visible for clarity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-1/jm201333e/production/images/large/jm-2011-01333e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201333e&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i103">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 20 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>American Cancer Society. <a href="http://www.cancer.org" class="extLink">http://www.cancer.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=American+Cancer+Society.+http%3A%2F%2Fwww.cancer.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span> <span class="citation_source-book">CANCER: Principles and Practice of Oncology</span>, <span class="NLM_edition">8</span>th ed.; <span class="NLM_contrib-group">Devita, V. T.,  Jr., Lawrence, T. A., Rosenberg, S. A.</span>, Eds.; <span class="NLM_publisher-name">Lippincott, Williams & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=V.+T.+Devita&author=T.+A.+Lawrence&author=S.+A.+Rosenberg&title=CANCER%3A+Principles+and+Practice+of+Oncology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DCANCER%253A%2520Principles%2520and%2520Practice%2520of%2520Oncology%26aulast%3DDevita%26aufirst%3DV.%2BT.%26pub%3DLippincott%252C%2520Williams%2520%2526%2520Wilkins%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Targeting cancer with small molecule kinase inhibitors</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">28</span><span class="NLM_x">–</span> <span class="NLM_lpage">39</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1038%2Fnrc2559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=19104514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1yg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=28-39&issue=1&author=J.+Zhangauthor=P.+L.+Yangauthor=N.+S.+Gray&title=Targeting+cancer+with+small+molecule+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cancer with small molecule kinase inhibitors</span></div><div class="casAuthors">Zhang, Jianming; Yang, Priscilla L.; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">28-39</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiol. constraints on growth and survival.  To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small mol. inhibitors for a host of other kinases that are implicated in cancer and other diseases.  Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations.  This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriSM3BN_uEz7Vg90H21EOLACvtfcHk0lhQiq07LQ8J2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1yg&md5=35bc38f414cd21eef5e61ce181b580fb</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fnrc2559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2559%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DP.%2BL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DTargeting%2520cancer%2520with%2520small%2520molecule%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26issue%3D1%26spage%3D28%26epage%3D39" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fedorov, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">The (un)targeted cancer kinome</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">169</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1038%2Fnchembio.297" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=20154661" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=166-169&issue=3&author=O.+Fedorovauthor=S.+Muellerauthor=S.+Knapp&title=The+%28un%29targeted+cancer+kinome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">The (un)targeted cancer kinome</span></div><div class="casAuthors">Fedorov, Oleg; Mueller, Susanne; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">166-169</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review and discussion.  The complexity of cancer signaling and the resulting difficulties in target selection have strongly biased kinase drug discovery towards clin. validated targets.  Recently, novel kinase targets that are uncharacterized have emerged from genome sequencing and RNAi studies.  Chem. probes are urgently needed to functionally annotate these kinases and to stimulate new drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwcnq0-qjPirVg90H21EOLACvtfcHk0lhg-2XBWCHGFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGntbk%253D&md5=198ae8d39d40247e17aef5e9de0f2a99</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.297&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.297%26sid%3Dliteratum%253Aachs%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DMueller%26aufirst%3DS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520%2528un%2529targeted%2520cancer%2520kinome%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26issue%3D3%26spage%3D166%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0lhg-2XBWCHGFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lu, K. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jong, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, G. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dia, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloughesy, T. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mischel, P. S.</span><span> </span><span class="NLM_article-title">Differential induction of glioblastoma migration and growth by two forms of pleiotrophin</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">26953</span><span class="NLM_x">–</span> <span class="NLM_lpage">26964</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=26953-26964&author=K.+V.+Luauthor=K.+A.+Jongauthor=G.+Y.+Kimauthor=J.+Singhauthor=E.+Q.+Diaauthor=K.+Yoshimotoauthor=M.+Y.+Wangauthor=T.+F.+Cloughesyauthor=S.+F.+Nelsonauthor=P.+S.+Mischel&title=Differential+induction+of+glioblastoma+migration+and+growth+by+two+forms+of+pleiotrophin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DK.%2BV.%26aulast%3DJong%26aufirst%3DK.%2BA.%26aulast%3DKim%26aufirst%3DG.%2BY.%26aulast%3DSingh%26aufirst%3DJ.%26aulast%3DDia%26aufirst%3DE.%2BQ.%26aulast%3DYoshimoto%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DM.%2BY.%26aulast%3DCloughesy%26aufirst%3DT.%2BF.%26aulast%3DNelson%26aufirst%3DS.%2BF.%26aulast%3DMischel%26aufirst%3DP.%2BS.%26atitle%3DDifferential%2520induction%2520of%2520glioblastoma%2520migration%2520and%2520growth%2520by%2520two%2520forms%2520of%2520pleiotrophin%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D26953%26epage%3D26964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">George, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Froehling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luther, W.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">London, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGrady, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zozulya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregor, V. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A.</span><span> </span><span class="NLM_article-title">Activating mutations in ALK provide a therapeutic target in neuroblastoma</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">455</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=455&publication_year=2008&pages=975-978&author=R.+E.+Georgeauthor=T.+Sandaauthor=M.+Hannaauthor=S.+Froehlingauthor=W.+Lutherauthor=J.+Zhangauthor=Y.+Ahnauthor=W.+Zhouauthor=W.+B.+Londonauthor=P.+McGradyauthor=L.+Xueauthor=S.+Zozulyaauthor=V.+E.+Gregorauthor=T.+R.+Webbauthor=N.+S.+Grayauthor=D.+G.+Gillilandauthor=L.+Dillerauthor=H.+Greulichauthor=S.+W.+Morrisauthor=M.+Meyersonauthor=A.+Look&title=Activating+mutations+in+ALK+provide+a+therapeutic+target+in+neuroblastoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DR.%2BE.%26aulast%3DSanda%26aufirst%3DT.%26aulast%3DHanna%26aufirst%3DM.%26aulast%3DFroehling%26aufirst%3DS.%26aulast%3DLuther%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DW.%26aulast%3DLondon%26aufirst%3DW.%2BB.%26aulast%3DMcGrady%26aufirst%3DP.%26aulast%3DXue%26aufirst%3DL.%26aulast%3DZozulya%26aufirst%3DS.%26aulast%3DGregor%26aufirst%3DV.%2BE.%26aulast%3DWebb%26aufirst%3DT.%2BR.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DDiller%26aufirst%3DL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DLook%26aufirst%3DA.%26atitle%3DActivating%2520mutations%2520in%2520ALK%2520provide%2520a%2520therapeutic%2520target%2520in%2520neuroblastoma%26jtitle%3DNature%26date%3D2008%26volume%3D455%26spage%3D975%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Morris, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirstein, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmer, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saltman, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, A. T.</span><span> </span><span class="NLM_article-title">Fusion of a Kinase Gene, ALK, to a Nucleolar Protein Gene, NPM, in Non-Hodgkin’s Lymphoma</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">263</span><span class="NLM_x">, </span> <span class="NLM_fpage">1281</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=263&publication_year=1994&pages=1281-1284&author=S.+W.+Morrisauthor=M.+N.+Kirsteinauthor=M.+B.+Valentineauthor=K.+G.+Dittmerauthor=D.+N.+Shapiroauthor=D.+L.+Saltmanauthor=A.+T.+Look&title=Fusion+of+a+Kinase+Gene%2C+ALK%2C+to+a+Nucleolar+Protein+Gene%2C+NPM%2C+in+Non-Hodgkin%E2%80%99s+Lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DS.%2BW.%26aulast%3DKirstein%26aufirst%3DM.%2BN.%26aulast%3DValentine%26aufirst%3DM.%2BB.%26aulast%3DDittmer%26aufirst%3DK.%2BG.%26aulast%3DShapiro%26aufirst%3DD.%2BN.%26aulast%3DSaltman%26aufirst%3DD.%2BL.%26aulast%3DLook%26aufirst%3DA.%2BT.%26atitle%3DFusion%2520of%2520a%2520Kinase%2520Gene%252C%2520ALK%252C%2520to%2520a%2520Nucleolar%2520Protein%2520Gene%252C%2520NPM%252C%2520in%2520Non-Hodgkin%25E2%2580%2599s%2520Lymphoma%26jtitle%3DScience%26date%3D1994%26volume%3D263%26spage%3D1281%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Palmer, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernersson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grabbe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallberg, B.</span><span> </span><span class="NLM_article-title">Anaplastic Lymphoma Kinase: Signalling in Development and Disease</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">420</span><span class="NLM_x">, </span> <span class="NLM_fpage">345</span><span class="NLM_x">–</span> <span class="NLM_lpage">361</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=420&publication_year=2009&pages=345-361&author=R.+H.+Palmerauthor=E.+Vernerssonauthor=C.+Grabbeauthor=B.+Hallberg&title=Anaplastic+Lymphoma+Kinase%3A+Signalling+in+Development+and+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalmer%26aufirst%3DR.%2BH.%26aulast%3DVernersson%26aufirst%3DE.%26aulast%3DGrabbe%26aufirst%3DC.%26aulast%3DHallberg%26aufirst%3DB.%26atitle%3DAnaplastic%2520Lymphoma%2520Kinase%253A%2520Signalling%2520in%2520Development%2520and%2520Disease%26jtitle%3DBiochem.%2520J.%26date%3D2009%26volume%3D420%26spage%3D345%26epage%3D361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Soda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, Y. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enomoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, S.-i.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurashina, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bando, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohno, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aburatani, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sohara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mano, H.</span><span> </span><span class="NLM_article-title">Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">448</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1038%2Fnature05945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=17625570" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosVSrtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=448&publication_year=2007&pages=561-566&author=M.+Sodaauthor=Y.+L.+Choiauthor=M.+Enomotoauthor=S.+Takadaauthor=Y.+Yamashitaauthor=S.+Ishikawaauthor=S.-i.+Fujiwaraauthor=H.+Watanabeauthor=K.+Kurashinaauthor=H.+Hatanakaauthor=M.+Bandoauthor=S.+Ohnoauthor=Y.+Ishikawaauthor=H.+Aburataniauthor=T.+Nikiauthor=Y.+Soharaauthor=Y.+Sugiyamaauthor=H.+Mano&title=Identification+of+the+transforming+EML4-ALK+fusion+gene+in+non-small-cell+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer</span></div><div class="casAuthors">Soda, Manabu; Choi, Young Lim; Enomoto, Munehiro; Takada, Shuji; Yamashita, Yoshihiro; Ishikawa, Shunpei; Fujiwara, Shin-ichiro; Watanabe, Hideki; Kurashina, Kentaro; Hatanaka, Hisashi; Bando, Masashi; Ohno, Shoji; Ishikawa, Yuichi; Aburatani, Hiroyuki; Niki, Toshiro; Sohara, Yasunori; Sugiyama, Yukihiko; Mano, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">448</span>
        (<span class="NLM_cas:issue">7153</span>),
    <span class="NLM_cas:pages">561-566</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Improvement in the clin. outcome of lung cancer is likely to be achieved by identification of the mol. events that underlie its pathogenesis.  Here we show that a small inversion within chromosome 2p results in the formation of a fusion gene comprising portions of the echinoderm microtubule-assocd. protein-like 4 (EML4) gene and the anaplastic lymphoma kinase (ALK) gene in non-small-cell lung cancer (NSCLC) cells.  Mouse 3T3 fibroblasts forced to express this human fusion tyrosine kinase generated transformed foci in culture and s.c. tumors in nude mice.  The EML4-ALK fusion transcript was detected in 6.7% (5 out of 75) of NSCLC patients examd.; these individuals were distinct from those harboring mutations in the epidermal growth factor receptor gene.  Our data demonstrate that a subset of NSCLC patients may express a transforming fusion kinase that is a promising candidate for a therapeutic target as well as for a diagnostic mol. marker in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomhAXuLtrJ6rVg90H21EOLACvtfcHk0limOMWfKjNEtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosVSrtrs%253D&md5=7f567e80814b9ccc87e5bceeebb467a7</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1038%2Fnature05945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature05945%26sid%3Dliteratum%253Aachs%26aulast%3DSoda%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DY.%2BL.%26aulast%3DEnomoto%26aufirst%3DM.%26aulast%3DTakada%26aufirst%3DS.%26aulast%3DYamashita%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DS.%26aulast%3DFujiwara%26aufirst%3DS.-i.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DKurashina%26aufirst%3DK.%26aulast%3DHatanaka%26aufirst%3DH.%26aulast%3DBando%26aufirst%3DM.%26aulast%3DOhno%26aufirst%3DS.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DAburatani%26aufirst%3DH.%26aulast%3DNiki%26aufirst%3DT.%26aulast%3DSohara%26aufirst%3DY.%26aulast%3DSugiyama%26aufirst%3DY.%26aulast%3DMano%26aufirst%3DH.%26atitle%3DIdentification%2520of%2520the%2520transforming%2520EML4-ALK%2520fusion%2520gene%2520in%2520non-small-cell%2520lung%2520cancer%26jtitle%3DNature%26date%3D2007%26volume%3D448%26spage%3D561%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koivunen, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zejnullahu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lifshits, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducko, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindeman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcoux, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaenne, P. A.</span><span> </span><span class="NLM_article-title">EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4275</span><span class="NLM_x">–</span> <span class="NLM_lpage">4283</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1158%2F1078-0432.CCR-08-0168" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=18594010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFyks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=4275-4283&author=J.+P.+Koivunenauthor=C.+Mermelauthor=K.+Zejnullahuauthor=C.+Murphyauthor=E.+Lifshitsauthor=A.+J.+Holmesauthor=H.+G.+Choiauthor=J.+Kimauthor=D.+Chiangauthor=R.+Thomasauthor=J.+Leeauthor=W.+G.+Richardsauthor=D.+J.+Sugarbakerauthor=C.+Duckoauthor=N.+Lindemanauthor=J.+P.+Marcouxauthor=J.+A.+Engelmanauthor=N.+S.+Grayauthor=C.+Leeauthor=M.+Meyersonauthor=P.+A.+Jaenne&title=EML4-ALK+fusion+gene+and+efficacy+of+an+ALK+kinase+inhibitor+in+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer</span></div><div class="casAuthors">Koivunen, Jussi P.; Mermel, Craig; Zejnullahu, Kreshnik; Murphy, Carly; Lifshits, Eugene; Holmes, Alison J.; Choi, Hwan Geun; Kim, Jhingook; Chiang, Derek; Thomas, Roman; Lee, Jinseon; Richards, William G.; Sugarbaker, David J.; Ducko, Christopher; Lindeman, Neal; Marcoux, J. Paul; Engelman, Jeffrey A.; Gray, Nathanael S.; Lee, Charles; Meyerson, Matthew; Jaenne, Pasi A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4275-4283</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The EML4-ALK fusion gene has been detected in ∼7% of Japanese non-small cell lung cancers (NSCLC).  We detd. the frequency of EML4-ALK in Caucasian NSCLC and in NSCLC cell lines.  We also detd. whether TAE684, a specific ALK kinase inhibitor, would inhibit the growth of EML4-ALK-contg. cell lines in vitro and in vivo.  We screened 305 primary NSCLC [both U.S. (n = 138) and Korean (n = 167) patients] and 83 NSCLC cell lines using reverse transcription-PCR and by exon array analyses.  We evaluated the efficacy of TAE684 against NSCLC cell lines in vitro and in vivo.  We detected four different variants, including two novel variants, of EML4-ALK using reverse transcription-PCR in 8 of 305 tumors (3%) and 3 of 83 (3.6%) NSCLC cell lines.  All EML4-ALK-contg. tumors and cell lines were adenocarcinomas.  EML4-ALK was detected more frequently in NSCLC patients who were never or light (<10 pack-years) cigarette smokers compared with current/former smokers (6% vs. 1%; P = 0.049).  TAE684 inhibited the growth of one of three (H3122) EML4-ALK-contg. cell lines in vitro and in vivo, inhibited Akt phosphorylation, and caused apoptosis.  In another EML4-ALK cell line, DFCI032, TAE684 was ineffective due to coactivation of epidermal growth factor receptor and ERBB2.  The combination of TAE684 and CL-387,785 (epidermal growth factor receptor/ERBB2 kinase inhibitor) inhibited growth and Akt phosphorylation and led to apoptosis in the DFCI032 cell line.  EML4-ALK is found in the minority of NSCLC.  ALK kinase inhibitors alone or in combination may nevertheless be clin. effective treatments for NSCLC patients whose tumors contain EML4-ALK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOXKywqERg6rVg90H21EOLACvtfcHk0limOMWfKjNEtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFyks7s%253D&md5=6e29703c783e6a29cf77e3c4b93fc15f</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0168&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0168%26sid%3Dliteratum%253Aachs%26aulast%3DKoivunen%26aufirst%3DJ.%2BP.%26aulast%3DMermel%26aufirst%3DC.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DMurphy%26aufirst%3DC.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DHolmes%26aufirst%3DA.%2BJ.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChiang%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26aulast%3DDucko%26aufirst%3DC.%26aulast%3DLindeman%26aufirst%3DN.%26aulast%3DMarcoux%26aufirst%3DJ.%2BP.%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DJaenne%26aufirst%3DP.%2BA.%26atitle%3DEML4-ALK%2520fusion%2520gene%2520and%2520efficacy%2520of%2520an%2520ALK%2520kinase%2520inhibitor%2520in%2520lung%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D4275%26epage%3D4283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Elenitoba-Johnson, K. S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crockett, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schumacher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenson, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rockwood, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, M. S.</span><span> </span><span class="NLM_article-title">Proteomic identification of oncogenic chromosomal translocation partners encoding chimeric anaplastic lymphoma kinase fusion proteins</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">7402</span><span class="NLM_x">–</span> <span class="NLM_lpage">7407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=7402-7407&author=K.+S.+J.+Elenitoba-Johnsonauthor=D.+K.+Crockettauthor=J.+A.+Schumacherauthor=S.+D.+Jensonauthor=C.+M.+Coffinauthor=A.+L.+Rockwoodauthor=M.+S.+Lim&title=Proteomic+identification+of+oncogenic+chromosomal+translocation+partners+encoding+chimeric+anaplastic+lymphoma+kinase+fusion+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElenitoba-Johnson%26aufirst%3DK.%2BS.%2BJ.%26aulast%3DCrockett%26aufirst%3DD.%2BK.%26aulast%3DSchumacher%26aufirst%3DJ.%2BA.%26aulast%3DJenson%26aufirst%3DS.%2BD.%26aulast%3DCoffin%26aufirst%3DC.%2BM.%26aulast%3DRockwood%26aufirst%3DA.%2BL.%26aulast%3DLim%26aufirst%3DM.%2BS.%26atitle%3DProteomic%2520identification%2520of%2520oncogenic%2520chromosomal%2520translocation%2520partners%2520encoding%2520chimeric%2520anaplastic%2520lymphoma%2520kinase%2520fusion%2520proteins%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D7402%26epage%3D7407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Christensen, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span> </span><span class="NLM_article-title">Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3314</span><span class="NLM_x">–</span> <span class="NLM_lpage">3322</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1158%2F1535-7163.MCT-07-0365" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=18089725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=3314-3322&author=J.+G.+Christensenauthor=H.+Y.+Zouauthor=M.+E.+Arangoauthor=Q.+Liauthor=J.+H.+Leeauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=G.+R.+Altonauthor=B.+Mroczkowskiauthor=G.+Los&title=Cytoreductive+antitumor+activity+of+PF-2341066%2C+a+novel+inhibitor+of+anaplastic+lymphoma+kinase+and+c-Met%2C+in+experimental+models+of+anaplastic+large-cell+lymphoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma</span></div><div class="casAuthors">Christensen, James G.; Zou, Helen Y.; Arango, Maria E.; Li, Qiuhua; Lee, Joseph H.; McDonnell, Scott R.; Yamazaki, Shinji; Alton, Gordon R.; Mroczkowski, Barbara; Los, Gerrit</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">3314-3322</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A t(2;5) chromosomal translocation resulting in expression of an oncogenic kinase fusion protein known as nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) has been implicated in the pathogenesis of anaplastic large-cell lymphoma (ALCL).  PF-2341066 was recently identified as a p.o. bioavailable, small-mol. inhibitor of the catalytic activity of c-Met kinase and the NPM-ALK fusion protein.  PF-2341066 also potently inhibited NPM-ALK phosphorylation in Karpas299 or SU-DHL-1 ALCL cells (mean IC50 value, 24 nmol/L).  In biochem. and cellular screens, PF-2341066 was shown to be selective for c-Met and ALK at pharmacol. relevant concns. across a panel of >120 diverse kinases.  PF-2341066 potently inhibited cell proliferation, which was assocd. with G1-S-phase cell cycle arrest and induction of apoptosis in ALK-pos. ALCL cells (IC50 values, ∼30 nmol/L) but not ALK-neg. lymphoma cells.  The induction of apoptosis was confirmed using terminal deoxyribonucleotide transferase-mediated nick-end labeling and Annexin V staining (IC50 values, 25-50 nmol/L).  P.o. administration of PF-2341066 to severe combined immunodeficient-Beige mice bearing Karpas299 ALCL tumor xenografts resulted in dose-dependent antitumor efficacy with complete regression of all tumors at the 100 mg/kg/d dose within 15 days of initial compd. administration.  A strong correlation was obsd. between antitumor response and inhibition of NPM-ALK phosphorylation and induction of apoptosis in tumor tissue.  In addn., inhibition of key NPM-ALK signaling mediators, including phospholipase C-γ, signal transducers and activators of transcription 3, extracellular signal-regulated kinases, and Akt by PF-2341066 were obsd. at concns. or dose levels, which correlated with inhibition of NPM-ALK phosphorylation and function.  Collectively, these data illustrate the potential clin. utility of inhibitors of NPM-ALK in treatment of patients with ALK-pos. ALCL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptqY0tUwGnurVg90H21EOLACvtfcHk0ljYErMcGbWqOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCjsrrL&md5=04fbbaf43ca527408bde8cabcd38e1fd</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-0365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-0365%26sid%3Dliteratum%253Aachs%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DAlton%26aufirst%3DG.%2BR.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DLos%26aufirst%3DG.%26atitle%3DCytoreductive%2520antitumor%2520activity%2520of%2520PF-2341066%252C%2520a%2520novel%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520and%2520c-Met%252C%2520in%2520experimental%2520models%2520of%2520anaplastic%2520large-cell%2520lymphoma%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2007%26volume%3D6%26spage%3D3314%26epage%3D3322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonnell, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, P.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nambu, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Los, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bender, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mroczkowski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christensen, J. G.</span><span> </span><span class="NLM_article-title">An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">4408</span><span class="NLM_x">–</span> <span class="NLM_lpage">4417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1158%2F0008-5472.CAN-06-4443" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=17483355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=4408-4417&author=H.+Y.+Zouauthor=Q.+Liauthor=J.+H.+Leeauthor=M.+E.+Arangoauthor=S.+R.+McDonnellauthor=S.+Yamazakiauthor=T.+B.+Koudriakovaauthor=G.+Altonauthor=J.+J.+Cuiauthor=P.-P.+Kungauthor=M.+D.+Nambuauthor=G.+Losauthor=S.+L.+Benderauthor=B.+Mroczkowskiauthor=J.+G.+Christensen&title=An+orally+available+small-molecule+inhibitor+of+c-Met%2C+PF-2341066%2C+exhibits+cytoreductive+antitumor+efficacy+through+antiproliferative+and+antiangiogenic+mechanisms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Exhibits Cytoreductive Antitumor Efficacy through Antiproliferative and Antiangiogenic Mechanisms</span></div><div class="casAuthors">Zou, Helen Y.; Li, Qiuhua; Lee, Joseph H.; Arango, Maria E.; McDonnell, Scott R.; Yamazaki, Shinji; Koudriakova, Tatiana B.; Alton, Gordon; Cui, Jingrong J.; Kung, Pei-Pei; Nambu, Mitchell D.; Los, Gerrit; Bender, Steven L.; Mroczkowski, Barbara; Christensen, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4408-4417</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The c-Met receptor tyrosine kinase and its ligand, hepatocyte growth factor (HGF), have been implicated in the progression of several human cancers and are attractive therapeutic targets.  PF-2341066 was identified as a potent, orally bioavailable, ATP-competitive small-mol. inhibitor of the catalytic activity of c-Met kinase.  PF-2341066 was selective for c-Met (and anaplastic lymphoma kinase) compared with a panel of >120 diverse tyrosine and serine-threonine kinases.  PF-2341066 potently inhibited c-Met phosphorylation and c-Met-dependent proliferation, migration, or invasion of human tumor cells in vitro (IC50 values, 5-20 nmol/L).  In addn., PF-2341066 potently inhibited HGF-stimulated endothelial cell survival or invasion and serum-stimulated tubulogenesis in vitro, suggesting that this agent also exhibits antiangiogenic properties.  PF-2341066 showed efficacy at well-tolerated doses, including marked cytoreductive antitumor activity, in several tumor models that expressed activated c-Met.  The antitumor efficacy of PF-2341066 was dose dependent and showed a strong correlation to inhibition of c-Met phosphorylation in vivo.  Near-maximal inhibition of c-Met activity for the full dosing interval was necessary to maximize the efficacy of PF-2341066.  Addnl. mechanism-of-action studies showed dose-dependent inhibition of c-Met-dependent signal transduction, tumor cell proliferation (Ki67), induction of apoptosis (caspase-3), and redn. of microvessel d. (CD31).  These results indicated that the antitumor activity of PF-2341066 may be mediated by direct effects on tumor cell growth or survival as well as antiangiogenic mechanisms.  Collectively, these results show the therapeutic potential of targeting c-Met with selective small-mol. inhibitors for the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEAWtGPOBHC7Vg90H21EOLACvtfcHk0ljYErMcGbWqOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltVyrsbg%253D&md5=798bf93e6cf8d5e9897e27485cba9002</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-06-4443&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-06-4443%26sid%3Dliteratum%253Aachs%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DMcDonnell%26aufirst%3DS.%2BR.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DKoudriakova%26aufirst%3DT.%2BB.%26aulast%3DAlton%26aufirst%3DG.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DNambu%26aufirst%3DM.%2BD.%26aulast%3DLos%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%2BL.%26aulast%3DMroczkowski%26aufirst%3DB.%26aulast%3DChristensen%26aufirst%3DJ.%2BG.%26atitle%3DAn%2520orally%2520available%2520small-molecule%2520inhibitor%2520of%2520c-Met%252C%2520PF-2341066%252C%2520exhibits%2520cytoreductive%2520antitumor%2520efficacy%2520through%2520antiproliferative%2520and%2520antiangiogenic%2520mechanisms%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D4408%26epage%3D4417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span> An Investigational Drug, PF-02341066 Is Being Studied versus Standard of Care in Patients with Advanced Non-Small Cell Lung Cancer with a Specific Gene Profile Involving the Anaplastic Lymphoma Kinase (ALK) Gene. <a href="http://www.clinicaltrials.gov/ct2/show/NCT00932893" class="extLink">http://www.clinicaltrials.gov/ct2/show/NCT00932893</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+An+Investigational+Drug%2C+PF-02341066+Is+Being+Studied+versus+Standard+of+Care+in+Patients+with+Advanced+Non-Small+Cell+Lung+Cancer+with+a+Specific+Gene+Profile+Involving+the+Anaplastic+Lymphoma+Kinase+%28ALK%29+Gene.+http%3A%2F%2Fwww.clinicaltrials.gov%2Fct2%2Fshow%2FNCT00932893."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Milkiewicz, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G. R.</span><span> </span><span class="NLM_article-title">Inhibitors of anaplastic lymphoma kinase: a patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1653</span><span class="NLM_x">–</span> <span class="NLM_lpage">1681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1517%2F13543776.2010.527332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Fjm201333e&amp;key=20961208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1653-1681&issue=12&author=K.+L.+Milkiewiczauthor=G.+R.+Ott&title=Inhibitors+of+anaplastic+lymphoma+kinase%3A+a+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of anaplastic lymphoma kinase: a patent review</span></div><div class="casAuthors">Milkiewicz, Karen L.; Ott, Gregory R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1653-1681</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase that belongs to the insulin receptor superfamily.  Aberrant ALK activity has been implicated in the oncogenesis of human cancers as a fusion protein in anaplastic large cell lymphoma, inflammatory myofibroblastic tumor, diffuse large B-cell lymphoma, systemic histiocytosis and NSCLC or through mutations in the full length protein in hereditary familial neuroblastoma.  Thus, abrogation of ALK signaling through direct kinase inhibition has become an attractive therapeutic intervention point for a subset of genetically defined human cancers.  Areas covered in this review: This manuscript provides a comprehensive review of the patent literature pertaining to ALK inhibitors and outlines their potential as anticancer therapeutic agents.  What the reader will gain: The reader will gain an understanding of the major structural classes of ALK inhibitors and insights into the future of this class of drugs.  Take home message: Multiple small-mol. ALK inhibitors have been reported with diverse chem. architecture, potency, kinase selectivity profiles and activity against potential resistance.  The breadth of inhibitors combined with the recent discoveries of the involvement of ALK in lung, breast and colorectal cancers has kept the field advancing at a rapid pace.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocXB5-B6Du8LVg90H21EOLACvtfcHk0ljYErMcGbWqOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7bF&md5=32d9d90cf43bba8dfef6385e6494cc0a</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.527332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.527332%26sid%3Dliteratum%253Aachs%26aulast%3DMilkiewicz%26aufirst%3DK.%2BL.%26aulast%3DOtt%26aufirst%3DG.%2BR.%26atitle%3DInhibitors%2520of%2520anaplastic%2520lymphoma%2520kinase%253A%2520a%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26issue%3D12%26spage%3D1653%26epage%3D1681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mesaros, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrish, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugan, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anzalone, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albom, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aimone, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quail, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ator, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ott, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorsey, B. D.</span><span> </span><span class="NLM_article-title">Novel 2,3,4,5-tetrahydro-benzo[<i>d</i>]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=463-466&issue=6&author=E.+F.+Mesarosauthor=J.+P.+Burkeauthor=J.+D.+Parrishauthor=B.+J.+Duganauthor=A.+V.+Anzaloneauthor=T.+S.+Angelesauthor=M.+S.+Albomauthor=L.+D.+Aimoneauthor=M.+R.+Quailauthor=W.+Wanauthor=L.+Luauthor=Z.+Huangauthor=M.+A.+Atorauthor=B.+A.+Ruggeriauthor=M.+Chengauthor=G.+R.+Ottauthor=B.+D.+Dorsey&title=Novel+2%2C3%2C4%2C5-tetrahydro-benzo%5Bd%5Dazepine+derivatives+of+2%2C4-diaminopyrimidine%2C+selective+and+orally+bioavailable+ALK+inhibitors+with+antitumor+efficacy+in+ALCL+mouse+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMesaros%26aufirst%3DE.%2BF.%26aulast%3DBurke%26aufirst%3DJ.%2BP.%26aulast%3DParrish%26aufirst%3DJ.%2BD.%26aulast%3DDugan%26aufirst%3DB.%2BJ.%26aulast%3DAnzalone%26aufirst%3DA.%2BV.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DQuail%26aufirst%3DM.%2BR.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DNovel%25202%252C3%252C4%252C5-tetrahydro-benzo%255Bd%255Dazepine%2520derivatives%2520of%25202%252C4-diaminopyrimidine%252C%2520selective%2520and%2520orally%2520bioavailable%2520ALK%2520inhibitors%2520with%2520antitumor%2520efficacy%2520in%2520ALCL%2520mouse%2520models%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D6%26spage%3D463%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marsault, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, M. L.</span><span> </span><span class="NLM_article-title">Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2004</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1012374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=1961-2004&author=E.+Marsaultauthor=M.+L.+Peterson&title=Macrocycles+are+great+cycles%3A+applications%2C+opportunities%2C+and+challenges+of+synthetic+macrocycles+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery</span></div><div class="casAuthors">Marsault, Eric; Peterson, Mark L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1961-2004</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Macrocycles occupy a unique segment of chem. space.  In the past decade, their chem. diversity expanded significantly, supported by advances in bioinformatics and synthetic methodol.  As a consequence, this structural type has now been successfully tested on most biol. target classes.  The goal of this article is to put into perspective the current applications, opportunities, and challenges assocd. with synthetic macrocycles in drug discovery.  Accordingly, the first part of this article is dedicated to the drug discovery aspects of macrocycles and highlights salient features of their medicinal chem.  This section is organized by target class, a choice aimed at providing the reader an appreciation of the structural diversity generated for each class.  To give the reader an appreciation of the tools available to construct macrocyclic scaffolds, the site and method of the pivotal macrocyclization step are indicated in the figures.  Readers are referred to the source articles for further details.  In the second part, the technologies and synthetic approaches that already have demonstrated utility or possess a high potential for macrocycle-based drug discovery are discussed.  Finally, a perspective on the future of synthetic macrocycles in medicinal chem. is offered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrygQLE6JraHrVg90H21EOLACvtfcHk0liRlCQHsUngYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVSjtbo%253D&md5=97c1120896e90a85790a9ac1274259f3</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1021%2Fjm1012374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1012374%26sid%3Dliteratum%253Aachs%26aulast%3DMarsault%26aufirst%3DE.%26aulast%3DPeterson%26aufirst%3DM.%2BL.%26atitle%3DMacrocycles%2520are%2520great%2520cycles%253A%2520applications%252C%2520opportunities%252C%2520and%2520challenges%2520of%2520synthetic%2520macrocycles%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D1961%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Williams, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A.C.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaraj, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaraman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasha, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethirajulu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span> </span><span class="NLM_article-title">Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4638</span><span class="NLM_x">–</span> <span class="NLM_lpage">4658</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4638-4658&author=A.+D.+Williamsauthor=A.C.-H.+Leeauthor=S.+Blanchardauthor=A.+Poulsenauthor=E.+L.+Teoauthor=H.+Nagarajauthor=E.+Tanauthor=D.+Chenauthor=M.+Williamsauthor=E.+T.+Sunauthor=K.+C.+Gohauthor=W.+C.+Ongauthor=S.+K.+Gohauthor=S.+Hartauthor=R.+Jayaramanauthor=M.+K.+Pashaauthor=K.+Ethirajuluauthor=J.+M.+Woodauthor=B.+W.+Dymock&title=Discovery+of+the+macrocycle+11-%282-pyrrolidin-1-yl-ethoxy%29-14%2C19-dioxa-5%2C7%2C26-triaza-tetracyclo%5B19.3.1.1%282%2C6%29.1%288%2C12%29%5Dheptacosa-1%2825%29%2C2%2826%29%2C3%2C5%2C8%2C10%2C12%2827%29%2C16%2C21%2C23-decaene+%28SB1518%29%2C+a+potent+Janus+kinase+2%2FFms-like+tyrosine+kinase-3+%28JAK2%2FFLT3%29+inhibitor+for+the+treatment+of+myelofibrosis+and+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DA.C.-H.%26aulast%3DBlanchard%26aufirst%3DS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DTeo%26aufirst%3DE.%2BL.%26aulast%3DNagaraj%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DE.%2BT.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DOng%26aufirst%3DW.%2BC.%26aulast%3DGoh%26aufirst%3DS.%2BK.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DPasha%26aufirst%3DM.%2BK.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DDiscovery%2520of%2520the%2520macrocycle%252011-%25282-pyrrolidin-1-yl-ethoxy%2529-14%252C19-dioxa-5%252C7%252C26-triaza-tetracyclo%255B19.3.1.1%25282%252C6%2529.1%25288%252C12%2529%255Dheptacosa-1%252825%2529%252C2%252826%2529%252C3%252C5%252C8%252C10%252C12%252827%2529%252C16%252C21%252C23-decaene%2520%2528SB1518%2529%252C%2520a%2520potent%2520Janus%2520kinase%25202%252FFms-like%2520tyrosine%2520kinase-3%2520%2528JAK2%252FFLT3%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520myelofibrosis%2520and%2520lymphoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4638%26epage%3D4658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Driggers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terrett, N. K.</span><span> </span><span class="NLM_article-title">The exploration of macrocycles for drug discovery—an underexploited structural class</span> <span class="citation_source-journal">Nat. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">608</span><span class="NLM_x">–</span> <span class="NLM_lpage">624</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm201333e&amp;key=10.1038%2Fnrd2590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnvFShsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=608-624&author=E.+M.+Driggersauthor=S.+P.+Haleauthor=J.+Leeauthor=N.+K.+Terrett&title=The+exploration+of+macrocycles+for+drug+discovery%E2%80%94an+underexploited+structural+class"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">The exploration of macrocycles for drug discovery - an underexploited structural class</span></div><div class="casAuthors">Driggers, Edward M.; Hale, Stephen P.; Lee, Jinbo; Terrett, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">608-624</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Natural products comprised of a macrocycle ring structure have proven their therapeutic applications as antibiotics, immunosuppressants as well as anticancer agents.  Despite this, macrocyclic compds. remain under-explored.  Terrett and colleagues review the properties and features of current macrocycle drugs, emphasizing the vast potential of synthetic macrocycles in drug discovery.  Macrocyclic natural products have evolved to fulfil numerous biochem. functions, and their profound pharmacol. properties have led to their development as drugs.  A macrocycle provides diverse functionality and stereochem. complexity in a conformationally pre-organized ring structure.  This can result in high affinity and selectivity for protein targets, while preserving sufficient bioavailability to reach intracellular locations.  Despite these valuable characteristics, and the proven success of more than 100 marketed macrocycle drugs derived from natural products, this structural class has been poorly explored within drug discovery.  This is in part due to concerns about synthetic intractability and non-drug-like properties.  This Review describes the growing body of data in favor of macrocyclic therapeutics, and demonstrates that this class of compds. can be both fully drug-like in its properties and readily prepd. owing to recent advances in synthetic medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDtW8LpE4ru7Vg90H21EOLACvtfcHk0liRlCQHsUngYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnvFShsbc%253D&md5=16e091818053e5b163b81078a8d03094</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1038%2Fnrd2590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2590%26sid%3Dliteratum%253Aachs%26aulast%3DDriggers%26aufirst%3DE.%2BM.%26aulast%3DHale%26aufirst%3DS.%2BP.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DTerrett%26aufirst%3DN.%2BK.%26atitle%3DThe%2520exploration%2520of%2520macrocycles%2520for%2520drug%2520discovery%25E2%2580%2594an%2520underexploited%2520structural%2520class%26jtitle%3DNat.%2520Rev.%26date%3D2008%26volume%3D7%26spage%3D608%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Freyne, E. J. E.; Willems, M.; Embrechts, W. C. J.; Van Emelen, K.; Van Brandt, S. F. A.; Rombouts, F. J. R.</span><span> </span><span class="NLM_article-title">2,4 (4,6) Pyrimidine Derivatives</span>. WO 2006061415, June 15,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=E.+J.+E.+Freyne&author=M.+Willems&author=W.+C.+J.+Embrechts&author=K.+Van+Emelen&author=S.+F.+A.+Van+Brandt&author=F.+J.+R.+Rombouts&title=2%2C4+%284%2C6%29+Pyrimidine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFreyne%26aufirst%3DE.%2BJ.%2BE.%26atitle%3D2%252C4%2520%25284%252C6%2529%2520Pyrimidine%2520Derivatives%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Bossi, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccardo, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menichincheri, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orsini, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardi Borgia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nesi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandiera, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogliatto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, J. A.</span><span> </span><span class="NLM_article-title">Crystal structures of anaplastic lymphoma kinase in complex with ATP-competitive inhibitors</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">32</span><span class="NLM_x">) </span> <span class="NLM_fpage">6813</span><span class="NLM_x">–</span> <span class="NLM_lpage">6825</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi1005514" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2010&pages=6813-6825&issue=32&author=R.+T.+Bossiauthor=M.+B.+Saccardoauthor=E.+Ardiniauthor=M.+Menichincheriauthor=L.+Rusconiauthor=P.+Magnaghiauthor=P.+Orsiniauthor=N.+Avanziauthor=A.+Lombardi+Borgiaauthor=M.+Nesiauthor=T.+Bandieraauthor=G.+Fogliattoauthor=J.+A.+Bertrand&title=Crystal+structures+of+anaplastic+lymphoma+kinase+in+complex+with+ATP-competitive+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fbi1005514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi1005514%26sid%3Dliteratum%253Aachs%26aulast%3DBossi%26aufirst%3DR.%2BT.%26aulast%3DSaccardo%26aufirst%3DM.%2BB.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DOrsini%26aufirst%3DP.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DLombardi%2BBorgia%26aufirst%3DA.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DBandiera%26aufirst%3DT.%26aulast%3DFogliatto%26aufirst%3DG.%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26atitle%3DCrystal%2520structures%2520of%2520anaplastic%2520lymphoma%2520kinase%2520in%2520complex%2520with%2520ATP-competitive%2520inhibitors%26jtitle%3DBiochemistry%26date%3D2010%26volume%3D49%26issue%3D32%26spage%3D6813%26epage%3D6825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Combs, A. P.; Sparks, R. B.; Yue, E. W.; Feng, H.; Bower, M. J.; Zhu, W.</span><span> </span><span class="NLM_article-title">Macrocyclic Compounds as Kinase Inhibitors and Their Preparation, Pharmaceutical Compositions and Their Use in the Treatment of JAK/ALK-Associated Diseases</span>. WO 2009132202, October 29,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+P.+Combs&author=R.+B.+Sparks&author=E.+W.+Yue&author=H.+Feng&author=M.+J.+Bower&author=W.+Zhu&title=Macrocyclic+Compounds+as+Kinase+Inhibitors+and+Their+Preparation%2C+Pharmaceutical+Compositions+and+Their+Use+in+the+Treatment+of+JAK%2FALK-Associated+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCombs%26aufirst%3DA.%2BP.%26atitle%3DMacrocyclic%2520Compounds%2520as%2520Kinase%2520Inhibitors%2520and%2520Their%2520Preparation%252C%2520Pharmaceutical%2520Compositions%2520and%2520Their%2520Use%2520in%2520the%2520Treatment%2520of%2520JAK%252FALK-Associated%2520Diseases%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Mulvihill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, Q.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coate, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foreman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenfeld-Franklin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulvihill, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nigro, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pirrit, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinig, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolz, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavares, P. A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, N. W.</span><span> </span><span class="NLM_article-title">Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-<i>a</i>]pyrazines as potent insulin-like growth factor (IGF-IR) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1359</span><span class="NLM_x">–</span> <span class="NLM_lpage">1375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=1359-1375&author=M.+J.+Mulvihillauthor=Q.-S.+Jiauthor=H.+R.+Coateauthor=A.+Cookeauthor=H.+Dongauthor=L.+Fengauthor=K.+Foremanauthor=M.+Rosenfeld-Franklinauthor=A.+Hondaauthor=G.+Makauthor=K.+M.+Mulvihillauthor=A.+L.+Nigroauthor=M.+O%E2%80%99Connorauthor=C.+Pirritauthor=A.+G.+Steinigauthor=K.+Siuauthor=K.+M.+Stolzauthor=Y.+Sunauthor=P.+A.+R.+Tavaresauthor=Y.+Yaoauthor=N.+W.+Gibson&title=Novel+2-phenylquinolin-7-yl-derived+imidazo%5B1%2C5-a%5Dpyrazines+as+potent+insulin-like+growth+factor+%28IGF-IR%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMulvihill%26aufirst%3DM.%2BJ.%26aulast%3DJi%26aufirst%3DQ.-S.%26aulast%3DCoate%26aufirst%3DH.%2BR.%26aulast%3DCooke%26aufirst%3DA.%26aulast%3DDong%26aufirst%3DH.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DForeman%26aufirst%3DK.%26aulast%3DRosenfeld-Franklin%26aufirst%3DM.%26aulast%3DHonda%26aufirst%3DA.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DMulvihill%26aufirst%3DK.%2BM.%26aulast%3DNigro%26aufirst%3DA.%2BL.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DM.%26aulast%3DPirrit%26aufirst%3DC.%26aulast%3DSteinig%26aufirst%3DA.%2BG.%26aulast%3DSiu%26aufirst%3DK.%26aulast%3DStolz%26aufirst%3DK.%2BM.%26aulast%3DSun%26aufirst%3DY.%26aulast%3DTavares%26aufirst%3DP.%2BA.%2BR.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26atitle%3DNovel%25202-phenylquinolin-7-yl-derived%2520imidazo%255B1%252C5-a%255Dpyrazines%2520as%2520potent%2520insulin-like%2520growth%2520factor%2520%2528IGF-IR%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D1359%26epage%3D1375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Lee, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambing, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hua, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michellys, P. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lesley, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spraggon, G.</span><span> </span><span class="NLM_article-title">Crystal structure of the anaplastic lymphoma kinase (Alk) catalytic domain</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">430</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2010&pages=425-437&author=C.+C.+Leeauthor=Y.+Jiaauthor=N.+Liauthor=X.+Sunauthor=K.+Ngauthor=E.+Ambingauthor=M.+Y.+Gaoauthor=S.+Huaauthor=C.+Chenauthor=S.+Kimauthor=P.+Y.+Michellysauthor=S.+A.+Lesleyauthor=J.+Harrisauthor=G.+Spraggon&title=Crystal+structure+of+the+anaplastic+lymphoma+kinase+%28Alk%29+catalytic+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DC.%2BC.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DNg%26aufirst%3DK.%26aulast%3DAmbing%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DM.%2BY.%26aulast%3DHua%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DKim%26aufirst%3DS.%26aulast%3DMichellys%26aufirst%3DP.%2BY.%26aulast%3DLesley%26aufirst%3DS.%2BA.%26aulast%3DHarris%26aufirst%3DJ.%26aulast%3DSpraggon%26aufirst%3DG.%26atitle%3DCrystal%2520structure%2520of%2520the%2520anaplastic%2520lymphoma%2520kinase%2520%2528Alk%2529%2520catalytic%2520domain%26jtitle%3DBiochem.%2520J.%26date%3D2010%26volume%3D430%26spage%3D425%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5149</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800475y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201333e&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5149-5171&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=D.+A.+Pippinauthor=J.+M.+Salvinoauthor=J.+P.+Mallamo&title=Knowledge+based+prediction+of+ligand+binding+modes+and+rational+inhibitor+design+for+kinase+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Knowledge Based Prediction of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery</span></div><div class="casAuthors">Ghose, Arup K.; Herbertz, Torsten; Pippin, Douglas A.; Salvino, Joseph M.; Mallamo, John P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5149-5171</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review describing the use of Protein Data Bank (PDB) entries specifically for kinase inhibitor drug discovery.  Topics discussed include: the current state of structure-aided ligand design, kinase structure queries and extn. from the PDB, alignment of protein structures, structural classification of ligands, anal. of ligands and binding modes, and ligand design strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDINDYVE15cbVg90H21EOLACvtfcHk0lgu6kljAdT9Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmurnM&md5=a1afc4d6c7f6fa4dd6aa9da8d78f1ee3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Fjm800475y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800475y%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge%2520based%2520prediction%2520of%2520ligand%2520binding%2520modes%2520and%2520rational%2520inhibitor%2520design%2520for%2520kinase%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5149%26epage%3D5171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Beruben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Normant, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Platzer, N.</span><span> </span><span class="NLM_article-title">Stereodefined substituted cyclopropyl zinc reagents from gem-bismetallics</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2488</span><span class="NLM_x">–</span> <span class="NLM_lpage">2501</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00113a032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=2488-2501&author=D.+Berubenauthor=I.+Marekauthor=J.+F.+Normantauthor=N.+Platzer&title=Stereodefined+substituted+cyclopropyl+zinc+reagents+from+gem-bismetallics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1021%2Fjo00113a032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00113a032%26sid%3Dliteratum%253Aachs%26aulast%3DBeruben%26aufirst%3DD.%26aulast%3DMarek%26aufirst%3DI.%26aulast%3DNormant%26aufirst%3DJ.%2BF.%26aulast%3DPlatzer%26aufirst%3DN.%26atitle%3DStereodefined%2520substituted%2520cyclopropyl%2520zinc%2520reagents%2520from%2520gem-bismetallics%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D2488%26epage%3D2501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hamersma, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, E. I.</span><span> </span><span class="NLM_article-title">Diimide reductions using potassium azodicarboxylate</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3985</span><span class="NLM_x">–</span> <span class="NLM_lpage">3988</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01022a532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1965&pages=3985-3988&author=J.+W.+Hamersmaauthor=E.+I.+Snyder&title=Diimide+reductions+using+potassium+azodicarboxylate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1021%2Fjo01022a532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01022a532%26sid%3Dliteratum%253Aachs%26aulast%3DHamersma%26aufirst%3DJ.%2BW.%26aulast%3DSnyder%26aufirst%3DE.%2BI.%26atitle%3DDiimide%2520reductions%2520using%2520potassium%2520azodicarboxylate%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1965%26volume%3D30%26spage%3D3985%26epage%3D3988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Angeles, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartlett, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hudkins, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephens, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaplan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionne, C. A.</span><span> </span><span class="NLM_article-title">Enzyme-linked immunosorbent assay for trkA tyrosine kinase activity</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=1996&pages=49-55&issue=1&author=T.+S.+Angelesauthor=C.+Stefflerauthor=B.+A.+Bartlettauthor=R.+L.+Hudkinsauthor=R.+M.+Stephensauthor=D.+R.+Kaplanauthor=C.+A.+Dionne&title=Enzyme-linked+immunosorbent+assay+for+trkA+tyrosine+kinase+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DSteffler%26aufirst%3DC.%26aulast%3DBartlett%26aufirst%3DB.%2BA.%26aulast%3DHudkins%26aufirst%3DR.%2BL.%26aulast%3DStephens%26aufirst%3DR.%2BM.%26aulast%3DKaplan%26aufirst%3DD.%2BR.%26aulast%3DDionne%26aufirst%3DC.%2BA.%26atitle%3DEnzyme-linked%2520immunosorbent%2520assay%2520for%2520trkA%2520tyrosine%2520kinase%2520activity%26jtitle%3DAnal.%2520Biochem.%26date%3D1996%26volume%3D236%26issue%3D1%26spage%3D49%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Rotin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolis, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohammadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daum, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ullrich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlessinger, J.</span><span> </span><span class="NLM_article-title">SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase Cγ</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">559</span><span class="NLM_x">–</span> <span class="NLM_lpage">567</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1992&pages=559-567&issue=2&author=D.+Rotinauthor=B.+Margolisauthor=M.+Mohammadiauthor=R.+J.+Dalyauthor=G.+Daumauthor=N.+Liauthor=E.+H.+Fischerauthor=W.+H.+Burgessauthor=A.+Ullrichauthor=J.+Schlessinger&title=SH2+domains+prevent+tyrosine+dephosphorylation+of+the+EGF+receptor%3A+identification+of+Tyr992+as+the+high-affinity+binding+site+for+SH2+domains+of+phospholipase+C%CE%B3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRotin%26aufirst%3DD.%26aulast%3DMargolis%26aufirst%3DB.%26aulast%3DMohammadi%26aufirst%3DM.%26aulast%3DDaly%26aufirst%3DR.%2BJ.%26aulast%3DDaum%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DFischer%26aufirst%3DE.%2BH.%26aulast%3DBurgess%26aufirst%3DW.%2BH.%26aulast%3DUllrich%26aufirst%3DA.%26aulast%3DSchlessinger%26aufirst%3DJ.%26atitle%3DSH2%2520domains%2520prevent%2520tyrosine%2520dephosphorylation%2520of%2520the%2520EGF%2520receptor%253A%2520identification%2520of%2520Tyr992%2520as%2520the%2520high-affinity%2520binding%2520site%2520for%2520SH2%2520domains%2520of%2520phospholipase%2520C%25CE%25B3%26jtitle%3DEMBO%2520J.%26date%3D1992%26volume%3D11%26issue%3D2%26spage%3D559%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XB7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2XB7','PDB','2XB7'); return false;">PDB: 2XB7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LCT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3LCT','PDB','3LCT'); return false;">PDB: 3LCT</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201333e&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm201333e%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-1%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201333e" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6798f3a95a6021e5","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
